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In this thesis, we investigated the role of NEAT1 in stress, cancer, and autophagy in breast 
cancer. In paper I, we studied NEAT1 in oxidative stress and heat shock. In the heat shock 
response, HSF1 translocates into the nucleus in order to activate its target gene, and we 
discovered a novel binding site for HSF1 in the promoter of NEAT1. The expression of NEAT1, 
as well as paraspeckle formation, were induced by both SFN and heat shock. The study further 
displayed that the proliferation of breast cancer cells is highly dependent on NEAT1 expression, 
in line with what previous studies have shown. In paper II, we have continued to study NEAT1 
in breast cancer tumors and also breast cancer cell lines. From analyses of four different breast 
cancer cohorts, we found that NEAT1_2 expression was positively correlated with HER2-
positive breast cancer tumor, whereas, it was negatively associated with ER-positive luminal A 
breast cancer. Interestingly, high levels of NEAT1_2 was observed in lactating tissue as well as 
in breast tissue of a pregnant female. As repeatedly reported, NEAT1 expression resulted in 
chemoresistance, and we also showed that NEAT1_2-depletion increased apoptosis in HER2-
positive breast cancer cells, when treated with the dual HER2 and EGFR inhibitor lapatinib. 
Finally, according to the results in paper I, we hypothesized that NEAT1 might affect the 
autophagy in breast cancer cell line. Therefore, we decided to investigate the role of this 
lncRNA in autophagy in paper III. Interestingly, our data revealed that NEAT1-depletion induce 
basal autophagy in breast cancer cell lines. Further, the results suggesting a role for NEAT1 in 
normal functionality of lysosome in cancer cells. Finally, we illustrated that the induction of 
autophagy was regulated by AMPK, but not mTOR. Activated AMPK bypasses mTOR and 
activates Ulk1 in our model.  
The introduction is divided into three main sections focused on present knowledge on NEAT1, 
heat shock response, and autophagy. A short description of breast cancer will be given, also 
providing an overview of the different subtypes. In the methodology section, we will discuss 
the logic behind the chosen method as well as their limitations and advantages. Finally, the 
main conclusions from the thesis will be further discussed according to the current knowledge 




























AD Activation domains  
ADARB2  Adenosine Deaminase, RNA Specific B2 
AKT Protein kinase B 
Ambra1  Activating molecule in Beclin-1-regulated autophagy 
AMPK AMP-activated protein kinase 
AR Androgen receptor 
ASO Antisence oligo 
ATF2 Activating transcription factor 2 
ATG AuTophaGy-related genes 
ATP7A ATPase Copper Transporting Alpha 
ATP7B ATPase Copper Transporting Beta 
ATRA All-trans retinoic acid 
Baf A1 Bafilomycin A1 
BCL2 Apoptosis Regulator Bcl-2 
BECN1  Beclin 1 
BRCA1 Breast Cancer Type 1 Susceptibility Protein 
CARM1 Coactivator-associated arginine methyltransferase 1 
CDK5R1 Cyclin dependent kinase 5 regulatory subunit 1  
CFIm Cleavage factor Im 
CMA Chaperone-mediated autophagy  
CNS Central nervous system  
CRPC Castrate-resistant prostate cancer 
DBD DNA-binding domain 
EMT Epithelial-mesenchymal transition 
ER Estrogen receptor 
FFPE Formalin-fixed paraffin-embedded 
FIP200 Focal adhesion kinase family interacting protein 200 kDa 
FOXN3 Forkhead Box N3 
FYCO1  FYVE and coiled-coil domain containing 1 
GABARAP Gamma-aminobutyric receptor-associated protein 
GATA3 GATA Binding Protein 3 
GATE16 Golgi-associated ATPase enhancer of 16 kDa  
HER2/ERBB2 Human epidermal growth factor receptor 2  
HIF-2α Hypoxia-Inducible Factor 2 Alpha 
HNRNPK Heterogeneous nuclear ribonucleoprotein K 
HOPS Homotypic fusion and protein sorting 
HOPS  Homotypic fusion and protein sorting 
HR Heptad repeat  
Hsc70 Heat shock cognate protein of 70kDa  
Hsc70 Heat shock cognate 71 kDa protein 
HSE Heat shock elements  
HSF Heat shock transcription factor 
HSP Heat shock protein 
HSR Heat shock response 
IL-8 Interleukin 8 
IRAlu Inverted repeated Alu element 
JNK C-Jun N-terminal kinases 
 10 
Ki-67  Proliferation-Related Ki-67 Antigen 
LAMP-2A Lysosome-associated membrane protein type 2A  
LC3B Microtubule-associated protein 1 light chain 3 
LLPS Liquid-liquid phase separation 
LNA Locked nucleic acid  
lncRNA Long non-coding RNA  
miRNA Micro RNA 
ncRNA Non-coding RNA 
NEAT1 Nuclear paraspeckle assembly transcript 1  
NF-κB Nuclear Factor Kappa B Subunit 1 
NONO POU domain-containing octamer-binding protein 
p53 Tumor protein p53 




PIK3C3/Vps34 Class III PIK3  
PLEKHM1  Pleckstrin Homology And RUN Domain Containing M1 
PN Proteostasis network 
poly I:C Polyinosinic:polycytidylic acid 
PR Progesterone receptor 
PSP1 Paraspeckle protein 1  
PTEN Phosphatase And Tensin Homolog 
PTM Post-translational modification 
Rab7a Ras-Related Protein Rab-7a 
RBP RNA-binding protein 
RD Regulatory domain  
RISC RNA-induced silencing complex 
RNP Ribonucleoprotein 
rRNA Ribosomal RNA  
SFPQ Splicing factor proline and glutamine-rich  
SIN3A  SIN3 Transcription Regulator Family Member A 
siRNA Small interfering RNA 
SM Smooth muscle 
SNARE Soluble N-ethylmaleimide-sensitive fusion (NSF) attachment protein 
SRF Serum response factor 
STK11/LKB1  Serine/Threonine Kinase 11 
TDP-43 TAR DNA-Binding Protein 43  
TLR3 Poll-like receptor 3  
TMA Tissue microarray 
TNBC Triple-negative breast cancers 
tRNA Transfer RNA 
ULK1 Unc-51 like kinase 1  
UVRAG UV irradiation resistance-associated gene 
VMP1  Vacuole membrane protein-1 
VPS Vacuolar protein sorting 
VSMC Vascular smooth muscle cells 
WDR5 Transcriptional co-activator WD repeat domain 5 




The human genome project and ENCyclopedia of DNA Elements (ENCODE) have provided a 
tremendous amount of information about the human genome and its complexity1. It is now well 
known that more than 85% of the human genome is transcribed, even though only 2% of the 
human genome encodes for proteins2. These comprehensive studies have shown that the 
number of protein-coding genes is very similar from nematodes to humans3, and that there is a 
direct correlation between the percentage of intron and non-coding RNAs (ncRNAs) with 
developmental complexity of species4. Accordingly, there is strong evidence that development 
in higher eukaryotes is under the control of RNAs signals4. Intergenic sequences are a large 
part of the human genome and for many years they were thought of as “junk DNA” as no 
functions had been discovered for these regions. However, today it is now clear that intergenic 
regions contain important functional elements, as well as ncRNA genes2.  
NcRNAs are RNA transcripts that do not code for proteins5, and they are implicated in a variety 
of biological functions. These RNA species have been found to control gene expression by 
regulating transcription, mRNA stability, and translation. Moreover, ncRNAs are involved in 
DNA synthesis and repair,  genome rearrangement, and cellular architecture and protein 
complexes6–8. NcRNAs are divided into two groups; small (20-200 nucleotides long) and long 
ncRNAs (longer than 200 nucleotides). Small ncRNAs include ribosomal RNA (rRNA), 
transfer RNA (tRNA), microRNAs (miRNAs), small interfering RNAs (siRNAs), small nuclear 
RNAs (snRNA), small nucleolar RNAs (snoRNA), and Piwi-interacting RNAs (piRNAs)5.  
LONG NON-CODING RNA  
Long non-coding RNAs (LncRNAs) have little or no coding potential9. They are mostly 
transcribed by RNA polymerase II and processed by 5´capping, polyadenylation, and splicing9. 
LncRNAs loci are often in close association with protein-coding genes, where they can be 
located intronic or exonic in either the sense or antisense orientation10. However, some of the 
lncRNAs are transcribed from intergenic regions2. Most lncRNAs are expressed at a lower 
levels than protein-coding genes, and many of them have a tissue-specific expression pattern11. 
LncRNAs have slightly longer exons than protein-coding genes, but they generally contain 
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fewer exons. For this reason, most of them are shorter in length in comparison to protein-coding 
genes12,13. 
LncRNAs are less conserved in evolution than the protein-coding gens14. The lesser conserved 
sequence may reflect that lncRNAs function are more dependent on higher-order structures 
than specific nucleotide sequences. Complementary base pairing or secondary structure of 
lncRNAs enable them to associate with DNA, RNA, and proteins to exert their functions15,16. 
Furthermore, lncRNAs can be localized in both the nucleus and the cytosol, where they can 
regulate gene expression at different levels17,18.  
LncRNAs are commonly classified according to their genomic location relative to protein-
coding genes and DNA regulatory elements19. The method is commonly used by 
GENCODE/Ensembl portal for annotation of new transcripts. Based on location, lncRNAs can 
be mainly divided into (Fig.1)13,20:  
1. Intergenic lncRNA/lincRNA: A ncRNA transcribed from a genomic region that does 
not cross any annotated genes.  
2. Exonic sense lncRNA: A ncRNA transcribed from in the sense direction of a protein-
coding gene and overlaps with one or more exons. 
3. Exonic antisense lncRNA: A ncRNA transcribed in the antisense direction of protein-
coding genes and overlaps with one or more exons. 
4. Intronic lncRNA: A ncRNA that resides inside an intron of a protein-coding gene, 
either in the sense or antisense direction, and terminates without overlapping any of 
the exons.  
5. Bidirectional transcript: A ncRNA that shares the same promoter as a protein-coding 
gene, but is transcribed in the opposite direction. The distance between the transcription 
start site of the ncRNA and the start site of the protein-coding gene should be less than 
1kb. 
LncRNAs can also be classified based on their function. According to this, lncRNAs can behave 
as a16,19: 
1) Scaffolding RNA that helps the assembly of a ribonucleoprotein (RNP) complex at a 
specific site21.  
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2) Guide RNA that physically binds to specific chromatin-regulatory complexes and 
guides them to specific chromatin loci. 
3) Ribo-activator that enhances protein activity. 
4) Ribo-repressor and RNA decoy that inhibits/minimizes protein activity by induction of 
allosteric modifications, inhibition of catalytic activity, and/or blocking protein binding 
sites. 
5) Competing endogenous RNA/RNA sponge that can remove miRNAs from their original 
targets. These lncRNAs are commonly pseudogenes or circular RNAs containing the 
complementary sequences for specific miRNAs.  
 
 
Nuclear enriched abundant transcript 1/Nuclear paraspeckle assembly transcript 1 
(NEAT1) 
Nuclear Enriched Abundant Transcript 1 (NEAT1), now more commonly referred to as nuclear 
paraspeckle assembly transcript 1, was discovered by Hutchinson et al. in 200722. NEAT1 is 
located on chromosome 11q13.1 and transcribed from the familial tumor syndrome multiple 
endocrine neoplasia (MEN) type 1 loci. The NEAT1 gene encodes two transcripts: NEAT1_1 
(3.7kb) and NEAT1_2 (22.3kb). Both isoforms share the same promoter and NEAT1_1 overlaps 
FIGURE 1. Classification of long non-coding RNAs. LncRNAs are classified into five 
groups: Sense, antisense, intronic, bidirectional, and intergenic. LncRNAs are shown as 






with the 5´ end of NEAT1_223. The NEAT1_1 isoform becomes polyadenylated, while a tRNA-
like structure forms at the 3´ end of NEAT1_2 that is subsequently cleaved by RNase P and 
stabilized through the formation of a triple helix structure24,25 (Fig. 2). The NEAT1_2 isoform 
forms when the polyadenylation signal in NEAT1_1 is suppressed. Heterogeneous nuclear 
ribonucleoprotein K (HNRNPK) has been shown to play a key role in this process by binding 
to Cleavage factor Im (CFIm) in a manner that outcompetes its binding to 3´ processing factors, 
and thereby inhibits cleavage and polyadenylation of NEAT1_1 allowing production of 
NEAT1_2 in cells26,27.  
 
NEAT1 is the fundamental RNA component of paraspeckles 
NEAT1_2 is essential for the formation of punctuated sub-nuclear structures called 
paraspeckles27,28. Paraspeckles are found in interchromosomal regions in the proximity of 
nuclear speckles, and they are nuclear RNA-protein complexes with the potential to regulate 
gene expression. Architectural NEAT1_2 associates with more than forty proteins to form 
paraspeckles29,30 (Table 1). Some of these proteins associate with each other in RNA-dependent 
manners such as Non-POU domain-containing octamer-binding protein 
(P54nrb/NONO), paraspeckle protein 1 (PSP1), and splicing factor proline and glutamine-rich 
(SFPQ)31. Paraspeckles have a core-shell spheroidal structure and are highly dynamic. A subset 
FIGURE 2. Schematic illustration of the NEAT1 locus. NEAT1 gene locus is located 
on chromosome 11q13.1. The NEAT1 locus encodes two overlapping isoforms: NEAT1_1 
of 3.7 kb and NEAT1_2 of 22.3 kb. NEAT1_1 is polyadenylated, whereas NEAT1_2 is 





of paraspeckle proteins (PSP) can fuse to/diffuse from paraspeckles dependent on cellular 
circumstances32. Many paraspeckle proteins contain prion-like domains, low complexity 
domains, intrinsically disordered regions, and coiled-coil domains (Table 1). Due to these 
features, they drive liquid-liquid phase separation (LLPS) to form paraspeckles as a liquid drop-
like membraneless organelle32,33. Two of the essential PSPs, fused in sarcoma (FUS) and RNA 
binding protein 14 (RBM14) seem to have a particular important role in phase separation as 
they readily form so-called hydrogels in vitro34,35. Depletion of NEAT1_2 showed that 
NEAT1_1 could form numerous non-paraspeckle structures in the vicinity of nuclear speckle, 
termed “microspeckles”, which may serve as a platform for a paraspeckle-independent function 
of NEAT1_136. Paraspeckles are seen in mammalian nuclei and most cultured cells, and also in 
some mammalian tissues like the tip of gut epithelium in mice28. Paraspeckles are absent in 
embryonic stem cells, but appear upon differentiation28,37. The number and the size of 
paraspeckles are cell-dependent; for example, HeLa cells have 13-17 paraspeckles per nucleus, 
while the number of paraspeckles in NIH3T3 is between 5-10 per nucleus23.  
The presence of some proteins is essential for the structure of paraspeckles such as NONO, 
SFPQ, HNRNPH3, HNRNPK, DAZAP1, FUS, RBM14, and HNRNPH327. NONO, SFPQ, and 
PSPC1 are the most studied paraspeckle proteins containing a common domain structure which 
has two RNA recognition motifs. Paraspeckles have an organized structure in which proteins 
and RNAs are arranged at specific sites. Immunohistochemistry analysis has shown that 
NONO, SFPQ, FUS, and PSPC1 are located in the core of the paraspeckle and RBM14 and 
BRG1 form small patches found both in the core and in the outer shell area. The 5´ and 3´ ends 
of NEAT1_2 are localized close to each other in the outer shell of the paraspeckles, whereas the 
middle part of NEAT1_2 is located in the core of the paraspeckle38. Paraspeckle proteins and 







 Table 1. Paraspeckle proteins 








1 HNRNPK Essential    27 
2 NONO Essential +   Core 29,31,8 
3 RBM14 Essential + + Patch 29,39 
4 SFPQ Essential +   Core 31,8,40,39,41 
5 DAZAP1 Essential +   27 
6 FUS Essential + + Core 27 
7 HNRNPH3 Essential +   27 
8 BRG1 Essential NO   Patch 42 
9 CPSF7 Important for paraspeckle integrity NO   27 
10 FAM98A Important for paraspeckle integrity +     27 
11 FAM113A Important for paraspeckle integrity    27 
12 FIGN Important for paraspeckle integrity +     27 
13 HNRNPA1 Important for paraspeckle integrity + +  27 
14 HNRNPR Important for paraspeckle integrity +     27 
15 HNRNPUL1 Important for paraspeckle integrity +   27 
16 RBM12 Important for paraspeckle integrity +     27 
17 TAF15 Important for paraspeckle integrity +   27 
18 SRSF10 Important for paraspeckle integrity NO     27 
19 ENOX1 Involved in paraspeckle formation    43 
20 FAM53B Involved in paraspeckle formation       43 
21 HECTD3 Involved in paraspeckle formation    43 




Inhibition of RNA polymerase II 
causes redistribution of paraspeckle 
components 
   44 
24 ANNEXIN A10 Overexpression reduces paraspeckle       45 
25 CPSF6 Dispensable NO   46 
26 NUDT21/CPSF5 Dispensable       27 
27 UBAP2L Dispensable +   27 
28 AHDC1 Dispensable NO     27 
29 AKAP8L Dispensable +   27 
30 CIRBP Dispensable NO     27 
31 EWSR1 Dispensable +   27 
32 PSPC1 Dispensable +   Core 29,39 
33 RBM3 Dispensable +   27 
34 RBM7 Dispensable NO     27 
35 RBMX Dispensable    27 
36 RUNX3 Dispensable +     27 
37 ZC3H6 Dispensable    27 
38 ZNF335 Dispensable       27 
39 CYBA Dispensable    43 
40 FAM53A Dispensable       43 
41 GATA1 Dispensable    43 
42 KIAA1683 Dispensable       43 
43 KLF4 Dispensable    43 
44 LMNB2 Dispensable       43 
45 SCYL1 Dispensable    43 
46 SH2B1 Dispensable       43 
47 SRSF11 Dispensable    43 
48 XIAP Dispensable       43 
49 ZNF444 Dispensable    43 
50 RBM4B Dispensable NO     27 
51 TDP-43 n.d +  Shell 27 
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52 BCL6 n.d       47 
53 BCL11A n.d    47 
54 CELF6 n.d NO     27 
55 CHMP6 n.d    43 
56 DLX3 n.d +     27 
57 HNRNPA1L2 n.d +   27 
58 HNRNPF n.d       27 
59 HNRNPH1 n.d +   27,39,41 
60 HNRNPM n.d       48 
61 KIAA1530 n.d    43 
62 MEX3C n.d       27 
63 SOX9 n.d    49 
64 SS18L1 n.d +     27 
65 v-FOS n.d    43 
66 WTX n.d       50 
67 WT1 (+KTS) n.d    51 
68 MEX3A n.d NO     27 
 
 
NEAT1 expression and paraspeckle formation are induced by cellular stress 
Increased expression of NEAT1 and elevated paraspeckle formation have been observed in 
many stress-induced situations like viral infection, hypoxia, proteasome inhibition, and 
oncogene-induced replication stress (Fig. 3)52–59. Emerging evidence suggests that NEAT1 has 
a cytoprotective role in cells since NEAT1-depleted cells are more sensitive to stress-induced 
cell death than wild type cells55.  
One of the first reports on NEAT1 being upregulated by cellular stress came in 2014 by Tetsuro 
Hirose et al55. They showed that NEAT1 levels increased in cells treated with the proteasome 
inhibitor MG-132. This was accompanied by a change in the morphology of the paraspeckles 
to become more elongated. The authors presented evidence that this upregulation was due to 
increased transcription of the NEAT1 gene55. This study was followed by a study by Choudry 
et al.59 showing that NEAT1 and paraspeckle formation were induced in breast cancer cells upon 
hypoxia. This was indeed shown to be due to transcriptional upregulation of the NEAT1 by 
Hypoxia-Inducible Factor 2 Alpha (HIF-2α).  In these papers, NEAT1-depleted cells were 
shown to be more sensitive to proteasome inhibition and hypoxia, respectively, than wild type 
cells. Recently, NEAT1 was shown to be a transcriptional target of tumor protein p53 (p53), the 
key guardian of the genome in mammalian cells which is activated by a variety of cellular 
stressors known to induce the DNA damage response (DDR)60,61. Importantly, NEAT1-depleted 
cells accumulated DNA damage and displayed replication stress and were more sensitive to 
Abbreviations: n.d, not determined27,30,354. 
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chemotherapy. A very recent study uncovered a cross-talk between mitochondria and 
NEAT1/paraspeckles62. Mitochondria generally sense internal and external stressors and sustain 
cell homeostasis by regulating energy production and intracellular signaling62. Mitochondrial 
stress induced NEAT1 transcription and the formation of elongated paraspeckles in a 
mechanism that was dependent on activating transcription factor 2 (ATF2) binding to the 
NEAT1 promoter. Furthermore, the presence of NEAT1 was vital for the normal function of 
mitochondria, as knockout of NEAT1 in HeLa cells resulted in a reduction in mitochondrial 
DNA content, impaired mitochondrial respiration, and reduced ATP production63.  Finally, 
NEAT1 has also been shown to be transcriptionally activated by Nuclear Factor Kappa B 
Subunit 1 (NF-κB) as in response to lipopolysaccharide stimulation of lung adenocarcinoma 
cells64. Taken together, all these reports show that NEAT1 is upregulated upon cellular stress 
by transcriptional activation mediated by key stress-induced transcription factors including 
HIF-2α, p53, ATF2, and NF-κB. (Fig. 3). 
NEAT1 expression is induced in cells in response to infections by a series of viruses and several 
lines of evidence suggests that NEAT1 plays a critical role in the innate immune response 
against viral infection52,54,57,58,65–69. Stimulation of cells by polyinosinic:polycytidylic acid (poly 
I:C) that mimics a dsRNA virus infection, induced NEAT1 expression through the toll-like 
receptor 3 (TLR3)52. Microarray analysis showed that NEAT1 is involved in the regulation of 
antiviral genes since depletion of NEAT1 reduced the expression of more than 250 poly I:C-
inducible genes in HeLa cells52.   
NEAT1 and paraspeckles regulate gene expression at different levels  
Even though the functions of NEAT1 and paraspeckles are not fully understood, several studies 
have shown that they can regulate the expression of specific genes at both transcriptional and 
post-transcriptional levels.  
Transcriptional regulation of gene expression by NEAT1 
Paraspeckles are dynamic structures, and elevated NEAT1 expression is associated with 
enhanced recruitment of proteins into paraspeckles52,55. Many of the paraspeckle-associated 
proteins have diverse functions in the nucleus. One such protein is SFPQ that also works as a 
transcriptional regulator. When NEAT1 levels increase, more SFPQ is recruited to the 
paraspeckles and thus the levels in the nucleoplasm decrease. This sequestration removes SFPQ 
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from the promoters of its target genes.  This is exemplified by the interleukin 8 (IL-8) gene52. 
In normal conditions, SFPQ binds to the promoter region and represses the transcription of IL-
8. Stimulation of cells with poly I:C increases NEAT1 expression and paraspeckle formation 
that subsequently relocates SFPQ from the IL-8 promoter allowing transcription of the IL-8 
gene52. SFPQ can also work as a transcriptional activator55. This has been demonstrated for the 
gene encoding the RNA-editing enzyme adenosine deaminase, RNA specific B2 (ADARB2). 
The elongation of paraspeckles upon proteasome inhibition sequesters SFPQ away from 
ADARB2 promoter, and thereby represses ADARB2 expression55. Enhanced NEAT1 
expression during neointima in vascular smooth muscle cells has also been shown to sequester 
the transcriptional co-activator WD repeat domain 5 (WDR5) away from its target genes70 (see 
below). 
The above-mentioned examples demonstrate an indirect role of NEAT1 in gene regulation 
through SFPQ or WDR5. It has, however, been reported that NEAT1 also binds directly close 
to the transcriptional start sites of active genes and influence their transcriptional activity71. 
Chakravarty et al. showed that NEAT1_1 can interact with chromatin via histone H3 and that 
this interaction is associated with the formation of active chromatin as measured by increased 
levels of H3K4Me3 and H3AcK9. This suggests that NEAT1_1 can change the epigenetic 
landscape of target gene promoter to regulate gene expression72.  
FIGURE 3. Cellular stress leads to increased paraspeckle 








Post-transcriptional regulation of gene expression by NEAT1 
Several reports have shown that NEAT1 and paraspeckles have an important role in the 
regulation of cytoplasmic export of certain mRNAs37,40. This was first described for mRNAs 
containing inverted repeated Alu elements (IRAlus) in their 3´ untranslated regions. The 
presence of IRAlus leads to the formation of double-stranded RNA regions subjected to 
adenosine to inosine editing. IRALus-containing mRNAs are recruited to paraspeckles upon 
specific cellular circumstances through direct interaction with NONO. This prevents their 
export to the cytoplasm and thus their translation into proteins37,40. Interestingly, upon 
mitochondrial stress and dysfunction, many nuclear-encoded mitochondrial mRNAs are 
retained in paraspeckles. This indicates that NEAT1 and paraspeckles play a regulatory role in 
mitochondrial biogenensis63. The formation of paraspeckles has been shown to follow a 
circadian rhythm in pituitary cells, leading to rhythmical retention of a range of mRNAs73.  The 
retention of mRNAs in the nucleus is opposed by coactivator-associated arginine 
methyltransferase 1 (CARM1). CARM1 methylates NONO that decreases its ability to bind to 
mRNAs containing 3´UTR IRAlus. CARM1 also reduces paraspeckle formation by suppressing 
NEAT1 at the transcriptional level74,75. 
Recently, it has been suggested that NEAT1 and paraspeckles facilitate the maturation of 
miRNAs. The NONO-SFPQ heterodimer was found to bind to a large group of pri-miRNAs 
and accelerate their processing into pre-miRNA in the nucleus. Furthermore, an interaction 
between NEAT1 and the Drosha–DGCR8 microprocessor was demonstrated. The authors 
proposed a “bird nest model” in which NEAT1 provides the cells with a platform to facilitate 
the processing of the pri-miRNAs to pre-miRNAs, eventually generally increasing the overall 
number of mature miRNAs in the cells76. NEAT1 has also been suggested to act as a so-called 
competing endogenous RNA sponging a whole series of miRNAs (reviewed in Klec et al)77. 
However, how a nuclear RNA sponges miRNAs is not well described, and therefore further 
experiments should be undertaken to prove that this is a true regulatory mechanism of NEAT1 
in vivo. 
Biological functions of NEAT1 and paraspeckles 
As mentioned above, increased NEAT1 expression and paraspeckles formation are induced by 
a variety of cellular stressors. Several lines of evidence also suggest that NEAT1 can regulate 
gene expression at different levels. Soon after its discovery, it became clear that NEAT1 is not 
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vital for the development of mammalians since Neat1-knockout mice can survive under normal 
conditions28. In line with this, human embryonic stem cells in culture do not express NEAT137. 
This suggests that NEAT1 has specific functions at certain biological circumstances. It has now 
been demonstrated that NEAT1 has a critical role in the development of the mammary gland78. 
Virgin Neat1-knockout mice display defect ductal outgrowth and branching during puberty. 
Furthermore, during pregnancy, lactation was severely compromised in NEAT1-depleted mice 
due to reduced proliferation of milk-producing luminal alveolar epithelial cells78. A subset of 
Neat1-knockout female mice developed impaired corpus luteum, the transient secretory gland 
in female ovaries79. Corpus luteum development is one of the critical steps in gestation and 
secretion of progesterone. The formation of corpus luteum is essential for the establishment and 
maintenance of pregnancy. Consequently, Neat1-knockout mice become pregnant less 
frequently than wild-type mice79. 
Recently, Neat1 and NONO were found to be vital for the establishment of embryonic and 
extra-embryonic lineages at a very early stage of mouse embryonic development. 
Microinjection of Neat1 antisense oligos at the 2-cell stage resulted in a developmental arrest 
at either the 16- (52.46% of embryos) or 32 cells (26.3% of embryos) stage.  This is partially 
caused by lack of paraspeckle recruitment of CARM1, which critically interfered with its ability 
to methylate histone H3 at arginine 26 (H3R26me2), causing an imbalance between cells 
destined to develop into embryonic and extra-embryonic tissue.   
It has recently been shown that NEAT1 is upregulated when vascular smooth muscle cells 
(VSMCs) switch from a contractile to a proliferative phenotype upon vascular injury, a process 
referred to as neointima70. This switch is associated with a profound change in the gene 
expression pattern where smooth muscle (SM)-specific genes are downregulated. The authors 
showed that knockdown of NEAT1 enhanced the expression of SM-specific genes by a 
mechanism involving the transcriptional co-activator WD repeat domain 5 (WDR5). WDR5 
stimulates the transcription of SM-genes by creating an active chromatin state that allows serum 
response factor (SRF) to bind to their promoters. The authors demonstrated that upon 
neointima, WDR5 is sequestered in nuclear structures believed to be paraspeckles, preventing 
its association with promoters of SM-specific genes. Importantly, in response to carotid artery 
ligation, neointima was severely compromised in Neat1-knockout mice70. Finally, it has been 
shown that NEAT1 has a pivotal role in myeloid differentiation, as knockdown of NEAT1 
inhibits all-trans retinoic acid (ATRA)-induce differentiation80. Taken together, many lines of 
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evidence suggest that NEAT1 has specific functions at certain developmental stages, cell 
differentiation, and under cellular stress, and it orchestrates changes in gene expression patterns 
both at the transcriptional and post-transcriptional levels. 
NEAT1 is abnormally expressed in cancer 
As described above, NEAT1 is believed to have an important role in cell survival upon cellular 
stress, including genotoxic stress and hypoxia that are prominent in cancer cells. In 2014, 
Chakravarty et al. reported that NEAT1 is upregulated and associated with poor prognosis in 
prostate cancer. This was followed by a study by Choudhry et al. showing that NEAT1 is 
overexpressed in hypoxic regions of breast cancer cell line xenografts and associated with poor 
clinical outcome of breast cancer. Now, NEAT1 has been found to be upregulated in tumor cells 
compared to normal cells in a series of human cancers including lung cancer, hepatocellular 
carcinoma, ovarian cancer, nasopharyngeal carcinoma, gastric cancer, osteosarcoma, 
glioblastoma, oral and esophageal carcinoma, clear cell renal carcinoma, and cervical 
carcinoma81–90. In most cases, high NEAT1 expression is associated with aggressive disease. 
Moreover, a large number of mutations in the NEAT1 sequence are frequently observed in 
hepatocellular carcinoma, prostate cancer, stomach cancer, lung adenocarcinoma, breast 
cancer, and B cell lymphoma91,92. A deep sequencing study of the promoter and regulatory 
elements in 360 breast cancer samples identified mutational hotspots in the core promoter of 
NEAT193. Interestingly, the majority of these mutations are associated with decreased 
expression in vitro. In the same study, NEAT1 was found to be focally deleted in 8% of the 
samples93. NEAT1 expression was also reduced in peripheral blood samples from patients 
suffering from acute promyelotic leukemia compared to samples from healthy donors94. Taken 
together, although enhanced NEAT1 expression is mostly associated with tumor cells and 
aggressive disease, it might also have a protective role depending on the type of cancer and 
cancer stage. This already has been demonstrated in two different cancer models in mice. Neat1 
knockout mice are less prone to develop squamous cell carcinoma in a two-stage DMBA-TPA 
skin carcinogenesis model56.  On the other hand, knockout of Neat1 in RasG12D genetic model, 
promoted the development of premalignant pancreatic intraepithelial neoplasia. This suggests 
that NEAT1 can also act as a tumor suppressor, preventing the development of pancreatic 
cancer95.  
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NEAT1 expression is associated with resistance to cancer therapy 
Aforementioned, high level of NEAT1 is associated with tumor progression and poor survival, 
just as its role in chemoresistance has been shown in several studies56,72,96–106. The expression 
level of NEAT1_2 correlates with response to chemotherapy, as higher expression of NEAT1_2 
conversely associates with progression-free survival in ovarian cancer patients who underwent 
platinum-based chemotherapy56. Targeting NEAT1_2 has also been shown to sensitize cancer 
cells to chemotherapy reagent such as poly (ADP-ribose) polymerase (PARP) inhibitors, ABT-
88856. Moreover, it has been shown that NEAT1 knockdown suppressed P-glycoprotein (cell 
membrane protein that pumps drugs out of the cell) and GST-π (involved in drug metabolism) 
level in paclitaxel-resistant ovarian cancer cells resulting in higher sensitivity to paclitaxel107. 
Furthermore, NEAT1 expression result in drug resistance in breast cancer. The breast cancer 
cell lines MCF7 and MDA-MB-231 became sensitized to Fluorouracil (5-FU) upon 
downregulation of NEAT1108. The analysis of triple negative breast cancer cell line illustrated 
that NEAT1 expression increased in cisplatin/taxol treated cancer cells, and targeting NEAT1 in 
combination with cisplatin/taxol treatment had a synergistic effect to inhibit cell growth97. 
Moreover, RT-qPCR data revealed that drug transporter, ATP7A and ATP7B were 
downregulated in NEAT1 knockdown cell97. The role of NEAT1 in the reduction of cisplatin-
sensitivity was also showed in osteosarcoma105. 
ERα-NEAT1 signaling promotes prostate cancer progression both in the androgen receptor 
(AR)-positive and AR-negative cell lines72. Although both ERα and AR antagonists (4-hydroxy 
tamoxifen and Enzalutamide, respectively) constrained NEAT1, longer treatment of prostate 
cancer cells by these drugs resulted in NEAT1 induction.  Consistently, NEAT1 and ERα were 
higher in castrate-resistant prostate cancer (CRPC) suggesting a role for NEAT1 in therapeutic 
resistance in prostate cancer72. Furthermore, targeting NEAT1 in docetaxel-resistant prostate 
cancer cell line increased the sensitivity of these cells to docetaxel98.  
NEAT1 in breast cancer 
Neat1 knockout mice are viable. However as mentioned above, they display impaired 
mammary gland development both in puberty and in pregnancy/lactation. Given this, it is 
reasonable to assume that NEAT1 could have a role in breast cancer. Indeed, the expression of 
NEAT1 is critical for proliferation and survival of breast cancer cell lines59,79,109–111. NEAT1 is 
also upregulated in breast tumor samples compared to adjacent normal tissue, and is associated 
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with poor clinical outcome59,109,112,113. NEAT1 is regulated by estrogen both in prostate and 
breast cancer cell lines72,114. In estrogen receptor positive (ER+) breast cancer cell line, NEAT1 
is responsible for the interaction between  FOXN3 and SIN3A114. The FOXN3-NEAT1-SIN3A 
complex promotes epithelial-mesenchymal transition (EMT) by repressing the expression of 
GATA binding protein 3 (GATA3). This promotes metastasis in vivo114. Another study showed 
that BRCA1 represses NEAT1 transcription115. BRCA1 mutations are well-known genetic 
causes of hereditary breast cancer and plays a pivotal role in the development of the mammary 
gland115. Deficiency of BRCA1 increases expression of NEAT1 and promotes tumorigenicity 
both in vivo and in vitro96.  
NEAT1 in neurodegenerative diseases 
Neurodegenerative disease is a general term for a wide range of diseases which affect neurons 
in the central nervous system (CNS). Specific subsets of neurons in specific functional anatomic 
systems can be affected resulting in hundreds of different neurodegenerative disorders such as 
amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), Huntington’s disease (HD), 
frontotemporal dementia (FTD), and Alzheimer disease (AD)116. Interestingly, NEAT1 is 
abnormally expressed in several of these diseases. Furthermore, genes encoding the paraspeckle 
associated proteins TAR DNA-Binding Protein 43 (TDP-43) and fused in sarcoma FUS are 
frequently mutated in ALS.  
Amyotrophic lateral sclerosis: ALS is a fatal motor neuron disorder in the spinal cord and 
motor cortex117. Mutations in genes encoding RNA-binding proteins (RBPs) or their regulators 
are frequent in ALS. As showed by Nakagawa et al. NEAT1_2 expression is low in adult CNS28, 
but the paraspeckle formation was detected in sporadic ALS (sALS) in two separate 
experiments118,119. Formation of paraspeckle is not only seen in sALS, but also detected in 
familial ALS (fALS)120. Approximately 25 proteins have a high association with ALS121. 
Interestingly, eight of these proteins have also been found in paraspeckles, including FUS, 
TDP-43, EWS, TAF15, SFPQ, MATR3, CREST, and hnRNPA1, suggesting the importance of 
NEAT1/paraspeckle in ALS pathogenesis121. Moreover, the aggregation of these proteins can 
affect paraspeckle indirectly since aggregated protein can recruit more paraspeckle proteins. 
For instance, aggregation of FUS and TDP-43 in ALS can sequester other paraspeckle 
components from the nucleus120. 
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Huntington’s disease: HD is a progressive, fatal inherited autosomal dominant 
neurodegenerative disorder. The extension of CAG repeats in the HTT gene, which encodes a 
polyglutamine stretch in the huntingtin protein is the cause of HD122,123. Two separate studies 
have shown that NEAT1 level is elevated in the caudate of affected individuals124, and RT-
qPCR analysis showed higher expression of NEAT1_2 in HD patients’ brain. In vitro studies 
on HD cell model revealed that overexpression of NEAT1_1 protected the cell against oxidative 
stress, whereas NEAT1_2 knockdown decreased cell survival125,126. 
Parkinson’s disease: PD is a chronic, progressive neurodegenerative disorder characterized by 
both motor and non-motor features which affect 1% of individuals over 60 years old. Meta-
analysis of the microarray from public dataset showed that NEAT1 is upregulated almost 1.5-
fold (gene expression ratio of value in HD patient/healthy group) in the substantia nigra of PD 
patients compared to healthy control127. Also, a high level of NEAT1 in the midbrain of 
Parkinson mouse model was reported. It has been shown that knockdown of NEAT1 increases 
survival of dopaminergic neurons in PD mouse model128,129.  
NEAT1 in Alzheimer’s disease (AD): AD is the most prevalent neurodegenerative disorder in 
individuals older than 65 years old. More than 95% of AD cases are sporadic by late onset (80-
90 years) in the patient. There are two clinical features which are typically associated with AD 
neuropathological process, namely, disability of cells to clear the amyloid-β (Aβ) peptide from 
the neurons and accumulation of hyperphosphorylated tau-protein intracellularly as 
neurofibrillary tangles. Symptoms of AD are started with slow progression of dementia, as well 
as gross atrophy in the cerebral cortical of the brain. A massive number of genetic risk factors 
have been reported for sporadic AD, however, less than 1% of patients have a mutation in genes 
involved in regulation of amyloid-β (Aβ) peptide; Individuals who carry the mutation develop 
the disease much earlier, at an average age of 45 years130,131,132. Microarray analysis revealed a 
high level of NEAT1 in five regions of the brain, namely, entorhinal cortex, hippocampus, 
middle temporal gyrus, posterior cingulate cortex, and the superior frontal gyrus133. 
Furthermore, two independent studies have reported overexpression of NEAT1 both in the 
hippocampus and temporal cortex in AD patients134,135. Interestingly, expression of cyclin-
dependent kinase 5 regulatory subunit 1 (CDK5R1), which has a pivotal role in the development 
of the brain, is positively correlated with NEAT1 expression, suggesting a neuroprotective role 
for NEAT1 in AD patients to compensate for increased CDK5R1 levels135. 
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Heat shock response  
Cells are frequently exposed to external and internal stressors that can affect important cellular 
processes leading to cell death. To counteract stressors and retain homeostasis, cells have 
developed a range of cytoprotective stress response mechanisms. One such stress response 
pathway is the heat shock response (HSR) pathway. The heat shock response pathway is 
conserved in evolution and activated by factors causing protein misfolding. Misfolded proteins 
often mislocalize and form aggregates within the cell and lose their original function.  Efficient 
function of proteins is pivotal for the health of the organism, and the functional state of each 
protein is precisely monitored by a dynamic network called the proteostasis network (PN)136. 
To keep the proteostasis, cells need to coordinate the triangle of protein synthesis and folding, 
conformation change, and degradation.  
Protein aggregation is associated with serious pathological disorders. It reduces the number of 
active proteins from the cell’s protein pool137–139. Aggregated proteins may result in toxicity 
regardless of their biological function. Protein aggregates can damage membranes and interact 
abnormally with macromolecules137–139. In response to protein aggregation, a series of 
molecular chaperones, under the control of HSR, become activated140. During the HSR, a group 
of proteins termed the Heat Shock Proteins (HSPs) are upregulated. Most HSPs act as molecular 
chaperones. Chaperones are proteins that mediate correct assembly of other proteins141. They 
facilitate de novo folding during translation, refolding of protein after stress trafficking, 
translocation, ubiquitination, and degradation of proteins, and in this way, HSPs monitor quality 
of the proteome to ensure proteostasis142,143. Most of the chaperones are classified as stress 
proteins, while they also have essential roles in normal cell physiology141. Chaperones can be 
classified based on different parameters such as size, cellular localization, chaperone’s action, 
and their specificity. They are usually divided into different classes based on their molecular 
weight including HSP40, HSP60, HSP70, HSP90, HSP100, and the small HSPs143,144.  
Heat shock transcription factors (HSFs) are a family of DNA-binding proteins that mainly 
regulate the HSR in proteotoxic stress145. They are highly conserved from fungi to mammals145. 
In human, six HSFs have been discovered, which include HSF1, HSF2, HSF4, HSF5, HSFX, 
and HSFY146 . HSF1 is a master regulator of the HSR since mammalian cells lacking the 
expression of the HSF1 are unable to induce a stress response147,148. In contrast, deficient cells 
for HSF2 and HSF4 are still able to induce the stress response149,150. HSF2 is mostly studied in 
the development of the brain and reproductive organ151,152, and it can form heterotrimers with 
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HSF1 to bind to promoters of genes encoding HSPs like the HSPA1A (HSP70) promoter.  
HSF3 has not been discovered in humans, but it has a crucial role in the induction of HSR in 
avian cells. It also controls non-HSPs heat shock genes in mice153. HSF4 has a pivotal role in 
growth and differentiation of the eye during lens development, and mutation in HSF4 leads to 
cataracts149,154. The functions of HSF5, HSFX, and HSFY remain to be explored; however, it 
has been shown that deletion of HSFY leads to male infertility153,155,156.  
The HSF1 protein consists of four conserved functional domains including N-terminal DNA-
binding domain (DBD), the heptad repeat (HR)-A/B/C, a regulatory domain (RD), and two 
activation domains (AD1, AD2) (Fig. 4A)145,157. The DBD is the best-conserved domain within 
the HSF family and contains a looped helix-turn-helix structure. Unlike many other 
transcription factors that form dimers, HSFs form a trimer to bind to the target sequence. This 
is mediated by the HR-A/B/C domains. Trimerization enables HSF1 to correctly recognize 
specific DNA sequences called Heat Shock Elements (HSE). HSEs are located in the upstream 
region of HSF1 target genes and consist of pentameric sequence nGAAn, where “n” can be any 
nucleotide.  The arrangement of HSE in a regulatory region can be varied, and three continuous 
inverted repeats of nGAAn are the best fit to be detected by HSF1145,157,158. While DBD in N-
terminal is responsible for DNA binding, ADs in C-terminal regulates transcriptional activation 
of target genes145,157.  
In normal physiological conditions, HSF1 is kept in the cytoplasm as a monomer by forming a 
complex with HSP70, HSP90, and HSP40159–162. Upon stress and presence of misfolded 
proteins, monomeric HSF1 is released from its inhibitory complex and undergoes trimerization 
(Fig. 4B)163,164. Activated HSF1 promotes the transcription of its target genes including those 
that encode HSP70 and HSP90.  These proteins inactivate HSF1 by a negative feedback loop. 
In this model, activation and inactivation of HSF1 are dependent on the concentration 
of HSP40, HSP70, and HSP90 in cells. After trimerization, HSF1 translocate to the nucleus and 
binds to consensus sequence163,165,166. HSF1 binds to its target through the DBD recognition 
helix containing conserved Ser-Phe-Val-Arg-Gln amino sequence. The sequence inserts into 
the major groove of the HSE and binds guanine of nGAAn sequence via conserved Arg167. 
Crystallographic studies have illustrated that DNA is surrounded by a carboxy-terminal helix 
of DBD and connect LZ1-3 to the other side of DNA. Acetylation of Lys80 neutralize positive 
charge on Lys and disrupts HSF1-DNA interaction168. 
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HSF1 also undergoes a variety of post-translational modifications (PTMs) such as 
phosphorylation, sumoylation, and acetylation in which phosphorylation is the most studied.  
PMTs influence HSF1 function and stability both positively and negatively166. For instance, 
phosphorylation of Ser121, Ser303, and Ser306 associates with repression of HSF1 
transcriptional activity in normal condition, whereas phosphorylation of HSF1 on Ser230, 
Ser320, and Ser326 is induced by stress. The acetyltransferase p300 control the turnover of 
HSF1 by acetylation of Lys208, and Lys298 which prevent proteasomal degradation. As 
mentioned above, p300 inhibits HSF1-DNA interaction by acetylation of Lys80 in HSF1169.  
FIGURE 4. HSF1 activation cycle.  A. Domain structure of the human HSF1 protein.     
B. HSF1 activation. Upon oxidative stress, heat shock, and accumulation of unfolded 
proteins, HSF1 is released from an inhibitory complex consisting of HSP70, HSP90, and 
HSP40, and undergoes a multistep activation process in which HSF1 translocates into 
nucleus and trimerized. Trimerized and activated HSF1 binds to its HSE regions in the 
promoters of its target genes, including HSP40, HSP70, and HSP90, to activate their 
expression. When the HSR is attenuated, HSF1 is inhibited and either degraded by the 26S 




Activation of HSF1 can protect cells against environmental stressors such as heat, ischemia, 
inflammation, oxidative stress, and other noxious conditions152,170–178. In most cases, activation 
of HSF1 is an acute and transient process. The deregulation of HSF1 causes different diseases 
including neurodegenerative disease and cancer152,170–178. The level of HSF1 is reduced in 
neurodegenerative diseases171–174. HSF1-depleteion exacerbates protein misfolding and 
aggregation as the expression of HSP chaperones are severely reduced. High levels of HSF1 
and HSPs has been reported in many cancers correlating with poor prognosis; They can support 
protein synthesise in cancer cells and also protect them from stress156,179. HSF1 helps cancer 
cells to adapt to hypoxia, acidosis, and nutrient deprivation175. Activation and overexpression 
of HSF1 have been discovered in different kinds of human tumors including breast cancer154,175–
178,180. In agreement with this, the lack of HSF1 in mice protects them from carcinogen-induced 
skin tumors175. In cancer, a variety of signaling pathways influence HSF1 via PMTs such as 
RAS, AMPK, GSK3, JNK, and PKA. For instance, MEK can phosphorylate HSF1 on Ser326 
resulting in HSF1 activation181 and, in turn, the high level of HSF1 increases MAPK activity 
which leads to proliferation and growth. Furthermore, chaperones can activate specific 
signaling pathways to promote oncogenesis and inhibit apoptosis. For example, HSP70 and 
HSP90 prevent stress-induced apoptosis through JNK and AKT, respectively. Moreover, 
chaperones also facilitate folding of abnormal proteins in cancer cells that are encoded by 
mutated genes156,182.  
Autophagy 
Autophagy is a conserved catabolism process through which cytosolic cargo such as long-lived 
proteins, organelles and pathogens are removed by the lysosomal system to maintain cell 
homeostasis183. The process was for the first time described by Christian De Duve who named 
the process Autophagy meaning ‘eating of self’184,185. In the 1990s, the Yoshinori Ohsumi lab 
discovered that autophagy mechanisms in yeast are very similar to those in mammalian cells.  
Using yeast as a model, many AuTophaGy-related genes (ATG) were discovered that are 
conserved in human cells. Up until now, 42 ATG genes have been identified among which 16 
ATG genes are known as core ATG genes since they are commonly involved in both non-
selective and selective macroautophagy186. Other ATG genes are associated with specific kinds 
of selective autophagy187. The non-selective autophagy unspecifically engulfs a part of the 
cytoplasm and containing component upon cellular stress such as starvation to recycle cellular 
component and ensure cell survival until new resources provided188. Furthermore, non-selective 
autophagy has a basal level activity for the removal of protein aggregates, damaged organelle, 
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and also an unnecessary substrate in cells188. Selective autophagy, on the other hand, targets a 
cargo by selective autophagy adaptors such as ubiquitin-binding protein p62/Sequestosome-1 
(p62/SQSTM1)189. Selective autophagy can remove lipid droplets (lipophagy), Mitochondria  
(Mitophagy), pathogenes (Xenophagy), iron bound ferritin (ferrintinophagy), lysosome 
(lysophagy), ER (reiculophagy), ribosome (ribophagy), aggregated protein (aggrephagy)190.  
Autophagy is divided into three types: Microautophagy, chaperone-mediated autophagy 
(CMA), and macroautophagy (Fig. 5)191. In microautophagy, part of mammalian cytoplasm is 
directly sequestered and engulfed by lysosomes (Fig. 5C)192. In CMA, a cytosolic chaperone 
protein, the heat shock cognate protein of 70kDa (Hsc70), recognizes a penta-peptide KFERQ-
like motif in the amino acid sequence of targeted cargo and guides the cargo to the surface of 
the lysosomes. Afterward, the protein-chaperone complex interacts with the cytosolic tail of the 
lysosome-associated membrane protein type 2A (LAMP-2A), and subsequently, they enter the 
lysosome after unfolding (Fig. 5B)193. Macroautophagy (hereafter called ‘autophagy) is a highly 
conserved multistep process in which a de novo double-membrane structure called the 
phagophore, engulfs a portion of cytosol and/or organelles. The phagophores expand their 
structure to surround their target completely generating an autophagosome. Finally, the 
autophagosome fuses with the lysosome creating autolysosome (Fig. 5A)194. Alternatively, 
autophagosomes can fuse with endosomes and generate amphisomes before fusing with 
lysosomes194. Autophagy is generally divided into three main steps: Initiation and nucleation, 
elongation and closure, and fusion and degradation. 
Initiation and nucleation 
Under normal physiological conditions, autophagy remains at a basal level to regulate the 
balance between biosynthesis and turnover of proteins195–197. Autophagy has also an important 
role in removing damaged cellular organelles and intracellular pathogenes. The rate of 
autophagy dramatically increases upon nutrient starvation to provide the cells with more 
internal nutrient supplies. A key step in the initiation of autophagy is the inactivation of 
mammalian target of rapamycin (mTOR). mTOR is a phosphoinositide 3 kinase-related 
serine/threonine kinase which has an instrumental role in regulating cellular growth and 
metabolism in response to growth factors, nutrients, energy, amino acids, and stress 195–197. It is 
involved in two complexes of mTORC1 and mTORC2. The mTORC1 complex consisting of 




FIGURE 5. Cellular autophagy pathways. A. Macroautophagy. mTOR and AMPK 
are key regulators of autophagy. When autophagy is induced, cytosolic components are 
engulfed into double membrane structures called autophagosomes. Autophagy is a 
multistep process that includes initiation and nucleation, elongation and closure, and 
fusion and degradation. These processes are regulated by several protein complexes. 
Initiation of the process is started by activation of Ulk1 protein leading to recruitment 
and activation FIP200, Atg13, and Atg101 into a complex. Next, the membrane becomes 
elongated by activation of a second complex containing Beclin1, PI3K/Vps34, 
ATG14L, and p150. LC3B binds to targeted cargo via p62, and autophagosomes then 
fuse with lysosomes for degradation of the cargo. B. Chaperone-mediated autophagy 
(CMA). In CMA, Hsc70 recognizes cargo that contains a recognition motif, KFERQ, 
and subsequently introduces it to lysosomal-associated membrane protein 2A (LAMP-
2A). The cargo becomes unfolded and enters lysosomes for 
degradation. C.  Microautophagy. In microautophagy, lysosomes directly engulf part of 






nutrients by phosphorylating and inactivating the Unc-51 like kinase 1 (Ulk1) complex. The 
Ulk1 complex consists of Ulk1, FIP200, Atg13, and Atg101 and, when activated, it initiates 
autophagy. Upon nutrient deprivation, mTOR1 is inactivated which leads to dephosphorylation 
of Ulk1, Ulk2, and Atg13. After dephosphorylation, Atg13 mediates the interaction of Ulk1 
and Ulk2 with focal adhesion kinase family interacting protein 200 kDa (FIP200)198,199. 
Forming of the Ulk1 protein complex stabilizes and promotes the kinase activity of Ulk1, 
resulting in the phosphorylation of FIP200 which is crucial for autophagy initiation200. Ulk1 is 
also under the control of AMP-activated protein kinase (AMPK). When the ratio of ATP 
decreases relative to AMP/ADP (a drop of energy level in the cell), AMPK directly 
phosphorylates Ulk1 to induce autophagy201.  
Initiation of autophagy also requires the activity of class III PIK3 (PIK3C3)/Vps34 complex 
(hereafter referred to as the Vps34 complex). In mammals, there are three types of PI3K which 
are classified based on lipid substrate specificity: Class I, - II, and- III.  The Vps34 converts 
phosphatidylinositol (PI) to phosphatidylinositol-3-phosphate (PI3P), and this phosphorylation 
is critical to driving autophagy202,203. In mammals, there are two types of Vps34 complexes. 
Complex-I consists of Vps34-P150-Atg14L/Barkor-Beclin-1, and complex-II consists of 
Vps34-p150-Beclin-1-UVRAG (UV irradiation resistance-associated gene)204. The Vps34 
complexes are mainly regulated by the Ulk1 complex through phosphorylation of Beclin-
1205,206. In normal conditions, Beclin-1 interacts with the apoptotic protein Bcl-2 (B-Cell 
CLL/lymphoma 2), which prevents it from taking part in the Vps34 complex to initiate 
autophagy. Due to lack of nutrients, Ulk1-mediated phosphorylation of Beclin-1 leads to its 
dissociation from Bcl-2, It is now free to interact with Vps34 and another pro-autophagy 
protein, Atg14L207,208.  Vps34 is activated upon interaction with Beclin-1 and generates PI3P, 
which is essential for phagophore formation206,209. Ulk1 binds to PIP3 and thus stabilizes and 
supports the Vps34 complex in the level of phagophore210. Finally, Ambra1 (activating 
molecule in Beclin-1-regulated autophagy) and VMP1 (Vacuole membrane protein-1) interact 
with Beclin-1 to govern the autophagosome formation211,212. 
Elongation and closure 
Elongation of the phagophore to eventually form the mature autophagosome is mediated by 
two ubiquitin-like conjugation systems involving the ubiquitin-like proteins Atg12 and Atg8 
213. Atg12 is conjugated to Atg5 via E1-like enzyme Atg7 and E2-like enzyme Atg10. Atg12–
Atg5 then interacts with Atg16L1 and associates with the phagophore. The Atg12–Atg5-
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Atg16L1 complex is then involved in targeting of Atg8 to the phagophore. In mammals, six 
homologs of yeast Atg8 have been reported and are divided into three groups: 1) microtubule-
associated protein 1 light chain 3 (MAP1LC3)-A, B, C, 2) gamma-aminobutyric receptor-
associated protein (GABARAP), and 3) Golgi-associated ATPase enhancer of 16 kDa 
(GATE16)214–216. The MAP1LC3s, often referred to as LC3, are the most studied Atg8 
members in autophagy in mammalian cells217. The conjugation of LC3 to 
phosphatidylethanolamine (PE) is crucial for the expansion of the phagophore. This lipidation 
of LC3 requires the activity of Atg4, Atg7, and Atg3. First, Atg4 cleaves at the C-terminus of 
LC3, generating LC3-I that exposes a C-terminal glycine 218. Second, Atg7 activates LC3-I. 
Activated LC3-I is then conjugated to PE by Atg3, generating the lipidated LC3-II form of 
LC3219,220. For binding of LC3-II to the phagophore, LC3-II needs the E3-like enzymatic 
activity of Atg12–Atg5-tg16L1 complex219,221. The WD repeat domain phosphoinositide-
interacting proteins-2 (WIPI2) binds to PI3P in the surface of phagophore and recruits Atg12–
Atg5-tg16L1 complex through Atg16L1 and facilitate lipidation of LC3/GABARAP222. The 
process of phagophore closure has not been fully understood. It seems that later stages of 
phagophore formation are regulated by Atg2A and Atg2B, since depletion of both Atg2A and 
Atg2B results in accumulation of unclosed phagophore223.  
Fusion and degradation 
The fusion between autophagosome and lysosome has to take place after closure of the 
autophagosome. Autophagosomes are spread all over the cytoplasm. Their location seems to 
be random224, whereas endosomes and lysosomes are mostly located in perinuclear region225. 
Therefore, autophagosome and lysosome have to move towards each other for the fusion 
step226,227,228. In the process of maturation, autophagosomes gradually lose Atgs from the outer 
membrane and recruit the machinery responsible for lysosomal delivery and also the machinery 
mediating lysosome and autophagosome fusion229,230. In this process, autophagosomes move 
along microtubules to reach in the proximity of nuclear before the fusion to lysosome224. Both 
dynein (a minus-end-directed microtubule motor) and kinesins (plus-end-directed microtubule) 
are involved in the movement of lysosome and autophagosome, as a number of autophagosome-
lysosome fusions decreases in cells which have dysfunction in dynein and kinesins231,232. Also, 
LC3 are vital for efficient movement of autophagosome224.  
Fusion step is dependent on three sets of protein families: Rab GTPase, membrane-tethering 
complexes, and soluble SNAREs 226,227,228. Ras-related protein Rab-7a (Rab7) has several roles 
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in the maturation of the autophagosome. Rab7 binds to late endosomes and lysosomes, and 
coordinates their motility and fusion to autophagosomes by interaction with dynein motor 
through its protein effector called RILP (RAB-interacting lysosomal protein)233. Furthermore, 
Rab7 on autophagosome also recruits kinesin motors via binding to FYCO1 (FYVE and coiled-
coil domain containing 1)234; and FYCO1 can also bind to LC3 and PI3P. Taken together, Rab7, 
PI3P, and LC3-binding protein FYCO1 are necessary for the movement of autophagosome 
towards nuclear region234,235.  
The HOPS (homotypic fusion and protein sorting) complex has a key role in tethering vacuoles 
and lysosomes for fusion in mammals236–238.  HOPS consists of six subunits including vacuolar 
protein sorting (Vps)11, Vps16, Vps18, Vps33A, Vps39, and Vps41236–238. The HOPS complex 
interacts with lysosomes via Rab7 and with autophagosomes via the SNARE protein STX17230. 
HOPS also facilitates autophagosome-lysosome fusion by binding to pleckstrin homology and 
RUN domain containing M1 (PLEKHM1) that also interacts with LC3 on the autophagosome 
membranes239. 
SNAREs are membrane-anchored proteins and are the core components of the fusion 
machinery in mammalian cells. SNAREs form four-helix bundles to fuse autophagosome and 
lysosome namely QSNAREs (Qa-SNARE, Qb-SNARE, Qc-SNARE), and R-SNARE. To fuse 
membrane vesicles in the cell, R-SNARE on donor membranes and Q-SNAREs on the acceptor 
membranes form a complex called trans-SNARE240. In autophagy, STX17 on autophagosomes 
acts as a Q-SNARE and binds to the R-SNARE VAMP8 on lysosomes229,230. After fusion, 
autophagosome and the inner membrane of the autolysosome degrade by lysosome resulting in 
additional resources for cells such as amino acids, nucleotides, sugars, and free fatty acids241,242.  
Autophagy in cancer 
Dysregulation of the autophagy process has been reported in different diseases. Knockout 
studies of ATG genes have shown that autophagy has a pivotal role in adaptive responses to 
stress, homeostasis, as well as cellular differentiation and development241–245. Parallel with this, 
systemic and tissue-specific knockdown studies of ATG genes have demonstrated the 
connection between autophagy and different disease including neurodegenerative disease, 
cancer, metabolic diseases, and infectious disease242–244,246–249. In cancer, autophagy has been 
referred to as a “double-edged sword” meaning that autophagy can behave as an inhibitor or an 
inducer of tumorigenesis250,251. This paradoxical role of autophagy suggests that autophagy has 
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distinct roles depending on the context and stages of carcinogenesis. It is believed that 
autophagy can prevent tumor initiation, whereas in advanced cancer stages, it may have pro-
metastatic roles. Autophagy assists metastatic cells in surviving and colonizing at a secondary 
site, and in case of failing to establish a new colony, it helps metastatic cells to stay in a dormant 
stage. Loss of autophagy can cause genotoxic stress due to the accumulation of reactive oxygen 
species. In this scenario, normal autophagy can be seen as a tumor suppressor mechanism that 
protects the genome252–254,77. Consistence with this, the deletion of BECN1 (encoding a 
necessary component for formation of phagophore) is observed in many cancers including 
breast cancer, ovarian cancer, and prostate cancers252,255,256. This leads to autophagy inhibition 
and induction of cell proliferation252,255,256. The knockout of other ATGs genes have also 
showed that autophagy can have a tumor suppressor role in cancer. This is exemplified by 
knockout of BIF-1 (Endophilin-B1), Atg7, and Atg5 in mice that promote tumor 
progression257,258. Some of the active signaling pathways in cancer such as RAS are dependent 
on autophagy for cancer development259,260. Upregulation of baseline autophagy levels has been 
reported in RAS-activated tumors such as pancreatic cancer. The inhibition of autophagy in 
these tumors results in a reduction in cellular proliferation and tumor regression both in cell 
lines and in a mouse model. The same role for autophagy has been reported in RAS-activated 
non-small cell lung cancer259–262. Oxidative stress in cancer cells and surrounding tissues leads 
to upregulation of autophagy, which can fuel cancer development263–267. Increased mitophagy 
in tumor stromal fibroblasts makes them dependent on aerobic glycolysis, leading to the 
production of produce lactate and ketones are taken up and used in metabolism by neighboring 
cancer cells263–267. Although autophagy process is a double-edged sword in cancer, 
manipulation of autophagy may help us to control cancer. Since it is not clear when autophagy 
should be on or off, deep knowledge of the autophagy process is critical for autophagy-based 
treatment250. 
The mammary gland and breast cancer 
Human female breast development starts from week 4-6 of gestation and continues to develop 
into adulthood. The branching of the breasts stays at a modest level until women are influenced 
by sex hormones during puberty, and this development continues during and after pregnancy268. 
The human female mammary gland consists of an extensive tree-like network of branched ducts 
that starts from the nipple and terminates in an alveolar structure called lobules. Both lobules 
and ducts are embedded in a collagen-rich stroma containing blood vessels, lymphatic vessels, 
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adipocytes, connective tissue, and macrophages269. The normal mammary epithelium is a 
bilayer structure consisting of an outer “basal” layer and inner “luminal” layer which have 
different features and functions. The outer basal/myoepithelial layer is in direct connection with 
the basement membrane, whereas the inner luminal layer contains polarized epithelial cells that 
can produce and secrete milk upon hormonal exposure268,269. The mammary glands are dynamic 
organs that experience extensive morphogenesis from a very early stage of development 
followed by puberty, pregnancy, lactation, and involution270. Thus, the mammary glands 
undergo proliferation, differentiation, cell death, and also tissue remodeling, all of which are 
dependent on a renewable stem cell population situated between the luminal and myoepithelial 
cells270,271.  
Breast cancer is the most common cancer among women worldwide; 3589 new cases were 
registered in Norway in 2017, and 629 persons died from breast cancer in 2017, which makes 
it the second highest cause of cancer-related deaths among women after lung cancer272. 
Statistics show that the number of registered breast cancer cases in Norway is increasing as 
9.7% more cases were detected in 2013-2017 than in 2008-2012272. The mortality rate has been 
stable since the 1990s when it began declining272. The decline in mortality in mid-90s is 
attributed to early detection by mammography screening and adjuvant therapy273,274. Although 
metastasis is not common in breast cancer patients at the time of the diagnosis, metastasis to 
liver, bone, lungs, and central nervous system is common at later time points (30%)275,276. While 
90% of breast cancer cases are due to the accumulation of somatic mutations, 10% are caused 
by hereditary mutations received from the previous generation277. The most common inherited 
genetic changes in breast cancer are mutations in tumor suppressors BRCA1, and BRCA2278,279, 
followed by germ-line mutation in the gene encoding p53 (Li-Fraumeni syndrome), PTEN 
germ-line mutation (Cowden syndrome), and STK11/LKB1 mutation (Peutz-Jegher 
syndrome)280,281.  
Prognosis, diagnosis, and treatment strategy of breast cancer are dependent on expression of 
biomarker including estrogen receptor (ER), progesterone receptor (PR), human epidermal 
growth factor receptor 2 (HER2), cytokeratins, and Ki-67282,283. The molecular subtypes of 
breast cancer can be determined by both immunohistochemistry (IHC) and gene expression 
patterns283. According to IHC staining of ER, PR, HER2+ receptors, and Ki-67 proliferative 
index, the subtypes of breast cancer in the clinic are classified as luminal A, luminal B, HER2-
enriched and basal-like breast cancers284. According to high throughput gene expression 
analysis, breast cancer is classified into five intrinsic subtypes: luminal A, luminal B, HER2-
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enriched, basal-like, and normal-like285. Both luminal A and luminal B subtypes are ER-
positive, but the expression of HER2, Ki-67, and PR expression are different in these subtypes. 
Luminal A cancers are HER2-negative with low expression of Ki-67 and high level of PR. 
Moreover, luminal A is characterized by expressing ER-related genes283,285. Luminal B breast 
cancers also express ER, but show worse prognosis due to the expression of proliferation-
associated genes such as Ki-67 and HER2 growth factor285–287. Luminal B is either ER+, PR+, 
HER-, Ki-67 (high expression) or ER+, PR+, HER2+, Ki-67 (high/low expression)287. The 
HER2-enriched subtypes of breast cancer are characterized by high expression of the ERBB2 
(HER2) and GRB7 genes.283,288,289. Triple-negative breast cancers (TNBC) are defined as ER-, 
PR-, HER2- and have the worst prognosis among the breast cancer subtypes. TNBC 
classification is faced with some ambiguity as a variety of subgroups have been identified by 























Aims of this study 
NEAT1 is the essential structural RNA component of nuclear paraspeckles. Several reports have 
shown that NEAT1 expression and paraspeckle formation are upregulated by a variety of 
cellular stressors, and at specific stages in development. NEAT1 and paraspeckles regulate the 
expression of specific genes at both transcriptional and post-transcriptional levels. It has for 
some time now been clear that NEAT1 is abnormally expressed in serious human diseases 
including cancer and neurological disorders. The aim of this study was to further add knowledge 
about the function of NEAT1 in cellular stress response pathways including autophagy and to 
further dissect the role of NEAT1 in breast cancer by analysing the expression in different breast 
cancer subtypes. 
The objectives of the study are: 
i) To contribute to a better understanding of the role of NEAT1 in cellular stress conditions 
that are prominent in cancer cells 
ii) To determine the expression pattern of NEAT1 in different subtypes of breast cancer. 
















Summary of papers 
 
Paper I: The long non-coding RNA NEAT1 and nuclear paraspeckles are upregulated 
by the transcription factor HSF1 in the heat shock response. 
NEAT1 is a highly abundant lncRNA that is critical for the formation of paraspeckles. NEAT1 
expression is induced upon intrinsic and extrinsic stress such as viral infections, proteasome 
inhibition, oncogene-induced replication stress, and hypoxia. In this paper, we show that the 
isothiocyanate sulforaphane (SFN) induces NEAT1 expression at the transcriptional level and   
elevates paraspeckle formation. SFN-mediated NEAT1 induction is not dependent on NRF2, 
whereas depletion of HSF1 severely compromises SFN-induced NEAT1 expression and 
paraspeckle formation. HSF1 binds to a novel conserved heat shock element (HSE) in NEAT1 
promoter. NEAT1 is also induced upon heat shock, suggesting that NEAT1 upregulation is a 
universal mechanism in the heat shock response. Finally, we show that NEAT1-depletion results 
in amplified and prolonged expression of HSP27, HSP70, and HSP90 mRNAs during heat 
shock.  
 Paper II: The expression of the long NEAT1_2 isoform is associated with human 
epidermal growth factor receptor 2-positive breast cancers  
The NEAT1 locus in transcribed into two overlapping isoforms, NEAT1_1 and NEAT1_2. 
NEAT1_2, but not total NEAT1, has recently been shown to predict progression-free survival 
of ovarian cancer treated with platinum-based chemotherapy. Therefore, the expression of 
NEAT1_2 was investigated in breast cancer. We have performed NEAT1_2-specific RNA-FISH 
analyzes on 74 needle biopsies taken from females at the time of diagnosis of breast cancer. 
NEAT1_2 expression correlates with HER2-positive cancers, and independently, with high-
grade disease. This was verified in a microarray-based expression cohort and in breast cancer 
cell lines. Moreover, NEAT1_2 expression associates with HER2-enriched and luminal B 
PAM50 subtypes of breast cancer in 3 cohorts. Total NEAT1 shows a distinct expression 
distribution between PAM50 subtypes compared to NEAT1_2, being highest in ER-positive 
luminal A cancers. This indicates that the relative expression between NEAT1_1 and NEAT1_2 
varies in different breast cancer subtypes. Finally, for the first time, we show that NEAT1_2 
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expression and paraspeckle formation increase in human breast tissue upon lactation, 
confirming what has previously been observed in mice.  
Paper III: Knockdown of the long non-coding RNA NEAT1 induces basal autophagy in 
breast cancer cell lines 
NEAT1 expression is induced by a variety of cellular stressors that are known to enhance 
autophagy, including hypoxia, heat shock, genotoxic and mitochondrial stress. We recently 
showed that NEAT1 is induced at the transcriptional level by SFN, a compound that is known 
to induce autophagy in cells. Here, we show that NEAT1 knockdown in breast cancer cell lines 
leads to the accumulation of lipidated LC3B, which is a marker of autophagy. The lipidated 
LC3B-II form continues to accumulate after inhibiting lysosomal activity with bafilomycin A1, 
indicating that the on-rate of autophagy is increased in NEAT1-depleted cells. In line with this, 
AMPK is activated in NEAT1-deficient cells. This is accompanied by increased 
phosphorylation of Ser317 and Ser555 of Ulk1, which is required for initiation of autophagy.  
We also report that NEAT1-depletion leads to a slight accumulation of the p62 protein. This 
might indicate that lysosomal functions are affected in NEAT1 knockdown cells. We speculate 
that NEAT1 deficiency leads to accumulation of damaged macromolcules and mitochondria, 

















Generation of NEAT1-depleted cells 
To study the cellular function of NEAT1, generation of an efficient knockout or knockdown 
strategy is instrumental. During the course of this study, several attempts were made to make 
stable NEAT1 knockdown cell lines. These experiments never succeeded (see below for further 
description and comments). Therefore, transient knockdown of NEAT1 with small 
oligonucleotides was done in papers I - III.   Generally, there are two main technologies that 
are used for knocking down the expression of a gene: Small interfering RNAs (siRNAs) and 
antisense oligos (ASOs)290,291.  siRNAs are double-stranded RNA molecules that are 
incorporated into the RNA-induced silencing complex (RISC) where the guide strand binds to 
and degrades the targeted mRNA. ASOs are single-stranded RNA, DNA or RNA/DNA hybrid 
oligonucleotides that bind to their RNA targets by complementary base pairing. The RNA 
duplex is then recognized and degraded by RNase H1290,291. NEAT1 is a highly abundant nuclear 
transcript. This has to be taken into consideration when trying to deplete NEAT1 expression in 
cell lines. As the RISC machinery operates in the cytoplasm where it targets mature mRNAs, 
we envisioned that the siRNA technology was not optimal for silencing NEAT1 expression. 
ASOs, on the other hand, can enter the nucleus and there are nuclear forms of RNase H1290,291. 
Therefore, we decided to use GapmeRs which are chimeric ASOs of 16 nucleotides, to 
transiently knockdown NEAT1 expression (Exiqon, QIAGEN). In this technology, a specific 
central sequence consisting of DNA nucleotides is flanked by blocks of modified Locked 
Nucleic Acid (LNA) ribonucleotides that protect it from degradation. In LNAs, the ribose ring 
is locked by a methylene bridge connecting the 2´-O atom and the 4´-C atom (Fig. 6). This 
modification makes the nucleotides ideal for Watson-Crick binding292,293. This increases the 
affinity and thus the specificity for the targeted RNA molecule. Off-target activities and toxicity 
are always an issue when using ASOs (or siRNAs). Therefore, ideally, different ASOs targeting 
the same RNA molecules should be used in functional assays. In our studies, NEAT1 expression 
was inhibited by two  GapmeRs: One recognizing the overlapping region between NEAT1_1 
and NEAT1_2 (referred to as NEAT1-specific) and one that solely silences the expression of the 
long NEAT1_2 isoform (Fig. 7)294–297. 
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In the paper I - III, Lipofectamine 2000 (Thermo Fisher Scientific) reagent was used for delivery 
of the GapmeRs and siRNAs to the cells. Lipofectamine 2000 is a cationic liposome which 
surrounds nucleic acid molecules and facilitates their entrance to cells. They have positive 
charge head group by which they interact with negatively charged sugar-phosphate backbone 
of nucleic acid strand so lipid bilayers encapsulate nucleic acid molecules and help them 
overcome electrostatic repulsion of cellular membrane298,299. Lipofectamine containing siRNA 
or GapmeR are taken up with endocytosis. However, the efficiency of lipid-based transfection 
can be affected by different biological barriers such as cellular uptake, intracellular trafficking, 
endosomal escape, and lysosomal degradation. Therefore, achieving consistent transfection 
efficiency can be challenging in lipid-based transfection300,301. According to the optimization 
result, a so-called reverse transfection protocol where the oligonucleotides and transfection 
reagent were mixed with trypsinized cells upon seeding, were used which gave consistent 
transfection efficiencies in almost all of the experiments. As suggested by the manufacturers, 
GapmeR stocks were aliquoted, and repeated thaw-freeze cycles were avoided (5 times at the 
max). Knockdown efficiencies were always analysed by RT-qPCR before further functional 
analyses were conducted.  
As mentioned above, our group has made several attempts to try to establish stable NEAT1 
knockout or knockdown cell lines using the CRISPR-Cas9 technology or short hairpin RNAs 
(shRNA). In the case of the shRNA, colonies expressing the shRNA were obtained, but NEAT1 
expression was not inhibited by this mechanism (Dr. Erik Knutsen, personal communication). 
NEAT1 is an abundant long non-coding RNA in the nucleus, whereas the shRNAs are processed 
by Dicer and loaded into RISC in the cytoplasm. We, therefore, postulate that the NEAT1-
FIGURE 6. GapmeR structure. Typically, GapmeR is 8-12 base single strand 
antisense DNA that flanked by 2-5 chemically modified nucleotides. RNase H1 





shRNA never got access to nuclear NEAT1. The CRISPR-Cas9 technology was also used to 
specifically deplete NEAT1_2 in MCF7, but single colonies did not survive (Dr. Erik Knutsen, 
personal communication). Since cell confluence is significantly compromised in NEAT1-
depleted cells (see paper I), it is likely that the survival of MCF7 cells is dependent on NEAT1. 
In the future, an inducible CRISPR-Cas9-mediated knockdown strategy can be an alternative.  
Methods for studying the role of NEAT1 in autophagy 
Autophagy is a dynamic multistep catabolic mechanism regulated by a variety of signaling 
pathways. A key step in autophagy is the formation of the phagosomes where the Atg8/LC3 
protein (hereafter just referred to as LC3) has a critical role. During maturation of the 
phagosomes, LC3 is conjugated onto phosphatidylethanolamine (PE) and thereby becomes 
lipidated forming the so-called LC3-II form. Measuring the lipidation of LC3 by western blott 
analyses looking for the faster migrating LC3-II form, or analysing the incorporation of LC3 
into punctuated phagosomes by fluorescence microscopy, are common methods for studying 
autophagy.  However, as these are intermediate steps in a highly dynamic process, accumulation 
of either LC3-punctas or LC3-II might be the result of either increased induction of autophagy, 
or decreased autophagic flux. Inhibition of lysosomal functions, low acidity of the lysosome, 
deficiency in fusion of phagosome to the lysosome, or dysregulation of the transport machinery 
results in accumulation of both LC3-II and LC3-puncta. Consequently, analyses of LC3-
puncta/LC3-II must be accompanied by other assays to avoid misinterpretation. In regard to the 
dynamic nature of autophagy, the analysis of a phenomenon at a specific time point cannot be 
conclusive. Thus analysis of autophagic flux from the beginning of the process to degradation 
in lysosome provides us with better understanding217. P62/SQSTM1 is one of the frequent 
autophagy markers which is usually used in parallel with LC3 in autophagy analyses. The p62 
proteins binds to ubiquitinated substrates and acts as a link between LC3-II and the autophagic 
cargo. As parts of LC3-II are reused in new autophagosomes, p62 is completely degraded in 
the autolysosome together with the cargo. Thus, the cargo degradation rate in autophagy can be 
estimated by p62 analyses. To sum up, the accumulation of both LC3-II and p62 usually 
indicate inhibition of autophagy in later steps, whereas the accumulation of LC3-II and 
degradation of p62 are an index for autophagy induction217. In this study, the amount of LC3-
II and LC3-puncta were detected by immunoblotting and immunocytochemistry, respectively 
in the presence and absence of lysosomal inhibitor (Bafilomycin A1)217. The activation of 
AMPK, mTOR and Ulk1 were monitored by immunoblotting with phosphospecific antibodies. 
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The ribosomal protein S6K is one of the first mTOR substrates, meaning the activation of S6k 
requires mTOR-mediated phosphorylation302. Therefore, phosphorylation of S6K on The389 
was monitored to check the activation of mTOR. As the activation of AMPK is dependent on 
phosphorylation of Thr172, phospho-Thr172 antibody was used to detect activated AMPK. 
Finally, the activation of Ulk1 was checked by phosphorylation of Ser317 and-Ser555 which 
are direct targets of activated AMPK. 
Reverse transcription quantitative polymerase chain reaction (RT-qPCR) 
Fluorescence-based reverse transcription quantitative PCR (RT-qPCR) was used for gene 
expression analyses in papers I - III using the SYBR Green method. Here, cDNA is made from 
total RNA, and specific primers were used to amplify the expressed gene of interest.  SYBR 
green binds to the minor groove of double-stranded DNA generated in the PCR reaction, and 
releases energy as fluorescence when bound to DNA. It can thus be used in real-time 
measurements of the amount of produced DNA. There are many factors that influence the 
expression of a gene in a sample, and RNA molecules are generally unstable. RT-qPCR is a 
very sensitive method and prone to technical variations. To compensate for different inputs of 
samples, the expression of the gene of interest is often normalized to a so-called reference 
housekeeping gene. Ideally, as good reference gene should be stably expressed independently 
of experimental conditions, and also between different populations of cells and individuals303. 
Although the mRNA levels of such housekeeping genes are supposed to stay constant in an 
experimental treatment, the expression of these genes have been reported to be changed under 
some experimental conditions304–307. Even very small changes in the housekeeping gene result 
in more significant noise or erroneous result, therefore, verification of internal control is vital 
FIGURE 7. The location of qPCR primers and GapmeR are shown in schematic 
picture of short and long isoform of NEAT1. 
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for the validity of the experiment308. We generally use glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) as a reference gene when analysing samples from experiments using 
only one cell line. In the paper II, NEAT1_2 expression in 9 different cell lines is compared. 
Here, we decided to use the average expression of 3 housekeeping genes, GAPDH, B2M, and 
RPLP0 for normalization. We analysed gene expression using the delta-delta Ct method. In the 
first step, delta Cq was calculated by subtracting the Cq value of the reference gene from the 
Cq value of the gene of interest. To calculate fold change, the treated groups were compared to 
a control sample using the 2-delta deltaCq formula, 2-(ΔCq treated) – (ΔCq control)309.  
RNA-FISH (Fluorescent In-Situ hybridization) 
The StellarisTM RNA-fluorescent in-situ hybridization (RNA-FISH) technology was used (in 
papers I and II) for detection of NEAT1 in cells. The StellarisTM RNA FISH are multiple singly 
labeled oligonucleotides, which are able to detect individual molecules of mRNA. As the 
binding of at least 10 probes are necessary for detection, the possibility of false positive is very 
low. Therefore, even if one off-target probe produces a weak signal, they have a significantly 
lower intensity compared to the main signal310. Two probe sets were used to detect NEAT1-one 
detected a region that is common in NEAT1_1 and NEAT1_2, while the other recognized only 
NEAT1_2 (paper I and II). RNA-FISH can be combined with 
immunocytohistohemistry/immunocytochemistry to simultaneously investigate the expression 
and localization of an RNA molecule and a protein311. Tissue handling and technical procedures 
are two important steps as RNA has to be preserved during the whole process. The tissue 
handling, including fixation and storage, is vital for preserving RNA in the cell.  
For FISH, the fixation method should be efficient enough to preserve the RNA, and also tissue 
morphology. In two separate experiments, formalin-fixed paraffin-embedded (FFPE) samples 
were produced from the patient. The first patient samples came from needle biopsy (paper II), 
while the other one was tissue microarrays (TMA) prepared from lumpectomy (data not 
shown). In needle biopsy samples, more than 40% of samples were positive for NEAT1, 
whereas, in the TMA samples, less than 3% of samples were positive. It means, the fixation 
step may take more time in bigger tissues which gives time to endogenous ribonuclease to 
degrade the RNAs, whereas needle biopsies became fixed significantly faster due to their 
thickness. To avoid degradation of RNA during the staining process, only nuclease free 
materials were used, and all the surfaces including slides, incubator, tweezers, and laboratory 
hood were wiped with RNAase removal solution. To check the specificity of the probes, NEAT1 
 46 
was knocked down with specific GapmeR transfections. This considerably decreased NEAT1 
signals, therefore verify that the probes are specific for NEAT1.  
Patent cohort and ethics 
Breast cancer samples and complete follow-up data from a total of 74 patients were collected 
from the time period 2012-2018 (REK: 2014/371). As a control, 27 non-cancerous samples 
were also collected including 23 fibroadenomas, 3 mammary reduction, and 1 BRCA1 
prophylactic mastectomy. Needle biopsies were performed at UNN hospital in Tromsø, and 
samples were prepared by pathologists. The study was approved by regional committees for 
medical and health research ethics (REK) and all the procedure were performed according to 
approved principles. To further investigate the association between NEAT1_2 expression and 
breast cancer subtypes, microarray gene expression data from three public breast cancer patient 
cohorts, METABRIC (PMID: 22522925), The Cancer Genome Atlas (TCGA - PMID: 
23000897), and Oslo2, were analysed. As the NEAT1_2 isoform is not poly-adenylated, 
standard sequencing methods which include a poly(A) purification step could not be used in 
our analyses. As total RNA is used as input for microarray gene expression analyses, cohorts 

























FIGURE 8. A pie chart showing number of patients in each cohort 
 47 
Discussion 
Mammalian cells are constantly exposed to intrinsic and extrinsic stressors. Cells have acquired 
a variety of mechanisms to preserve cellular homeostasis during stress. Such mechanisms 
involve the activation of one or several stress response pathways. DNA-damaging reagents 
activate DNA repair pathways, proteotoxic stress activates the heat shock response or the 
unfolded protein response pathways, mitochondrial dynamics and functions change upon 
hypoxia,  and nutrient deprivation results in activation of autophagy312. Initially, cells will try 
to preserve homeostasis by inducing cell repair mechanism. If the cells do not manage to re-
establish the balance, they will go through apoptosis, necrosis, and/or cell death caused by 
extensive autophagy312–314. The aim of this study was to add knowledge to the role of the long 
non-coding RNA NEAT1 in stress response pathways and breast cancer. We have found that 
NEAT1 expression and paraspeckle formation are induced during the heat shock response 
through HSF1-mediated transcriptional activation of the NEAT1 promoter. We further show 
that NEAT1_2 expression associates with HER2-positive cancers and hypothesize that 
NEAT1_1 and NEAT1_2 have distinct distribution and functions in different breast cancer 
subtypes.  Finally, we present evidence that autophagy is induced upon depletion of NEAT1 in 
breast cancer cell lines.  
SFN activates NEAT1 transcription through the heat shock response 
From the very beginning of this project, we hypothesized that NEAT1 could have a role in 
cellular autophagy. That made us analyse NEAT1 expression after exposing cells to a variety of 
agents known to induce autophagy (data not shown). One such agent is sulforaphane (SFN).  
As demonstrated in the paper I, SFN potently induces NEAT1 expression and paraspeckle 
formation. SFN is a well-known activator of the transcription factor NRF2315. The basal activity 
of NRF2 under non-stressed conditions is low due to its ubiquitination and rapid degradation 
by the 26 S proteasome. The turnover is tightly regulated by the redox sensitive protein Kelch-
like ECH-associated protein 1 (KEAP1) that binds to NRF2 in the cytoplasm and functions as 
an adaptor for the Cul3 ubiquitin ligase complex. SFN binds directly to and modifies cysteine 
151 of KEAP1 that leads to a conformational change that abolishes the interaction with NRF2. 
As this function of SFN is so established, we initially hypothesized that SFN-mediated 
activation of NEAT1 was dependent on NRF2 and a part of a cellular oxidative stress pathway. 
However, knockdown of NRF2 in MCF7 cells did not have any effect on SFN-induced NEAT1 
expression, indicating that the compound upregulated NEAT1 through another mechanism. We 
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then switched our attention to the heat shock response as heat shock factor 1 (HSF1) is also 
known to be activated by SFN316 transcription factor HSF1, within expression is not dependent 
on NRF2. In the paper I, we indeed demonstrate that HSF1 is responsible for transcriptionally 
upregulation of the NEAT1 gene via binding to a heat shock element (HSE) in the promoter. 
We show that this site is highly conserved in NEAT1 promoters among mammalian species, 
clearly supporting that activation of NEAT1 transcription is a universal and important 
mechanism in the heat shock response. Studies in mice indicate that Neat1 knockout mice and 
HSF1 knockout mice share some common features that supports that HSF1 is an important 
regulator of NEAT1. Both Neat1 and HSF1 knockout mice are viable suggesting that they are 
not required for normal development of the mouse embryo317,318. Both Neat1 and HSF1 are 
important for female fertility317. Interestingly, HSF1 is critical for mammary gland 
morphogenesis, as HSF1-knockout mice showed a severe defect in ductal branching and 
alveolar branching similar to what is observed in  Neat1 knockout mice78,319,320. Finally, both 
Neat1 knockout mice and HSF1 knockout mice are less susceptible to develop a tumor in a two-
step DMBA-TPA carcinogenesis model; and their depletion is associated with lesser 
proliferation, growth, invasion, and metastasis in a wide range of cancer cells56,77,156,175.  
The role of NEAT1 in the heat shock response is still unclear. In paper I, we show that NEAT1 
knockdown enhances and prolongs the upregulation of HSP70, HSP27, and HSP90 mRNAs 
during heat shock. This might indicate that NEAT1 has a regularly role in the turnover of the 
HSF1 protein. Alternatively, NEAT1 depletion might lead to accumulation of misfolded 
proteins that will activate HSF1, and thus give an additive effect during heat shock. In line with 
this, we do see a slight increase in the background expression of HSP70, HSP27, and HSP90 
upon NEAT1 deficiency. We hypothesize that NEAT1 has a protective role counteracting the 
accumulation of misfolded proteins, but further experiments should be undertaken to add proof 
to this hypothesis. The mechanism for this is obscure, but one might assume that increased 
NEAT1 expression and formation of paraspeckles during the heat shock response can lead to 
the sequestration of specific gene regulatory proteins or mRNAs, and thereby change the 
expression of specific genes.      
Findings of paper I endorse the importance of NEAT1 in stress response pathways. A general 
concept is emerging where NEAT1 expression is upregulated by key stress-activated 
transcription factors including HIF-2α, NF-κB, p53, ATF2, and now HSF1, to protect cells 
cellular functions and preserve homeostasis.  Most established cell lines grown in culture are 
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highly dependent on NEAT1 expression. It is important to acknowledge that the majority of the 
cell lines are transformed and constantly exposed to oncogenic stress.  
NEAT1_2 expression is associated with HER2-postive breast  
The two isoforms of NEAT1, NEAT1_1 and NEAT1_2, are overlapping and transcribed from 
the same promoter. Recent reports suggest that they may have distinct function in gene 
regulation36,321,322. NEAT1_2 is essential for the assembly of paraspeckles and exerts it gene 
regulatory function by sequestering specific mRNAs and proteins into these structures28,37,55,323. 
NEAT1_1, on the other hand, has also been suggested to interact directly with chromatin72,322. 
Given this, it is logical to hypothesize that they can have distinct functions in cancer. 
Importantly, NEAT1_2, but not NEAT1_1 expression, has recently been shown to predict 
progression-free survival of ovarian cancer that had been treated with platinum-based 
chemotherapy56. This prompted us to specifically investigate the expression of NEAT1_2 and 
paraspeckle formation in breast cancer subtypes. We chose a strategy where we first analysed 
a cohort of 74 breast cancer samples by NEAT1_2–specific RNA-FISH analyses. The samples 
were selected to represent ER-positive, HER2-positive and triple negative breast cancers. We 
then inspected microarray data from 2 publically available cohorts, as well as from a cohort 
generated by collaborators. Microarray data was preferred over RNA-Seq data, as the 
microarray technology use total RNA as input while RNA-Seq often includes an enrichment 
step for polyadenylated transcripts. As NEAT1_2 is not polyadenylated, RNA-Seq experiments 
including a poly(A) enrichment step will not be able to sequence the long isoform. We found 
that NEAT1_2 expression associates with high tumor grade and HER2-positive breast cancer. 
Moreover, we found a negative correlation between NEAT1_2 expression and ER-positive 
tumors. A similar expression pattern was also observed in breast cancer cell lines, where the 
highest expression of NEAT1_2 was detected in HER2-positive cell lines. Furthermore, in the 
3 different breast cancer cohorts NEAT1_2 expression was highest in cancers subclassified as 
HER2 enriched or luminal B, using to the PAM50 expression signature. Luminal A breast 
cancers showed the lowest expression of NEAT1_2 in all three cohorts. The association between 
HER2 and NEAT1_2 expression, suggests that NEAT1_2 is upregulated by a HER2-driven 
signalling pathway. As we in paper I showed that HSF1 activates NEAT1 transcription, it is 
reasonable to assume that HSF1 also had an important role in NEAT1 activation in HER2-
positive cancers. Indeed, it has been shown that HSF1 is required for HER2-mediated 
transformation in breast cancer cell lines324. Nuclear HSF1 staining and expression of HSF1-
target genes correlate with high-grade breast cancers, and with worse prognosis170,324,325. This 
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is however, independent of HER2 expression170. In contrast, it was recently shown that MCF7 
cells engineered to overexpress HER2, displayed increased levels of HIF-2, but not HIF1, 
both in normoxia and hypoxia326. In line with this, the HIF2A gene was highly expressed in 
HER2-enriched cancers. The expression of both HIF2A and HIF-2 target genes correlated 
with poor clinical outcome in HER2-positive cancers. It has been shown that HIF-2, but not 
HIF-1, can upregulate NEAT1 expression in breast cancer cells upon hypoxia59. As we can’t 
rule out that HSF1 is involved in upregulation of NEAT1_2 expression in HER2-positive 
cancers, it is logical to assume that this at least partially, can be a result of increased HIF-
2 expression. We are currently generating tissue micro arrays of our NEAT1 pilot cohort 
described in paper II, and will analyse the expression of the HSF1 protein by 
immunohistochemistry. Of note, we have found that HCC1569 that expresses high levels of 
NEAT1_2, display constitutive nuclear localization of activated HSF1 (Data not shown).  
An important observation described in paper II is that the distribution of total NEAT1 and 
NEAT1_2 expression is different among different breast cancer subtypes. NEAT1 expression in 
the TCGA microarray is measured by 5 different probes in total, of which one probe specifically 
binds to NEAT1_2 and the remaining 4 to the region that is common in both NEAT1_1 and 
NEAT1_2. By analysing data generated from the 4 overlapping probes, we found that total 
NEAT1 expression was highest in luminal A cancers that are ER-positive. This made us 
hypothesize that NEAT1_1 is highly expressed in ER-positive cancers. As discussed in paper 
II, this is in line with a recent publication by Li et al showing that NEAT1 is engaged in a 
repressor complex with FOXN3 and SIN3A that inhibits the expression of GATA3 specifically 
in ER-positive cancers322. The authors suggest that it is indeed the NEAT1_1 isoform that 
participates in this complex. Generally, in future studies, it is important to acknowledge that 
the two different isoforms of NEAT1 might have distinct expression patterns and functions, and 
care should be taken when choosing an experimental strategy. The overlapping nature of the 
two transcripts, will obviously hamper NEAT1_1 specific analysis by hybridization-based 
assays like RT-qPCR.  
As NEAT1_1 and NEAT1_2 are transcribed from the same promoter, it is not likely that 
transcriptional upregulation accounts for the isotype-specific expression in different breast 
cancer subtypes. Proteins that are specifically expressed in HER2-postive cancers might 
stabilize the NEAT1_2 transcript in paraspeckles. The production of NEAT1_1 might also be 
specifically inhibited in HER2-positive cancers. In the future, experiments should be 
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undertaken to further elucidate the mechanism behind isoform-specific expression of the 
NEAT1 in breast cancer.   
We report that NEAT1_2 is upregulated in human breast tissue during lactation and pregnancy 
confirming what has previously been reported in Neat1 knockout mice. This strongly suggests 
that NEAT1 expression is regulated by hormones or growth factors that orchestrate proliferation 
and/or differentiation of the mammary gland. A better understanding of this mechanism will be 
important to further understand the role of abnormal NEAT1 expression in breast cancer. 
Relevant to this, initial experiments in our lab failed to show any connections between prolactin 
treatment and NEAT1 levels in breast cancer cell lines.  
NEAT1 has role in basal autophagy 
NEAT1 expression is induced by a variety of stressors, and several lines of evidence suggest 
that it plays a role in cytoprotection and cell survival55,59. Cells depleted of NEAT1 have been 
shown to accumulate DNA damages and have dysfunctional mitochondria56,63. As we have 
shown that NEAT1 is activated upon the heat shock response, it is tempting to speculate that 
NEAT1 can counteract accumulation of misfolded proteins. Taken together, all these 
observations might indicate that NEAT1 plays a role in the regulation of cellular autophagy. In 
paper I, we indeed show that SFN that is known to induce autophagy, upregulates NEAT1 
expression. This led us to further investigate the impact of NEAT1 in autophagy. We started up 
by measuring the formation of lipidated LC3B, referred to as LC3B-II, in NEAT1 knockdown 
cells by western blot analyses. As lipidated LC3B is localized in the membranes of 
autophagosomes and autolysosomes, it is a marker of autophagic activity in cells. NEAT1-
depletion not only enhanced SFN-induced LC3B-II accumulation, but was sufficient to alter 
basic autophagy in 2 different breast cancer cell lines. Immunofluorescence analyses showed 
increased punctuated staining of endogenous LC3B in the cells. These punctas continued to 
accumulate after inhibition of lysosomal acidification by bafilomycin A. This led us to 
hypothesize that autophagy is induced upon NEAT1 deficiency. mTOR is a master regulator of 
autophagy that actively suppresses the process under normal physiological conditions198,199.  
Our results show that the mTOR activity is not affected upon NEAT1 depletion. In contrast, we 
found AMPK activity to be enhanced in NEAT1 knockdown cells. This was accompanied by 
increased phosphorylation of Ulk1 at Ser317 and Ser555, which is essential for autophagy 
induction201,327.  
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Recently, it was reported that NEAT1-depletion impaired mitochondrial dynamics and function, 
as paraspeckle disassembly affected the sequestration of mitochondrial mRNAs in the 
nucleus63. The same study showed that mitochondrial dysfunction was associated with lower 
mitochondrial respiration, lower ATP production, and reduction in mitochondrial DNA63. 
Therefore, it is very likely that a change in the ATP/AMP ratio activates AMPK that 
subsequently will initiate autophagy. A relevant question is whether NEAT1 is actively 
participating in one of the steps in autophagy, or if induction of autophagy is merely a 
consequence of accumulation of damaged macromolecules and organelles upon NEAT1 
deficiency. Based on recent reports, the latter is highly likely. Mitochondrial dysfunction upon 
NEAT1-depletion might induce mitophagy. Moreover, it is easy to envision that the severe 
effect on mitochondria will lead to the accumulation of reactive oxygen species (ROS)328–330. 
ROS can induce double stranded DNA breaks that can trigger autophagy via p53-dependent 
and independent mechanisms331. NEAT1-depletion will also lead to the disassembly of 
paraspeckles and potentially mislocalization of paraspeckle-associated proteins that again can 
elicit autophagy. Here, the potential mislocalization of the disease-associated proteins TAR 
DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS) is particularly interesting as 
they can influence autophagy332,333. Interstingly, TDP-43 can regulate autophagy by 
stabilization of the ATG7 mRNA332. One might envision that this ability can be repressed by 
sequestering TDP-43 into paraspeckles, and that NEAT1-depletion would relieve this 
repression. Finally, we have demonstrated that NEAT1 is activated by the heat shock response. 
Even though further mechanistic studies are required, it is tempting to speculate that NEAT1 
might function to counteract the accumulation of misfolded proteins that normally occurs when 
cells are exposed to agents that activate the heat shock response pathway. Thus NEAT1-
depletion might lead to the accumulation of misfolded proteins that will activate autophagy 
along with the ubiquitin-proteasome pathway (UPS)334. We can’t rule out that NEAT1 more 
specifically negatively regulates autophagy by repressing the expression of key autophagy 
genes at either transcriptional or post-transcriptional levels. This should be a subject for future 
research. 
In paper III, we suggest that NEAT1-depletion leads to the induction of autophagy. This would 
normally lead to reduced levels of the selective autophagy receptor p62 as it is degraded with 
its cargo in autolysosome217. However, we repeatedly observed an accumulation of the p62 
protein in NEAT1 knockdown cells. This might indicate that NEAT1 expression is required for 
normal lysosomal activity. It has been shown that loss of mitochondrial functions severely 
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affects the structure and function of the lysosomes335–337. Therefore, experiments aimed at 
analysing lysosomal activity should be undertaken in NEAT1-depleterd cells in the future. As 
discussed in paper III, ROS can also activate the expression of the SQSTM1 gene that encodes 
p62 via the transcription factor NRF2. Initial experiments in our lab suggest that this indeed 
can be the case, but further studies are required to confirm this.   
NEAT1 in human diseases 
In this doctoral thesis, we have shown that NEAT1 expression and paraspeckle formation are 
activated during the heat shock response and provided evidence suggesting that NEAT1-
depletion leas to induction of autophagy. Interestingly, defects in both these processes are 
associated with neurodegenerative diseases. The heat shock response has a critical role in 
repairing or degrading misfolded proteins338. Misfolded proteins generally tend to form 
aggregates that disturb ordinary functions within a cell. Formation of protein aggregates or 
inclusions are known to destroy neurons and is the direct cause of neurodegenerative diseases 
including amyotrophic lateral sclerosis (ALS), Huntington’s disease, Parkinson’s disease, and 
Alzheimer339. Loss of HSF1 expression or activity is frequently observed in these 
diseases174,340–342. Autophagy has also a critical role in clearance of protein aggregates, and 
autophagy is severely abrogated in most neurological diseases249.On the other hand, excessive 
autophagy can have an adverse effect on neuronal cells343. As our results suggest that NEAT1 
has a role in both in the heat shock pathway and autophagy, it is no surprise that also NEAT1 
has been found to be abnormally expressed in neurodegenerative disorders. Several reports have 
shown that NEAT1 is abnormally expressed in ALS and Huntington's disease118,120,126. 
Emerging evidence suggests that NEAT1 expression and paraspeckle formation might have a 
protective role in neuronal cells in early stages of ALS and Huntington's disease. As mentioned 
above, two paraspeckle proteins, FUS and TDP-43, are associated with ALS344. Paraspeckles 
are highly dynamic structures119,120,126. It is natural to assume that loss of paraspeckles might 
lead to mislocalization and aggregation of TDP-43 and FUS. Importantly, both proteins have 
also been shown to regulate the morphology and function of paraspeckles120. One might 
envision that HSF1 induces NEAT1 expression at an early stage in the disease in order to protect 
neuronal cells from misfolded proteins. HSF1 can also induce autophagy through 
transcriptional activation of the ATG7 gene345. However, the very intricate interconnection 
between NEAT1, paraspeckle formation, the heat shock response and autophagy in neurological 
disorders needs to be further explored.  
 
 54 
NEAT1 is abnormally expressed in many cancers. Cancer cells are constantly exposed to 
intrinsic and extrinsic stressors346–348. Consequently, many stress response pathways, including 
the heat shock pathway, are constitutively activated in malignant cells156. Emerging evidence 
suggests that NEAT1 has a role in protecting organelles and macromolecules form stress-
induced damages55,59. Therefore, it is likely that NEAT1 has an important cell survival function 
in cancer cells. This is potentially a serious obstacle in cancer therapy. Chemotherapeutic agents 
and radiation therapy act by increasing the stress burden in cancer cells. Importantly, elevated 
NEAT1 expression is associated with drug resistance. In paper II we show that NEAT1_2 is 
specifically expressed in breast cancer tissue, but not in normal surrounding tissue. This is 
indicating that NEAT1 can be a promising target for therapeutic intervention.  Cancer drugs 
based on antisense oligos have indeed attracted attention as they are highly specific349. We 
present evidence that NEAT1 can repress autophagy. Loss of autophagy is associated with 
initiation of cancer252,350,351. However, at later stages of cancer development, enhanced 
autophagy is associated with drug resistance. Thus, NEAT1 targeting in cancer cells should be 
accompanied by agents that inhibit autophagy.  
Future perspective 
Mammalian cells express a plethora of non-coding RNA molecules352,353. The function of the 
vast majority of them is still enigmatic, and many of them might by seen as transcriptional by-
products. In this regard, NEAT1 is clearly an exception. Although viable, mice lacking Neat1 
expression display developmental defects with compromised mammary gland formation being 
the most pronounced78. Since its discovery in 2007, several studies have shown that NEAT1 is 
activated upon cellular stress, and several lines of evidence suggest that it confers cell protection 
and survival upon such conditions. The NEAT1 locus is transcribed into two overlapping 
isoforms, NEAT1_1 and NEAT1_2. NEAT1_2 is critical for the assembly of paraspeckles23. 
Although both isoforms of NEAT1 are implicated in gene expression regulation, recent research 
suggests that they have distinct subcellular localization and functions36. NEAT1 is abnormally 
expressed in cancer and in neurons upon neurodegenerative diseases. During the last few years, 
a large number of papers have suggested NEAT1 as a biomarker in a variety of cancers, and 
many researchers have suggested it works as a competing endogenous RNA sponging 
miRNAs77. However, proper mechanistic studies aimed at clearly elucidating the role of NEAT1 
in   physiology and pathophysiology, are still scarce. This is probably partially due to technical 
difficulties, and isoform-specific studies are hampered by the overlapping nature of the two 
transcripts. More than 40 proteins have been shown to be associated with paraspeckles. 
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Paraspeckles are highly dynamic structures that change in morphology and probably functions 
depending on NEAT1_2 expression and the presence and recruitment of specific proteins27,30,354. 
Many of the RNA binding proteins in the paraspeckles have features that lead to liquid-liquid 
phase separation in the nucleus, and paraspeckles can be regarded as liquid drop-like 
membraneless organelles32,33. This dynamic feature is probably instrumental for their roles in 
widely regulating gene expression. As the number of proteins associated with paraspeckles are 
high, and they retain a wide variety of mRNAs, we still probably only see the top of the iceberg 
when it comes to the number of gene regulatory incidences they participate in. Thus, the gene 
regulatory functions of both isoforms of NEAT1 should be a topic for further research. Recently 
it was reported that NEAT1 paraspeckles actively crosstalk with mitochondria63. This is a 
particularly interesting feature as it might account for many of the functions of NEAT1 upon 
stress and pathological conditions. These interactions need to be further analysed in the future.  
 As mentioned above, NEAT1 is abnormally expressed in many human diseases including 
cancer and neurological disorders. These are devastating diseases that desperately need 
increased understanding and identification of new therapeutic targets. This should motivate 
further studies to understand the role of NEAT1 in cellular stress and pathogenesis. As 
mentioned above, RNA molecules are theoretically attractive drug targets. They can be targeted 
by antisense oligos that are highly specific. And as NEAT1 is frequently seen specifically 
overexpressed in cancer cells, probably due to malignancy-associated stress, a therapeutic 
window should exist.  
In the future it is important to address whether NEAT1_1 and NEAT1_2 have different 
expression and functions in diseases. It has been shown that NEAT1_2, but not NEAT1_1, can 
predict the disease free survival of cervical cancer after treatment56. We have also suggested 
that the relative expression of the two isoforms differs in different breast cancer subtypes. This 
may contribute to the different gene expression pattern we see in different breast cancer 
subtypes, and potentially also predict the outcome of specific treatment. Furthermore, we 
observed a positive correlation between the level of NEAT1_2 and subtypes of breast cancers. 
As each subclass of breast cancer have an exclusive genetic signature and specific phenotype, 
the mechanism that breast cancer cell gain capability to generate longer isoform can suggest a 
therapeutic strategy. Luminal A breast cancer with the highest level of NEAT1_1 has the best 
survival among other subtypes, whereas, Her2-positive breast cancer with the highest level of 
NEAT1_2 had worse prognosis suggest that different isoform of NEAT1 can play different roles 
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in breast cancer, as it also showed in colorectal cancer355. Therefore, it emphasizes the need for 
more research on the signalling pathway and function of NEAT1 in breast cancer. Finally, the 
majority of the publication confirmed the oncogenic role of NEAT1 in cancer. Moreover, 
targeting NEAT1 has been shown to reduce proliferation and resistance to chemotherapy, as it 
has been verified in our study56,72,96–106. Therefore, it could be a great deal if we can design a 
therapeutic strategy to specifically inhibit NEAT1_1 or NEAT1_2 in breast cancer cells in vivo 
and finally in patients. 
Conclusion 
In this doctoral thesis, we have showed that NEAT1 is involved in the heat shock response and 
autophagy. We have also demonstrated that NEAT1_2 is highly expressed in HER2-positive 
breast cancers. We suggest that the two NEAT1 isoforms might have distinct expression pattern 
in different cancers. Our work is an important contribution to the understanding of the role of 
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The long non-coding RNA (lncRNA) NEAT1 is the 
architectural component of nuclear paraspeckles, 
and has recently gained considerable attention as it 
is abnormally expressed in pathological conditions 
such as cancer and neurodegenerative diseases.  
NEAT1 and paraspeckle formation are increased in 
cells upon exposure to a variety of environmental 
stressors, and believed to play an important role in 
cell survival.  The present study was undertaken to 
further investigate the role of NEAT1 in cellular 
stress response pathways. We show that NEAT1 is 
a novel target gene of heat shock transcription 
factor 1 (HSF1), and upregulated when the heat 
shock response pathway is activated by 
Sulforaphane (SFN) or elevated temperature. HSF1 
binds specifically to a newly identified conserved 
heat shock element (HSE) in the NEAT1 promoter. 
In line with this, SFN induced the formation of 
NEAT1-containing paraspeckles via a HSF1-
dependent mechanism. HSF1 plays a key role in the 
cellular response to proteotoxic stress by promoting 
the expression of a series of genes, including those 
encoding molecular chaperones.  We have found 
that the expression of HSP70, HSP90, and HSP27 
is amplified and sustained during heat shock in 
NEAT1-depleted cells compared to control cells, 
indicating that NEAT1 feeds back via an unknown 
mechanism to regulate HSF1 activity. This 
interrelationship is potentially significant in human 
diseases such as cancer and neurodegenerative 




 NEAT1 (Nuclear Enriched Abundant 
Transcript 1) is a highly abundant long non-coding 
RNA (lncRNA) that is essential for the formation 
of specific nuclear bodies called paraspeckles (1-3). 
There are two overlapping isoforms of NEAT1 
transcribed from the same promoter: NEAT1_1 of 
3.7 kb and NEAT1_2 of 22.3 kb (2-4). NEAT1_2 
is indispensable for paraspeckle formation and is 
generated when the polyadenylation signal, and 
thus termination of the NEAT1_1 transcript, is 
suppressed by an hnRNPK-dependent mechanism 
(4). Unlike NEAT1_1, the 3’ end of NEAT1_2 is 
not polyadenylated, but processed by RNAse P 
cleavage and subsequently stabilized through 
formation of a triple helical structure (3,5,6). 
 http://www.jbc.org/cgi/doi/10.1074/jbc.RA118.004473The latest version is at 



















Whereas NEAT1_1 is highly expressed in many 
tissues in mice, the expression pattern of 
NEAT1_2, and consequently the presence of 
paraspeckles, are more restricted (7). Recently, 
NEAT1 was found to be required for mammary 
gland development and lactation in mice (8). 
NEAT1 has also a critical role in corpus luteum 
formation (9). Even though the function of NEAT1 
is still not fully understood, several reports have 
suggested that increased NEAT1 expression 
regulates the expression of certain genes by 
sequestering specific mRNAs and proteins into 
paraspeckles (10-12). NEAT1 expression is 
upregulated in response to different cellular 
stresses including viral infections, proteasome 
inhibition, oncogene-induced replication stress, 
and hypoxia (11-17). Emerging evidences suggest 
that NEAT1 plays a cytoprotective role, as cells 
deficient of NEAT1 display increased sensitivity 
towards stress-induced cell death (11,15). In line 
with this, NEAT1 was found to be transcriptionally 
activated by HIF2 in response to hypoxia in 
cancer cells, and more recently, reported as a p53 
target gene that prevents replication stress and 
DNA damage induced by mutagenic agents and 
oncogenes (13,15,18,19). Interestingly, high levels 
of NEAT1 are associated with tumorigenic 
characteristics and poor clinical outcome in several 
human cancers (13,15,20).  
 Cells are constantly subjected to extrinsic 
and intrinsic stressors that might have detrimental 
effects unless neutralized by specific cytoprotective 
mechanisms. The heat shock response is a universal 
cellular defense mechanism towards agents causing 
proteotoxic stress (21,22) . Elevated temperatures, 
as well as wide range of oxidative and electrophilic 
agents, cause misfolding and damage of cellular 
proteins that will lead to cellular dysfunction or 
death unless repaired and/or removed. The heat 
shock transcription factor 1 (HSF1) plays a key role 
in this response mechanism (21-24). Under normal 
conditions, HSF1 is kept in an inactive form in the 
cytoplasm by a multichaperone complex consisting 
of Hsp90, Hsp70, Hsp40, and TriC (23,25-29). 
Upon activation, HSF1 is released from the 
repressive complex, undergoes a series of 
posttranslational modifications, and forms 
homotrimers that accumulates in the nucleus 
(21,23,30). Here, HSF1 stimulates the transcription 
of genes encoding proteins involved in repair and 
clearance of damaged proteins (21,23,31). HSF1 
specifically binds to heat shock elements (HSE), 
inverted repeats of nGAAn where “n” is any 
nucleotide, in the upstream regulatory regions of its 
target genes (32,33). Among the best-studied target 
genes of HSF1 are those encoding protein 
chaperones including Hsp70 and Hsp90 that restore 
proteostasis by regulating folding, activity, and 
degradation of proteins (34,35). The heat shock 
response is attenuated when HSF1 is released from 
the promoters of its target genes, and either 
degraded or re-engaged into the HSF1-repressive 
multichaperone complex by a negative feedback 
mechanism (21,36).  
 Here, we report that the isothiocyanate 
compound sulforaphane (SFN) induces NEAT1 
expression and paraspeckle formation in MCF7 
cells. This is not dependent on the Keap1-NRF2 
pathway, but on binding and transcriptional 
activation of the NEAT1 promoter by HSF1. We 
have identified a HSE site in the NEAT1 promoter 
that is highly conserved among vertebrates. 
Moreover, we show that NEAT1 is upregulated in 
response to heat shock demonstrating that 
upregulation of NEAT1 is a general event in the 
heat shock response. Finally, we demonstrate that 
the expression of HSP70, HSP90, and HSP27 is 
enhanced and sustained in the heat shock response 




SFN induces NEAT1 expression and paraspeckle 
formation 
Several lines of evidence clearly point towards 
NEAT1 being a stress-induced lncRNA that is 
involved in cytoprotection (11,13,15). NEAT1 
expression has recently been shown to be induced 
by hypoxia and confers protection to hypoxia-
induced cell death in breast cancer cells (15). To 
further determine the role of NEAT1 in oxidative 
stress, MCF7 cells were treated with the 
isothiocyanate sulforaphane (SFN), which triggers 
an antioxidative response in cells by modifying 
thiol groups in several proteins, including Keap1 in 
the Keap1-NRF2 pathway (37,38).  NEAT1 
expression was assessed by RT-qPCR using two 
different primer sets; one recognizing both 
isoforms and one solely recognizing the long 



















rapidly induced the expression of NEAT1 in MCF7 
cells (Fig. 1A). Pretreatment of cells with N-
acetylcysteine, a strong antioxidant and precursor 
of cellular glutathione, counteracted the effect of 
SFN on NEAT1 expression (Fig. 1B).  
Paraspeckles are dynamic ribonucleoprotein 
complexes that form around the NEAT1_2 isoform 
in the nucleus (4). To determine if SFN-induced 
NEAT1 expression is associated with increased 
paraspeckle formation, we performed RNA-
fluorescence in-situ hybridization (RNA-FISH) on 
untreated and SFN-treated MCF7 cells using 
probes recognizing the long NEAT1_2 isoform. 
Whereas NEAT1_2-containing punctas appeared 
small and scarcely distributed in the nucleus of 
untreated MCF7 cells, SFN treatment potently 
increased the numbers and the overall signal 
intensity of the paraspeckles (Fig., 1C and D).  
 
SFN-induced NEAT1 expression is not dependent 
on NRF2 
SFN stimulates several stress signaling pathways in 
cells, of which the Keap1-NRF2 pathway is the 
most prominent. To determine if NRF2 is involved 
in SFN-induced NEAT1 expression, MCF7 cells 
were transfected with an siRNA towards NRF2 and 
stimulated with SFN for 6 hours. The NRF2 protein 
accumulated after 6h SFN treatment, but its 
depletion did not interfere with the induction of 
NEAT1 (Fig. 2A). We also assessed the NEAT1 
expression in control and NRF2-depleted cells after 
a prolonged treatment with SFN for 24 hours. 
Elevated levels of NEAT1 were observed in both 
control and siNRF2-transfected cells (Fig. 2B). In 
contrast, SFN-mediated induction of NQO1 
mRNA, a well-established target of NRF2, was 
severely reduced in NRF2-depleted cells (Fig. 2C). 
We conclude that SFN-induced NEAT1 expression 
is not dependent on the Keap1-NRF2 pathway. 
 
SFN-induced NEAT1 expression and paraspeckle 
formation are dependent on HSF1 
SFN, as well as other oxidants, have recently been 
shown to stimulate HSF1, the key transcription 
factor conferring cellular protection to agents 
causing protein misfolding (39,40). We therefore 
sought to determine if SFN-induced NEAT1 
expression is dependent on a mechanism involving 
HSF1. SFN treatment indeed induced a mobility 
shift of HSF1, which is associated with its 
activation, and nuclear accumulation of the protein 
(Fig. 3, A and B). Consistent with the observed shift 
and nuclear translocation of HSF1, SFN potently 
induced the expression of the HSP70 mRNA, a 
prominent target gene of HSF1 (Fig. 3C). We next 
transfected MCF7 cells with two different siRNAs 
specifically silencing HSF1 expression, and 
determined the effect on SFN-induced NEAT1 
expression. Both siRNAs significantly reduced the 
increase in NEAT1 levels observed after SFN 
treatment (Fig. 3D). The same was observed when 
HSF1 expression was silenced in SFN-treated 
HeLa cells (Fig. 3E).  To determine if SFN-induced 
paraspeckle formation is dependent on HSF1, we 
performed co-immuno-FISH analyses on control 
and HSF1-depleted cells using an HSF1 antibody 
and probes specifically binding to NEAT1_2. In 
line with the observations described above, SFN 
enhanced the nuclear staining of HSF1 (Fig. 4, A 
and B) and the formation of NEAT1_2 containing 
paraspeckles (Fig. 4, A and C). Importantly, SFN-
induced paraspeckle formation was severely 
compromised in HSF1-depleted cells (Fig. 4, A and 
C). Taken together, our data clearly demonstrate 
that HSF1 is essential for increased NEAT1 
expression and paraspeckle formation as response 
to SFN-treatment in MCF7 cells.   
 
NEAT1 is transcriptionally regulated by HSF1 
Having established that SFN induces NEAT1 
expression by an HSF1-dependent mechanism, we 
next asked if SFN treatment leads to transcriptional 
activation of the NEAT1 gene. A luciferase 
reporter vector containing nucleotides -4040 to 
+144 of the NEAT1 upstream regulatory region 
was generated and transfected into MCF7 cells.  
Reporter gene assays were performed in extracts 
from untreated and SFN-treated cells. SFN 
significantly stimulated the NEAT1 promoter-
driven luciferase activity (Fig. 5A). This 
stimulation was severely compromised upon co-
transfection with an HSF1-directed siRNA, 
demonstrating that SFN-induced activation of the 
NEAT1 promoter is dependent on HSF1 (Fig. 5B). 
HSF1 binds to heat shock elements (HSE) within 
its target genes that are composed of alternating 
inverted repeats of 5 base pairs, nGAAn where “n” 
is any nucleotide (32,33). We carefully inspected 
the NEAT1 promoter, and identified three putative 



















445 and -431 specifically caught our attention as it 
is highly conserved between species (Fig. 5C).  To 
determine if this region is involved in SFN-
activated NEAT1 transcription, a truncated 
construct of the NEAT1 promoter reporter vector 
was made containing nucleotides -470 to +144. We 
also made a mutated version where we introduced 
four point mutations in the predicted HSE core, and 
both constructs were transfected into MCF7 cells. 
SFN potently stimulated transcription from the 
truncated NEAT1 promoter (Fig. 5D). This 
stimulation was absolutely dependent on an intact 
HSE core, as point mutations in this region totally 
abolished the SFN-induced increase in NEAT1 
promoter driven luciferase activation. To analyze if 
HSF1 can bind to the NEAT1 promoter in vivo, 
ChIP experiments were conducted on untreated and 
SFN treated MCF7 cells using an antibody against 
HSF1 and RT-qPCR primers amplifying a 100 base 
pair fragment of the NEAT1 promoter 
encompassing the HSE site. HSE-containing 
NEAT1 promoter fragments co-precipitated with 
the HSF1 antibody (Fig. 5E). Importantly, SFN 
robustly increased HSF1 binding to NEAT1 HSE 
fragments. Primers amplifying a GAPDH fragment 
and a region of the NEAT1 promoter upstream of 
the HSE site (“upstr”) were used as controls. 
Control ChIPs with IgG gave very high Ct values 
compared to that of the HSF1 antibody and, 
importantly, showed no differences upon SFN 
stimulation. 
 
NEAT1 is induced by heat shock 
Having established that NEAT1 levels are 
enhanced by an HSF1-dependent mechanism upon 
SFN treatment, we next sought to determine if 
NEAT1 is induced as response to heat shock (HS). 
MCF7 cells were incubated at 43°C for 30 min, and 
either harvested directly, or after recovery at 37°C 
for the indicated periods. HSF1 was rapidly 
activated during HS as assessed by a mobility shift 
in western blot (Fig. 6A). This was accompanied by 
increased expression of the HSP70 mRNA (Fig. 
6B). Importantly, HS rapidly and transiently 
stimulated the expression of NEAT1 (Fig. 6C). 
This indicates that elevated NEAT1 expression is a 
general mechanism in the heat shock response 
pathway. 
 
Proliferation is compromised and expression of 
HSF1 target genes is amplified in NEAT1-depleted 
cells  
Elevated NEAT1 levels and paraspeckle formation 
in response to cellular stress are widely observed, 
and believed to play a pro-survival role by 
regulating the expression of specific genes. To start 
unravelling the function of NEAT1 in the heat 
shock response, we measured the sensitivity of 
control and NEAT1-depleted cells to heat shock by 
cell confluence proliferation assays. MCF7 cells 
were transfected with NEAT1-specific gapmeR 
antisense oligonucleotides (ASOs), which 
generally reduced the NEAT1 expression by 70-80 
% for up to 120 hours, or a control gapmeR. Cell 
confluence was then monitored for 96 hours using 
the IncuCyte® live cell analysis system. After the 
first 48 hours, half of the cells were subjected to 
heat shock for 30 min, and then returned to 
IncuCyte system for another 48 hours. Strikingly, 
NEAT1-depletion severely decreased the 
confluency of MCF7 cells, indicating that NEAT1 
is necessary for their proliferation or survival (Fig. 
7A). The proliferation rate was not further 
decreased after heat shock compared to cells kept 
at 37°C over the whole monitoring period (Fig. 7A 
and B). Taken together, this suggests that NEAT1 
is generally required for the proliferation or 
survival of MCF7 cells, and that an additional stress 
such as heat shock, does not further affect the 
already growth-inhibited cells. Control-transfected 
cells generally recovered well after heat shock with 
only a slight reduction in confluency (Fig 7A and 
B). 
 To further analyze the role of NEAT1 in the 
heat shock response, we assayed the expression of 
the HSF1 target genes HSP70, HSP90, and HSP27 
in control and NEAT1-depleted cells. MCF7 cells 
were transfected with two different gapmeR ASOs, 
which either targeted both isoforms of NEAT1, or 
solely the long NEAT1_2 isoform. Transfected 
cells were exposed to heat shock and HSP70, 
HSP90, and HSP27 expression was assessed by 
RT-qPCR.  Interestingly, the expression of all 
target genes was repeatedly amplified and 
sustained in cells where NEAT1 was silenced, 
compared to cells transfected with a control 
gapmeR (Fig. 8). Moreover, the background 
expression in unstressed cells was slightly 



















target genes was observed for cells transfected with 
the gapmeR targeting both isoforms of NEAT1, 
compared to those transfected with the gapmeR 
only silencing the NEAT1_2 isoform. Taken 
together, our data suggest that NEAT1-depletion, 
by some mechanism, potentiates the HSF1 activity 
by either creating additional proteotoxic stress in 
the cells, or by regulating the turnover or the 
activity of the HSF1 protein.  
 
DISCUSSION 
High-throughput RNA-sequencing has 
demonstrated that most cells express a plethora of 
long non-coding transcripts (41,42). During the last 
few years, huge efforts have been made to reveal 
their biological function, and many of them now 
appear as important contributors to gene regulation 
at different levels. NEAT1 is the architectural 
component of nuclear ribonucleoprotein complexes 
called paraspeckles, and has recently gained 
considerable attention as several reports have 
shown that the transcript is abnormally expressed 
in human diseases including cancer (13,15,20). The 
function of NEAT1 remains elusive, but emerging 
evidences suggest that NEAT1 and paraspeckles 
have a role in cytoprotection. Here, we show that 
NEAT1 is induced at the transcriptional level by 
the isothiocyanate compound sulforaphane (SFN). 
This is accompanied with increased paraspeckle 
formation. SFN mimics oxidative stress in cells by 
modifying thiol groups in cellular proteins, and 
induces antioxidative response pathways of which 
Keap1-NRF2 is the most prominent (37,38).  We 
demonstrate that SFN-induced NEAT1 expression 
is not dependent on NRF2. In contrast, depletion of 
HSF1 severely abrogates SFN-induced NEAT1 
expression and paraspeckle formation. Several 
reports have shown that SFN and other sulfhydryl-
reactive compounds can stimulate the heat shock 
response pathway in cells by activating HSF1 
(39,40,43,44). The mechanism for how SFN 
activates HSF1 is somewhat obscure, but previous 
studies have shown that oxidative compounds 
might promote the DNA-binding activity of HSF1 
by modifying cysteine residues in the DNA-
binding domain (45,46). SFN has also been shown 
to modify Hsp90 and thereby disrupt complex 
formation between Hsp90 and its protein partners 
(47,48). Recently, Naidu et al. reported that 
phenethyl isothiocyanate (PEITC) indeed modified 
cysteine residues within Hsp90 leading to 
dissociation and activation of HSF1 (44).  
 Our results show that HSF1 accumulates in 
the nucleus upon SFN treatment and binds to the 
NEAT1 promoter in vivo. We have identified a 
conserved HSE in the NEAT1 promoter that is 
critical for SFN-induced transcriptional activation 
of the NEAT1 gene. Intriguingly, this site overlaps 
with a recently reported NF-B binding site, which 
is necessary for LPS-induced NEAT1 expression in 
lung cancer cells (49). An overlapping NF-B and 
HSF1 binding site has been identified previously in 
the promotor of the gene encoding MHC Class I 
Chain-Related Protein A (MICA) (50). Here, HSF1 
and NF-B bind mutually exclusive to the site, and 
overexpression of a truncated version of HSF1 
containing only the DNA-binding domain 
outcompetes NF-B binding and abolishes TNF-
induced MICA expression. If the overlapping 
HSF1/NF-B site in the NEAT1 promoter 
represents a regulatory hub, coordinating outputs 
from different signaling pathways, remains to be 
resolved.  
 In the present study we show that NEAT1, 
as well as being induced by SFN, is also induced 
upon heat shock. This clearly suggests that NEAT1 
upregulation is a general phenomenon in the heat 
shock response. This is supported by a study by 
Hirose et al., demonstrating that NEAT1 
expression and paraspeckle formation are induced 
by inhibition of the 26S proteasome by MG132 or 
Bortezomib (11).  Proteasome inhibition causes a 
proteotoxic stress in the cells as proteins that are 
destined for degradation form aggregates in both 
the cytoplasm and the nucleus (11,51). Activation 
of HSF1 to induce expression of molecular 
chaperones, is a general cellular response 
mechanisms to proteasome inhibition (52-54).  
Thus, we envision that NEAT1 induction upon 
proteasome inhibition might be mediated by HSF1-
mediated transcriptional activation of the NEAT1 
promoter.   
 Several reports have shown that NEAT1-
depletion sensitizes cells to a variety of stressors. 
Thus, we hypothesized that knock down of NEAT1 
expression would make cells more susceptible to 
heat shock. However, we repeatedly observed that 
transient transfection with NEAT1 antisense oligos 
by itself, dramatically reduced the proliferation of 



















reinforced by heat shock. This shows that MCF7 
cells cultivated in vitro, are highly dependent on 
NEAT1. To further dissect the function of NEAT1 
in the heat shock response, we knocked down 
NEAT1 expression by antisense oligos and 
assessed the effect on the expression of three HSF1 
target genes including HSP70, HSP90, and HSP27. 
Interestingly, knockdown of NEAT1 amplified and 
prolonged the expression of these target genes. The 
mechanism for this is still obscure. NEAT1-
depletion abrogates the formation of paraspeckles  
(4). This might lead to mislocalization of 
paraspeckle-associated proteins that disturbs 
proteostasis in the cells, and thereby contribute to 
the activation of HSF1. Alternatively, NEAT1 
might regulate the turnover of the HSF1 protein or 
activity by a negative feedback mechanism. 
Interestingly, the effect of NEAT1-depletion on 
HSF1 target genes, was significantly stronger when 
cells were transfected with a gapmeR targeting both 
isoforms compared to one only reducing NEAT1_2 
expression. This indicates that the short NEAT1_1 
isoform has an important function in the regulation 
of the heat shock response. 
 HSF1 plays a critical role in the cellular 
defense to proteotoxic stress. Many 
neurodegenerative diseases including amyotrophic 
lateral sclerosis (ALS), Huntington’s disease, and 
Alzheimer are associated with the formation of 
protein aggregates (31,55). Loss of HSF1 
expression or activity is frequently observed in 
these diseases (55-58). Our results demonstrate that 
HSF1 activates the expression of NEAT1 during 
the heat shock response. Interestingly, several 
reports have shown that NEAT1 is abnormally 
expressed in ALS and Huntinton’s disease (59-61). 
Moreover, mislocalization of two paraspeckle 
proteins, FUS (Fused in sarcoma) and TDP-43 
(TAR DNA-binding protein-43) is well-known to 
be associated with ALS (62). It has been speculated 
that NEAT1 expression and paraspeckle formation 
might have a protective role in neuronal cells in 
early stages of ALS and Hungtinton’s disease 
(60,61,63). In line with this, Hirose et al. showed 
that mouse embryonic fibroblasts from NEAT1 
knockout cells displayed an increased sensitivity to 
proteasome inhibitors causing formation of protein 
aggregates, compared to wild-type cells (11). The 
crosstalk between NEAT1, paraspeckle formation, 
sub-cellular localization of FUS and TDP-43, and 
HSF1 in these devastating diseases should be a 
focus of future research.  
 Constitutive activation of HSF1 and 
abnormal expression of NEAT1 are both frequently 
observed in human cancers (13,15,20,64-66). There 
are clear evidences that both HSF1 and NEAT1 
have cytoprotective roles in tumors and are 
associated with poor prognosis. In the present 
study, we demonstrate that NEAT1 is a novel target 
gene of HSF1. It remains to be determined if there 
is any correlation between HSF1 activation and 
NEAT1 expression in cancer. 
 
EXPERIMENTAL PROCEDURES 
Cell culture and treatments 
MCF7 (ATCC® HTB-22™) and HeLa (ATCC® 
CCL-2™) cells were purchased from American 
Type Culture Collection and maintained in minimal 
essential medium (MEM, Sigma-Aldrich) 
supplemented with 10% fetal bovine serum 
(Biochrom) and 1% penicillin-streptomycin 
(Sigma-Aldrich). MCF7 cells were cultured in the 
presence of 0.01 mg /ml insulin (Sigma-Aldrich). 
All Cells were grown at 37°C in humidified 
condition containing 5% CO2. Sulforaphane (SFN, 
cat# S4441) and N-acetyl cysteine (NAC, cat# 
A9165) were purchased from Sigma-Aldrich. SFN 
was added to the cells at a final concentration of 20 
M for short-term treatments up to 8 hours, and at 
a final concentration of 10 M for long-term 
treatment (24 hours). When included, NAC (5 mM) 
was added to the media 1 hour before SFN 
treatment. To induce a cellular heat shock response, 
cells were incubated at 43°C for 30 minutes, and 




The human NEAT1 promoter (-4040/+144) was 
cloned from genomic DNA by performing two 
PCR amplification reactions using 
PrimeSTAR®GXL DNA Polymerase (Takara Bio 
Inc, R050Q) generating fragments of 1756 bp 
(primers NP1.1F/NP2.1R) and 2414 bp (nested 
PCR, outer primer set NP2.1F/NP3.1R; inner 
primer set NP2.2F/NP3.2R). The 1756 bp fragment 
was digested with NheI (provided in primer) and 
HindIII (internal) and cloned into corresponding 
sites in pGL3-Basic (Promega). This was followed 



















HindIII site using internal HindIII sites. The 
resulting pNEAT1(-4040/+144)-Luc plasmid was 
verified by sequencing. pNEAT1(-470/+144)-luc 
was generated from a promoter construct 
containing the 2414 PCR-product (pNEAT1(-
2384bp/+144)-luc) by cutting with KpnI and PstI 
followed by religation. pNEAT1(-470/+144)-
HSEmut-luc was made by site-directed 
mutagenesis according to the QuickChange II Site-
Directed Mutagenesis kit protocol (Agilent 
Technologies). All primer sequences are provided 
in Table 1. 
 
RNA interference  
siNRF2 (siGENOME SMART pool Human 
NFE2L2, DM-003-755-02) was purchased from 
Dharmacon, and siHSF1_#1 (Silencer® Select, 
s6950), siHSF1_#2 (Silencer® Select, s6952), and 
Silencer® Select Negative Control No.2 were 
obtained from Thermo Fisher Scientific. Locked 
nucleic acid (LNA)-GapmeR NEAT1 antisense 
oligos and control GapmeRs were purchased from 
Exiqon. All sequences are provided in Table 1. 
Cells were transfected using Lipofectamine 2000 
according to the reverse transfection protocol 
provided by the manufacturer (Thermo Fisher 
Scientific).  Successful knock down was verified by 
RT-qPCR or Western blot analyses. 
 
Reverse transcription and quantitative PCR  
Cells were lysed in 300 µl Tri Reagent, and total 
RNA was isolated with Direct-zol RNA MiniPrep 
(Zymo Research) according to the manufacturer. 
RNA concentration was measured by NanoDrop 
2000 (Thermo Fisher Scientific), and cDNA 
synthesis of total RNA was performed with 
SuperScript™ IV Reverse Transcriptase (Thermo 
Fisher Scientific). 2.5 μM of random hexamer 
primer (Thermo Fisher Scientific) and 
approximately 250 ng of template was used for the 
reaction. Total RNA was denaturated at 65ºC for 5 
min, and cDNA was synthesized at 50 ºC for 10 
minutes. Quantitative PCR was run on a 
LightCycler 96 (Roche Life Science) with the 
SYBR green reaction mix FastStart Essential DNA 
Green Master (Roche Life Science) and 0.25 μM 
forward and reverse primer.  (Thermal cycle 
conditions; 95°C 10 minutes and 40 cycles of 95°C 
10 seconds, 60°C 10 seconds and 72°C for 10 
seconds). All primers sequences are provided in 
Table 1. Experiments were done in triplicates, and 
the ΔΔCq method was used for fold change 
calculations. GAPDH was used as reference gene.  
 
Immunoblotting 
Whole-cell extracts (WCE) were made by lysing 
cells directly in 2 x NuPAGE LDS Sample Buffer 
(Thermo Fisher  Scientific). Nuclear extracts (NE) 
were isolated using the NE-PER™ Nuclear and 
Cytoplasmic Extraction kit (Thermo Fisher  
Scientific) according to manufacturer’s instruction. 
In brief, cells were resuspended in Cytoplasmic 
Extraction reagent I and II and nuclei were pelleted 
by centrifugation at 16 000 g. The pellet was 
resuspended in ice-cold Nuclear Extraction 
Reagent, vortexed for 1 minute and incubated on 
ice for 10 minutes. This step was repeated 3 more 
times before centrifugation at 16 000 g for 10 
minutes. Proteins were resolved on SDS-PAGE 
gels and transferred to nitrocellulose membranes. 
Equal loading of proteins was verified by probing 
the membranes with an antibody recognizing actin 
(WCE) or lamin B (NE). The following primary 
antibodies were used, all at 1:000 dilution: Rabbit 
anti-NRF2 (Abcam, cat# ab62359), rabbit anti-
HSF1 (Cell Signaling, cat# 4356), rabbit anti-
Lamin B (Proteintech, ca# 12987-1-AP), mouse 
anti-Actin (Millipore, MAB1501). The blots were 
detected with IRDye®-conjugated secondary 
antibodies (LI-COR Biosciences) at a 1:10 000 
dilution (800CW goat anti-rabbit, cat# 926-32211; 
680LT goat anti-mouse, cat# 926-68020), and the 
Odyssey® CLx Infrared Imaging System.  
 
RNA-fluorescence in situ hybridization and 
immunofluorescence staining 
Stellaris® NEAT1 RNA FISH probes recognizing 
the NEAT1_2 isoform (VSMF-2251-5, Quasar® 
670-conjugated) were purchased from LGC 
Biosearch Technologies. Preparation of cells, 
hybridization, and mounting were performed 
according to the Stellaris® RNA FISH Probes 
manuals. In brief, cells were seeded onto circular 
coverslips in 12-well dishes and allowed to attach 
for 2-3 days. They were fixed with 4% freshly made 
formaldehyde at room temperature, and 
permeabilized with 70% ethanol. Hybridization 
was done at 37ºC in a humidifying chamber 
overnight. For co-immuno-FISH experiments, the 



















and cells were subsequently incubated in 1% 
RNAse-free BSA for 30 minutes, and then stained 
with anti-HSF1 antibody for 1 hour (1:50, Cell 
Signaling, cat# 4356A).  Cells  were incubated with 
goat anti-rabbit Alexa 488-conjugated secondary 
antibody (1:500, Thermo Fisher Scientific, cat# 
A11070), and mounted using Vectashield® 
Antifade Mounting Medium containing DAPI 
(Vector Laboratories, H-1200). Images were 
generated using a Zeiss LSM780 confocal 
microscope (Carl Zeiss Microscopy GmbH, Jena, 
Germany). In all samples, Z-stacks (5 slices, 2.5 
m total height) images were taken at 40x 
magnification.  For all images, the middle Z slice 
was positioned at DAPI’s best focus. The same 
treatment and setting were applied to all replicates, 
and for each slide at least ten pictures were taken 
for volocity analysis. The Volocity software 
(PerkinElmer, version 6.3) was used to measure 
signals intensity for both NEAT 1_2 and HSF1 
signals. At least 250 cells in each group of 
treatment were analyzed by volocity software. The 
mean intensity of NEAT 1_2 or nuclear HSF1 
signals in the SFN-treated group were normalized 
against CTRL.  
 
Reporter gene assays 
Sub-confluent MCF7 cells in 12-well plates were 
transfected with 150 ng of luciferase reporter 
plasmids using Lipofectamine®2000 reagent 
(Thermo Fisher Scientific) according to the manual 
provided by the manufacturer. After 24 hours, cells 
were either left untreated or treated with SFN (20 
M) for 8 hours.  Cells were harvested and 
luciferase assays were performed using the Dual-
Light® Luciferase & β-Galactosidase Reporter 
Gene Assay System (Thermo Fisher Scientific). Of 
note, cells were initially co-transfected with 
luciferase reporter plasmids and an expression 
vector for -galactosidase, but as SFN repeatedly 
interfered with the -galactosidase activity in the 
cells, the expression vector was omitted from the 
transfections and only the luciferase activity was 
included in the analyses. Co-transfections with 
siRNA and plasmid DNA were performed in two 
steps using Lipofectamine®2000. First, siRNAs 
were introduced into the cells by reverse 
transfection. After 48 hours, plated cells were re-
transfected with plasmid DNA and left for another 
24 hours.  
Chromatin immuoprecipitation (ChIP) assays 
MCF7 cells were seeded at a density of 6 million 
cells per 10 cm dish the day before use. The cells 
were left untreated or treated with SFN (20 µM) for 
6 hours before harvesting. Two 10 cm dishes were 
used per condition. The “iDeal ChIP-seq kit for 
Transcription Factors” (Diagenode, C01010055) 
was used for harvest and ChIP according to the 
manufacturers instruction. The two dishes for each 
treatment were combined, and the approximate cell 
number was estimated to be 15 mill of cells. 
Volumes of buffers used in the kit was adjusted to 
this. Cells were fixed for 15 minutes. Sonication 
was performed in ice cold water on a Bioruptor 
UCD-200 (Diagenode), 30 sec pulses on/off for 3 x 
10 min. Samples run on an agarose gel showed 
majority of DNA with size from 100-400 bp after 
shearing. For immunoprecipitation, 10 µl of anti 
HSF1 antibody (Cell Signaling, 4356) or 1 µl of 
IgG (provided with the kit) was used with 200 µl 
sheared chromatin. Two µl (1%) of input chromatin 
was set aside. The eluate had a volume of 25 µl, 
which was diluted 1/10 before 5 µl was used in a 
qPCR reaction. qPCR was performed in triplicates 
on a LightCycler 96 (Roche Life Science). The 
relative amount of immunoprecipitated (IP) DNA 
compared to input DNA was calculated using the 
“percent input method” as follows: Since the input 
chromatin was 1%, a dilution factor of 100 (6,644 
cycles, log2 of 100) was subtracted to adjust input 
Ct value to 100%. To calculate the percentage of 
specific chromatin co-immunoprecipitated with the 
HSF1 antibody or the IgG control, the triplicate 
average Ct values, Ct(IP), for the specific qPCR 
primers (HSE, “upstream”, and GAPDH)  were 
used in the equation 100*2^(Adjusted input - 
Ct(IP)). Primer sequences are given in Table 1. 
 
Cell confluence proliferation assay 
MCF7 cells were transfected in solution with 
indicated LNA-GapmeR antisense oligoes and 
seeded in 96 well plates at an initial confluency of 
approximately 30% (20 000 cells per well) and 
immediately  placed in an IncuCyte® S3 live-cell 
analysis system, which is equipped a fully 
automated microscope for cell confluence 
monitoring. Three phase contrast images were 
acquired from each well at 120 minute intervals 
over a period of 96 hours, using a 20x objective. 























GraphPad software (Prism version 7, Mac OS X) 
was used to analyze quantitative data. Statistical 
significance was evaluated with unpair student t-
Test or one-way ANOVA followed by the Dunnett 
multiple comparison test. The data were considered 
statistically significant when p ≤ 0.05. For all 
experiments significance is expressed as ***, p ≤ 
0.001, **, p ≤ 0.01, and *, p ≤ 0.05. The error bars 
indicate ± S.D. in all figures. All the experiments 
were performed at least three times.  
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Table 1. Primer and siRNA/ASO sequences 
























NP1.1F F- GGACGCTAGCCTCCCTTCCTCAGTCAGTCCACAA 
NP2.1R R- CCAAGTCTCCTTTGTGCCCTTGTAT 
NP2.1F F- GTAGAGGAAGAGAGCAGAACCCAG 
NP3.1R R- CTGACTCCTCCACCCCTTCTACCT 
NP2.2F F- AACGAGCTGTGTGGAACTTGGAGG 
NP3.2R R- CTAGACCTAGTCTCCTTGCCAAGCT 














Name siRNA and ASO sequences 
siRNA 








Silencer Select Negative Control No.2 siRNA (ThermoFisher 
Scientific, 4390847) 
Antisense LNA GapmeR Standard 
NEAT1 
TAAGCACTTTGGAAAG 
 (described in ref 13) 
NEAT1_2 
CTCACACGTCCATCT 
(described in ref 13) 
























































































FIGURE 1. NEAT1 expression and paraspeckle formation are induced by SFN. A, MCF7 cells were treated with 
SFN (20 μM) for the indicated time points. RNA was isolated and the expression of NEAT1 (both isoforms) and 
NEAT1_2 was determined by RT-qPCR.  The mean value ± SD of three biological replicates in one experiment is 
presented as fold change relative to untreated cells. The results are representative of three independent experiments. B, 
MCF7 cells were pre-incubated with N-acetylcysteine (NAC, 5 mM) and then treated with SFN for 6 h.  NEAT1 
expression was determined as described in A. C, MCF7 cells were left untreated or treated with SFN for 6 h, fixed and 
subjected to RNA-fluorescent in situ hybridization (RNA-FISH) using probes recognizing the NEAT1_2 isoform. 
DAPI was used to visualize the nuclei. Bars, 10 μm. D. The overall intensity of the dots in at least 250 cells were quan-
titated using the Volocity software. Mean values ± SD of three biological replicates are shown and presented as fold 
change relative to untreated cells. P values were calculated using ANOVA (A) or student’s T-test (B, D) with p < 0.05 




















































































FIGURE 2. NEAT1 induction by SFN is not dependent on NRF2. A, MCF7 cells were transfected with an siRNA 
specifically targeting NRF2 (siNRF2) or control siRNA (siCtrl). Twenty-four h post-transfection, cells were either left 
untreated or treated with SFN (20 μM) for 6 h. NEAT1 expression was determined by RT-qPCR as described in Fig 1. 
Depletion of NRF2 expression in whole cell extracts was verified by western blot analyses using an NRF2 antibody. The 
membrane was re-probed with an anti-actin antibody to ensure equal loading.  B, C, MCF7 cells were transfected as 
described in A, and subjected to a long-term treatment with SFN (10 μM) for 24 h. The expression of NEAT1 and 
NEAT1_2 (B), and NQO1 (C) was determined by RT-qPCR. Experiments were performed in triplicates and the graph 














































































































FIGURE 3. SFN-induced NEAT1 expression is dependent on HSF1. A, B, MCF7 cells were left untreated or treated 
with SFN (20 uM) for 6 h. HSF1 expression in whole cell extracts (WCE) (A) and nuclear extracts (NE) (B) was deter-
mined by immunoblot analyses. Equal loading was verified by re-probing the membranes with actin (A) or lamin B (B) 
antibodies. C, Cells were treated with SFN as described above, and HSP70 expression was determined by RT-qPCR. 
D, MCF7 cells were transfected with two different siRNAs targeting HSF1, siHSF1_#1 and siHSF1_#2, or a control 
siRNA. Forty-eight hours post-transfection, cells were left untreated or treated with SFN for 6 h. NEAT1 expression 
was assessed by RT-qPCR. SiRNA-mediated HSF1 depletion was verified by immunoblot analyses. E, HeLa cells 
were transfected with siHSF1_#2 or control siRNA and after 48 h SFN-induced NEAT1 expression was determined by 
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FIGURE 4. HSF1-depletion abrogates SFN-induced paraspeckle formation. A, MCF7 cells were transfected with 
an HSF1-specific siRNA or a control siRNA. After 48 h, cells were left untreated or treated with SFN for 6 h, fixed 
and subjected to coimmuno-FISH analyses by confocal microscopy using an antibody recognizing HSF1 (red) and 
fluorescent probes binding to NEAT1_2 (green). Nuclei were visualized with DAPI (blue). All experiments were 
performed in triplicates. Bars, 10 μm. B, C, The intensities of NEAT1_2 containing paraspeckles and nuclear HSF1 

























































































































































FIGURE 5. HSF1 binds to and transcriptionally activates the NEAT1 promoter. A, MCF7 cells were transfected 
with a luciferase reporter vector containing 4040 bp of the NEAT1 upstream region (pNEAT1-luc) or empty control 
vector. After 24 h, cells were left untreated or treated with SFN (20 μM) for 8 h and luciferase assays were performed. 
The experiments were performed in triplicates and mean values ± SD are shown. The result is representative of three 
independent experiments. B, MCF7 cells were co-transfected with pNEAT1-luc and siHSF1_#2 as described in experi-
mental procedures. Cells were left untreated or treated with SFN for 8 h and luciferase assays were performed. C, 
sequence conservation within NEAT1 upstream regions is illustrated by PhyloP Basewise Conservation scores from 
100 vertebrates (USCS Genome Browser). An alignment of conserved HSE core sequences from human, rhesus, 
mouse, dog, and elephant is shown. D, A truncated mutant of the NEAT1 promoter luciferase reporter construct 
encompassing the putative HSE site was generated and transfected into MCF7 cells along with a version harboring 4 
point mutations within the HSE consensus sequence. SFN-induced luciferase activity was measured 24 h post-trans-
fection. E, MCF7 cells were left untreated or treated with SFN (20 uM) for 6 h and ChIP assays were performed using 
an anti-HSF1 antibody. RT-qPCR was performed with primers flanking the HSE site. Primers flanking a region further 
upstream in the NEAT1 promoter (“upstr”), as well as primers amplifying a region of the GAPDH promoter, were used 
as negative controls. The relative amount of immunoprecipitated DNA compared to input DNA for each primer set is 
shown for the HSF1 ChIP. The values obtained by the IgG ChIP was less than 0.003% for the HSF1 and control prim-
ers. The result is representative of three independent ChIP experiments, where qPCR reactions were done as tripli-
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FIGURE 6. NEAT1 is induced by heat shock. A and B, MCF7 cells were subjected to heat shock by incubation at 43° 
for 30 minutes, and then returned to 37° to recover for the indicated time periods. Activation of HSF1 was verified by 
shifted migration in western blot analyses (A) and by induction of HSP70 mRNA expression (B). C, Cells were treated 
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FIGURE 7. Proliferation is compromised in NEAT1-depleted cells. A, MCF7 cells were transfected with two 
LNA-gapmeR antisense oligos targeting NEAT1, or a negative control oligo, and immediately placed in a IncuCyte® 
live cell analysis system for cell confluence monitoring. After 48 h, cells were removed from the incubator, and for 
half of the cells the media was changed at 37°C, whereas the other half was subjected to heat shock at 43°C for 30 
minutes. All the cells were then returned to the IncuCyte® live cell analysis system and monitored for another 48 
hours. Confluency (%) was calculated using the IncuCyte® S3 software. Mean values ± SD of 15 images (3 images 
from each well of 5 wells in total) are shown. The results are representative for three independent experiments. B, The 
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FIGURE 8. NEAT1 knockdown amplifies the expression of HSF1 target genes upon heat shock. MCF7 cells were 
transfected with two different LNA-gapmeR NEAT1 antisense oligos either targeting both isoforms of NEAT1 or 
solely the long NEAT1_2 isoform, and a negative control oligo. After 48 hours, cells were subjected to heat shock and 
recovered for the indicated time periods. The expression of HSP70, HSP90, and HSP27 was determined by RT-qPCR. 
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ABSTRACT  
 
The long non-coding RNA NEAT1 locus is transcribed into two overlapping isoforms, 
NEAT1_1 and NEAT1_2, of which the latter is essential for the assembly of nuclear 
paraspeckles. NEAT1 is abnormally expressed in a wide variety of human cancers. Emerging 
evidence suggests that the two isoforms have distinct functions in gene expression regulation, 
and recently it was shown that NEAT1_2, but not NEAT1_1, expression predicts poor clinical 
outcome in cancer. Here, we report that NEAT1_2 expression correlates with HER2-positive 
breast cancer and high-grade disease. HER2-positive breast cancer cell lines are highly 
dependent on NEAT1 expression, and NEAT1-depletion slightly enhances their sensitivity to 
lapatinib treatment. We provide evidence that NEAT1_1 and NEAT1_2 have distinct expression 
pattern among different intrinsic breast cancer subtypes. Finally, we show that NEAT1_2 
expression and paraspeckle formation increase upon lactation in humans, confirming what has 




The long non-coding RNA (lncRNA) NEAT1 (Nuclear Paraspeckle Assembly Transcript 1) 
has recently gained considerable attention as it is abnormally expressed in human diseases, 
including cancer and neurodegenerative disorders. The NEAT1 gene is transcribed into two 
isoforms, NEAT1_1 of 3.7 kb and NEAT1_2 of 22.3 kb, where NEAT1_1 completely overlaps 
with the 5’ end of NEAT1_2 [1-3]. NEAT1_2 is essential for the assembly of paraspeckles, 
dynamic ribonucleoprotein complexes that phase-separate from the nucleoplasm to form liquid 
drop-like structures [4-7]. In contrast, NEAT1_1 expression is not sufficient to induce 
paraspeckle formation and recent reports suggest that NEAT1_1 can localize to structures that 
are distinct from paraspeckles [7, 8]. NEAT1 expression and paraspeckle formation are 
upregulated in response to a variety of cellular stressors including mitochondrial stress, 
proteasome inhibition, oncogene-induced replication stress, hypoxia, heat shock, and viral 
infections [2, 9-17]. It is today generally accepted that NEAT1 and paraspeckles regulate gene 
expression at both transcriptional and post-transcriptional levels by acting as hubs that sequester 
specific gene-regulatory proteins and mRNAs [15-19].  Several lines of evidence suggests that 
NEAT1 and paraspeckles play critical roles in stress response pathways in general, and at 
specific developmental stages. NEAT1 knockout mice display compromised mammary gland 
development and corpus luteum formation [20, 21]. Moreover, it was recently shown that 
maternal and zygotic NEAT1-depletion frequently led to early developmental arrest at the 16- 
or 32-cell stage in mouse embryonic cells [22]. 
Cancer cells are exposed to a variety of extrinsic and intrinsic stressors like hypoxia, 
proteotoxicity, DNA damage, and reactive metabolic intermediates [23]. Such malignancy-
associated stress has been shown to induce NEAT1 expression in vivo [14-16].  NEAT1 levels 
are elevated in hypoxic regions of breast cancer cell line xenografts, and genotoxic stress 
induces formation of NEAT1-expressing skin tumors in mice [14, 16].  In consistence with these 
observations, NEAT1 is overexpressed in many cancers [16, 24-35]. In most cases, NEAT1 
expression is associated with aggressive disease and poor clinical outcomes.  
Breast cancer is the most common type of cancer in women, and covers a broad spectrum 
of different malignant neoplasms with clinical and genomic heterogeneity [36]. In clinical 
diagnosis, breast cancer is classified according to histological grade, Ki-67 proliferative index, 
and to the expression of hormone and growth factor receptors including estrogen receptor (ER), 
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The 
classification of breast cancer has been stratified by gene expression profiling leading to the 
identification of a 50-gene signature (PAM50) that groups breast cancer into luminal A, luminal 
B, HER2-enriched, basal-like, and normal-like intrinsic subtypes [37, 38]. Several studies have 
demonstrated that NEAT1 is required for proliferation and survival of breast cancer cell lines 
[9, 16, 20, 39-41]. Moreover, NEAT1 is frequently overexpressed in breast tumor samples 
compared to adjacent normal tissue and associated with poor overall survival [16, 40-42]. 
Recently, genomic analyses of 360 primary breast tumors showed that the core promoter of the 
NEAT1 gene is frequently mutated in cancer and most of these mutations are associated with 
loss of expression in vitro assays [43]. Moreover, focal deletions within the NEAT1 gene was 
found in 8% of breast cancer and mutations are frequently found in the exonic region [43, 44]. 
This suggests that NEAT1 expression might either protect or enhance cancer initiation and 
progression dependent on tumor stage. 
Most studies on NEAT1 and breast cancer have not addressed the relative contribution of 
the short and the long isoform, as they are, with a few exceptions, based on RT-qPCR analyses 
using primers recognizing both NEAT1_1 and NEAT1_2. Moreover, refined studies 
systematically analyzing NEAT1 expression in intrinsic breast cancer subtypes are still scarce. 
Here, we have examined the relationship between NEAT1_2 expression and breast cancer 
subtypes by performing RNA-FISH analyses on core needle biopsies using probes solely 
recognizing the NEAT1_2 isoform. We report that NEAT1_2 expression associates with HER2-
positive breast cancers, and independently, with high tumor grade. This is verified by in silico 
analyses of microarray data from three independent breast cancer cohorts showing that 
NEAT1_2 is most highly expressed in luminal B and HER2-enriched cancers. HER2-positive 
cell lines are highly dependent on NEAT1 expression as NEAT1-depletion induces apoptosis 
and enhances their sensitivity to lapatinib. Interestingly, we find that total NEAT1 expression 
shows a distinct distribution among breast cancer subtypes compared to NEAT1_2, being 
highest in ER-positive luminal A cancers. This indicates that the relative expression of 
NEAT1_1 and NEAT1_2 varies in the different breast cancer subclasses. Finally, we report that 




NEAT1_2 expression is associated with high tumor grade and HER2 positive breast cancers 
The NEAT1_2 isoform is essential for the assembly of paraspeckles that regulate the 
expression of specific genes at certain cellular circumstances [1-3, 15-19]. Recently, it was 
shown that the expression of NEAT1_2, but not NEAT1_1, predicts progression-free survival of 
ovarian cancer treated with platinum-based chemotherapy [14]. This prompted us to specifically 
investigate the expression of NEAT1_2 in breast cancer. To determining the relationship 
between breast cancer subtypes and both NEAT1_2 expression and associated paraspeckle 
formation, we performed NEAT1_2-specifc RNA-FISH analyses on 74 formalin-fixed paraffin-
embedded needle biopsies taken from females at the time of diagnosis of breast cancer. The 
samples were selected to represent cancers clinically diagnosed as luminal A (n=23), luminal 
B (n=27), triple negative/basal-like (n=15) and HER2-positive (n=9). We also included 27 non-
cancerous breast samples in the study (23 fibroadenomas, 3 mammary reduction, and 1 BRCA1 
prophylactic mastectomy). Cancer cells were identified by trained pathologists, and NEAT1_2 
expression was manually scored from “0” to “3” based on the presence and morphology of 
punctuated nuclear signals corresponding to paraspeckles (Figure 1A).  Samples in which 
NEAT1_2 was detected in more than 50% of the cells (scored as “2” and “3”), were defined as 
NEAT1_2-positive. Twenty-nine patients (39%) were positive for NEAT1_2 expression (Table 
1). In all cases, the expression was strictly restricted to cancer cells, with no detectable 
NEAT1_2 signals in surrounding stromal tissue, infiltrating immune cells, or in unaffected 
breast tissue. In sharp contrast, none of the benign breast tissue samples were NEAT1_2-
positive, with no detection in 25 of the samples, and detection in less than 50% of luminal 
epithelial cells in 2 samples (scored as “0” and “1”, respectively) (Table 1). Clinicopathological 
characteristics were acquired from each sample and correlated with NEAT1_2 expression 
(Table 2). NEAT1_2 levels significantly associated with higher tumor grade (p<0.05) (Figure 
1B, Table 2), confirming what has previously been reported by others on total NEAT1. 
Importantly, NEAT1_2 expression also correlated with HER2 expression (p<0.05) (Figure 1C, 
Table 2). To verify these results, we analyzed microarray expression data from 390 breast 
cancer patients (Oslo-2), using data generated by a NEAT1_2-specific probe. We confirmed 
that high NEAT1_2 expression associated with high-grade tumors (p<0.001) and HER2 
expression (p<0.001) (Figure 2, A and B). Intriguingly, we also found that NEAT1_2 expression 
negatively correlated with ER-positive tumors in this cohort (p<0.01) (Supplementary figure 
1). Finally, we assessed the expression of NEAT1_2 by RNA-FISH and RT-qPCR in nine breast 
cancer cell lines classified according to the expression of hormone- and growth factor receptors 
into ER/PR-positive HER2-negative cells (MCF7, T-47D), HER2-positive cells (BT474, 
HCC1569, SK-BR-3), and triple negative cells (BT549, Hs 578T, MDA-MB-231, MDA-MB-
468). In consistence with previous reports, the morphology, as well as the number and size of 
NEAT1_2-containing paraspeckles, varied substantially between the different cell lines 
(Supplementary figure 2) [45]. We also observed cell-to-cell variations within each cell line. In 
general, both the number and size of NEAT1_2-containing punctas were hard to determine as 
they frequently formed clusters. We therefore measured the average intensities of NEAT_2 
signals per cell in all cell lines (Figure 2C). Interestingly, HER2-positive BT474 and HCC1569 
clearly expressed the highest levels of NEAT1_2. Moreover, NEAT1_2 expression levels in 
HER2-positive SK-BR-3 cells were only exceeded by those in MCF7 cells. This was confirmed 
by RT-qPCR analyses using primers specifically amplifying the NEAT1_2 isoform (Figure 2D). 
Generally, results obtained by imaging and RT-qPCR were concordant, only showing 
deviations for the BT549 cell line. We conclude that NEAT1_2 expression correlates with 
HER2-positive breast cancer, and independently, with high-stage disease. Moreover, the 
presence of NEAT1_2 and paraspeckles are highly specific for cancer cells as neither 
surrounding normal tissue nor non-cancerous samples contain NEAT1_2 signals. 
 
NEAT1_2 expression is associated with the HER2-enriched and luminal B breast cancer 
subtypes 
We demonstrated above that NEAT1_2 expression correlates with HER2-positive breast 
cancer. HER2 overexpressing cancers are classified as HER2-enriched or luminal B using the 
PAM50 gene expression signature identifier. To assess the correlation between NEAT1_2 
expression and intrinsic breast cancer subtypes, we analyzed microarray gene expression data 
derived from the Oslo-2 cohort described above, and two publicly available breast cancer 
patient cohorts, METABRIC [46] and The Cancer Genome Atlas (TCGA) [47]. Patients were 
subclassified according to the PAM50 expression signature and only data generated from 
probes solely recognizing the NEAT1_2 isoform were considered. In all three cohorts, NEAT1_2 
was most highly expressed in HER2-enriched and luminal B breast cancers, but with different 
intrinsic distributions (HER2-enriched > luminal B in METABRIC and Oslo-2; Luminal B > 
HER2-enriched in TCGA) (Figure 3, A-C).  Luminal A breast cancers had the lowest expression 
of NEAT1_2 in all three cohorts. Taken together, these results are in accordance with the 
observed correlation between NEAT1_2 expression and HER2-positive cancers.  
 
Knock down of NEAT1_2 induces apoptosis and increases sensitivity of HER2-positive cells 
to lapatinib  
NEAT1 has previously been associated with chemotherapy resistance and poor overall 
prognosis [14, 16, 24, 48]. This prompted us to compare the sensitivity of control and NEAT1-
depleted SK-BR-3 cells to lapatinib, a HER2 and epidermal growth factor receptor (EGFR) 
inhibitor that is used in second-line treatment of advanced HER2-positive breast cancers. SK-
BR-3 cells were transfected with a control GapmeR oligonucleotide or GapmeR antisense 
oligonucleotides (ASOs) targeting both isoforms of NEAT1 that generally reduced the 
expression by 70-80% (Supplementary figure 3). Forty-eight hours post-transfection, cells were 
left untreated or treated with 0.05 µM lapatinib for 24 h and apoptosis was assessed by Annexin 
V-staining and flow cytometry. Importantly, NEAT1-depletion was sufficient to potently induce 
apoptosis in SK-BR-3 cells (Figure 4A). Moreover, although not significant (p<0.096), NEAT1-
depletion slightly increased the sensitivity of the cells to lapatinib (Figure 4A). 
 
Total NEAT1 expression is highest in luminal A breast cancers 
Previous reports have demonstrated that the NEAT1 gene is transcriptionally activated by ERα 
in both prostate and breast cancer, and the transcript participates in a gene repressor complex 
that induces EMT in a mouse model of ER-positive breast cancer [24, 42]. Here, we have found 
that the expression of the long NEAT1_2 isoform negatively correlates with ER-expression in 
the Oslo-2 breast cancer cohort (Supplementary figure 1). This potential discrepancy made us 
analyze the expression of total NEAT1 using microarray data derived from probes binding to 
both NEAT1_1 and NEAT1_2 from the TCGA cohort. Interestingly, total NEAT1 expression 
showed a different distribution among the PAM50 subtypes compared to NEAT1_2, being most 
highly expressed in luminal A cancers (Figure 5, A-D). This indicates that the relative 
expression of NEAT1_1 and NEAT1_2 varies in the different breast cancer subclasses, and that 
NEAT1_1 is highly expressed in luminal A cancers. 
 
NEAT1_2 expression is upregulated in human breast tissue during lactation 
We have demonstrated that NEAT1_2 is not, or infrequently expressed, in normal human 
breast tissue. NEAT1 female knock-out mice display compromised mammary gland 
development during puberty and pregnancy, and fail to lactate due to impaired proliferation of 
luminal alveolar cells [21]. This suggests an important function for NEAT1 in mammary gland 
development and during pregnancy and lactation. In order to investigate if NEAT1_2 is 
expressed during lactation in humans, we analyzed eight needle biopsies taken from females 
with lactation-related benign changes in the mammary gland. Importantly, 50% (n=4) of the 
lactating breast tissue samples were positive for NEAT1_2 using the same scoring scheme as 
above (Figure 1A and 6A). Of note, we also had access to one sample from a pregnant woman, 
which was scored as NEAT1_2 positive. In both the lactating tissue and the breast tissue from 
the pregnant female, the expression of NEAT1_2 was restricted to the luminal breast epithelial 
cells (Figure 6B).  
  
DISCUSSION 
The lncRNA NEAT1 locus is conserved in mammalian species and encodes two overlapping 
transcripts, NEAT1_1 and NEAT1_2, of which the latter is essential for the assembly of 
paraspeckles [1-3]. Early analyses in mice indicated that whereas NEAT1_1 is ubiquitously 
expressed, the expression pattern of NEAT1_2, and thus the presence of paraspeckles, are more 
restricted [6]. Emerging evidence now suggests that NEAT1_2 and paraspeckles play critical 
roles in orchestrating specific gene expression upon cellular stress and at specific 
developmental stages [2, 9-17, 20-22]. Importantly, it was recently shown that the expression 
of NEAT1_2, but not total NEAT1, was associated with aggressive cancers [14]. Here, we have 
specifically analyzed the expression of NEAT1_2 in breast cancer. By performing RNA-FISH 
on 74 breast cancer needle biopsies, we found that NEAT1_2 expression and paraspeckle 
formation associated with HER2-positive cancers. We verified this by inspecting microarray 
data generated by a NEAT1_2-specific probe from a cohort of 390 patients. Moreover, we found 
that NEAT1_2 is highly expressed in HER2-positive compared to HER2-negative breast cancer 
cell lines. Finally, in three different breast cancer cohorts, NEAT1_2 expression associated with 
HER2-enriched and luminal B PAM50 intrinsic subtypes. Around 20% of all breast cancers 
overexpress the HER2 receptor due to the amplification of the ERBB2 gene on chromosome 
17, and HER2-driven cancers are generally aggressive [49, 50]. The HER2 receptor is an orphan 
member of the epidermal growth factor receptor family that upon overexpression forms 
homodimers or heterodimers with either EGFR, HER3, or HER4, which elicit signaling 
pathways, including the MEK-ERK and PI3-kinase-Akt pathways, that drive tumorigenesis [49, 
50]. NEAT1 expression is generally regulated at the transcriptional level, and it is reasonable to 
assume that HER2-signaling leads to the activation of the NEAT1 promoter. Indeed, NEAT1 
transcription is activated by a series of stress-induced transcription factors including HIF2α, 
HSF1, and NF-κB, which have been shown to be constitutively upregulated or activated in 
HER2 overexpressing cells [51-54]. However, as discussed below, transcriptional upregulation 
is most likely not the only mechanism accounting for the high levels of NEAT1_2 in HER2-
positive cancer cells. NEAT1_2 is produced when the polyadenylation signal required for the 
formation of NEAT1_1, is suppressed by a hnRNPK-dependent mechanism [7, 55]. Moreover, 
key paraspeckle-associated proteins including NONO and SFPQ bind to and stabilize NEAT1_2 
[56] . Further experiments should be undertaken to determine their expression and subcellular 
localization in HER2-positive cell lines. 
As NEAT1_1 and NEAT1_2 is transcribed from the same promoter, it is logical to 
hypothesize that the expression pattern of NEAT1_1 mirrors that of NEAT1_2. Importantly, by 
analyzing microarray data derived from probes binding to both isoforms, we found that total 
NEAT1 expression showed an entirely different distribution among the PAM50 subtypes, being 
highest in ER-positive luminal A cancers. This is in agreement with previous reports showing 
that NEAT1 is transcriptionally activated by ERα in both prostate and breast cancer cell lines 
[24, 42]. Contradictory to this, we find a negative correlation between NEAT1_2 and 
ERα expression levels in breast cancer patients. Thus, our analyses strongly suggest that the 
relative levels of NEAT1_1 and NEAT1_2 vary in different breast cancer subtypes. Recently, Li 
et al. found that NEAT1 participates in a transcriptional repressor complex with FOXN3 and 
SIN3A in ER-positive breast cancer cells [42]. The complex induces epithelial-mesenchymal 
transition in vitro by downregulating GATA3 expression and promotes metastasis in mouse 
models of ER-positive breast cancer. The FOXN3-NEAT1-SIN3A complex also binds to and 
represses the promoter of the ESR1 gene indicating the presence of a negative feed-back 
regulatory mechanism. Importantly, the authors suggest that the FOXN3-NEAT1-SIN3A 
complex functions independently of paraspeckles and that it is the NEAT1_1 isoform that 
participates in this complex. In line with this, Chakravarty et al demonstrated that NEAT1_1, 
but not NEAT1_2, binds directly to histone H3 and recruits ERα to the PSMA promoter in 
prostate cancer cell lines [24]. We hypothesize that in ER-positive cancers, NEAT1_1 
contributes to the tumorigenic phenotype by directly participating in transcriptional regulation 
at the chromatin level. This mechanism might be less important in HER2-positive cancers 
where increased NEAT1_2 levels and paraspeckle formation is required for their adaptation to 
malignancy-associated stress and survival. We have indeed shown that NEAT1-depletion is 
sufficient to induce apoptosis in HER2-positive SK-BR-3 cells, and slightly increased their 
sensitivity to the HER2- and EGFR-inhibitor lapatinib. Furthermore, it was recently shown that 
the expression of NEAT1_2, predicted progression-free survival of ovarian cancer treated with 
platinum-based chemotherapy [14]. Our NEAT1_2 RNA-FISH analyses were done on needle 
biopsies taken at the time of diagnosis of breast cancer. In the future, it will be important to 
monitor if NEAT1_2 expression changes in the course of treatment of HER2-positive cancers, 
and if it is a predictor of therapy response. Relevant to this, unpublished data from our group 
show that NEAT1_2 levels increase in HER2-positive cell lines upon lapatinib treatment. It 
should be noted that RNA stability is a technical challenge when analyzing NEAT1_2 
expression in patient samples by RNA-FISH. We performed RNA-FISH on tissue micro arrays 
of 409 breast cancer patient samples diagnosed between 1961 and 2008. Here, only 12 samples 
(2.9%) were positive for NEAT1_2 (data not shown) as opposed to 39% of the needle biopsies.  
We find that NEAT1_2 is not expressed in normal tissue surrounding breast cancer cells at 
levels that can be detected by RNA-FISH. Furthermore, none of the analyzed benign breast 
tissue samples were NEAT1_2 positive using detection in >50% of cells as a cut-off. Murine 
Neat1 is critical for normal development of the mammary gland, and Neat1_2 and paraspeckles 
were detected in 30-50% of K8/K18-positive luminal cells in adult mice [21]. The number of 
Neat1_2 positive cells increased upon pregnancy and lactation. To further inspect NEAT1 
expression pattern in human mammary gland development, we performed RNA-FISH on 8 
benign breast tissue samples taken from lactating women. We detected NEAT1_2 and 
paraspekles in more than 50% of the cells in 4 samples (50%). Our data strongly supports the 
observations done in mice and suggests that NEAT1_2 and paraspeckle formation are 
upregulated during lactation also in humans. The mechanisms behind this upregulation should 
be further studied as they also can give important hints about abnormal NEAT1 expression in 
breast cancer, as well as the normal function of NEAT1.  
We provide evidence that NEAT1_2 expression associates with HER2-positive cancers and 
suggest that the relative expression of NEAT1_1 and NEAT1_2 varies in breast cancer subtypes. 
The overlapping nature of the NEAT1_1 and NEAT1_2 hampers isoform-specific analyses and 
might affect the interpretation of expression data. NEAT1_2 is not polyadenylated, which needs 
to be taken into account when analyzing poly(A)-enriched RNA-sequencing data. Nevertheless, 
both NEAT1_1 and NEAT1_2 are likely to contribute to breast cancers tumorigenesis and the 
cancer-specific expression of NEAT1_2 makes it a promising target for therapeutic intervention 
in the future. 
  
EXPERIMENTAL PROCEDURES 
Cell Culture and Treatments 
BT474 (ATCC® HTB-20™), BT549 (ATCC® HTB-122™), HCC1569 (ATCC® CRL-
2330™), Hs 578T (ATCC® HTB-126™), MDA-MB-231 (ATCC® HTB-26™), MDA-MB-
468 (ATCC® HTB-132™), MCF7 (ATCC® HTB-22™), SK-BR-3 (ATCC® HTB-30™), and 
T-47D (ATCC® HTB-133™) cells were all purchased from the American Type Culture 
Collection (ATCC). BT474, BT549, HCC1569, MDA-MB-231, MDA-MB-468, SK-BR-3, and 
T-47D were cultured in RPMI 1640 (Sigma-Aldrich) supplemented with 10% Fetal bovine 
serum (FBS) (Biochrom) and 1% penicillin-streptomycin (Sigma-Aldrich). BT549 cells were 
grown in the presence of 0.001 mg/ml insulin (Sigma-Aldrich) and T-47D were grown in the 
presence of 0.006 mg/ml insulin. Hs 578T were cultured in Dulbecco's Modified Eagle's 
Medium (DMEM; Sigma-Aldrich) supplemented with 10% FBS, 1% penicillin-streptomycin, 
and 0.01 mg/ml insulin. MCF7 were cultured in Minimum Essential Medium Eagle (MEM; 
Sigma-Aldrich) supplemented with 10% FBS, 1% penicillin-streptomycin, and 0.01 mg/ml 
insulin. All cell lines were incubated in a 5% CO2 humidified incubator at 37°C. 
Lapatinib (L-4899) was purchased from LC Laboratories and diluted in DMSO to a final 
concentration of 1 M. For apoptosis assay, a final concentration of 0,05 uM lapatinib in full 
media was added to the cells 24H before assessed by Annexin V-staining and flow cytometry. 
An equal volume of DMSO was used as control. 
 
RNA Isolation, cDNA Synthesis, and RT-qPCR 
Cells were lysed in 300 µl Tri Reagent, heated for 10 min at 55 degree Celsius, and total RNA 
was isolated with Direct-zol RNA MiniPrep (Zymo Research) according to the manufacturer’s 
recommendation. RNA concentration was measured by NanoDrop 2000 (Thermo Fisher 
Scientific). cDNA synthesis of total RNA was performed with SuperScript™ IV Reverse 
Transcriptase (ThermoFisher Scientific). 2.5 μM of random hexamer primer (ThermoFisher 
Scientific) and approximately 400 ng of template were used for the reaction. Total RNA was 
denaturated at 65ºC for 5 min, and cDNA was synthesized at 50 ºC for 10 min.  
For RT-qPCR of cDNA from total RNA, 12,5 ng cDNA was mixed with FastStart Essential 
DNA Green Master (Roche Life Science) and 0.25 μM forward and reverse primer. All primers 
sequences are provided in Supplementary Table 1. The LightCycler® 96 was used for 
quantification, and the ΔΔCq-method was used to calculate fold change using GAPDH, B2M, 
and/or RPLPO as internal reference. 
 
RNA Interference 
Antisense locked nucleic acid (LNA)-GapmeR were purchased from Exiqon. For transfection, 
Lipofectamine® 2000 were used according to the protocols provided by the manufacturer. 30 
μM NEAT1 antisense oligos (TAAGCACTTTGGAAAG and CTCACACGTCCATCT) or 
control GapmeR (AACACGTCTATACGC) were used in the knock down experiments.  
 
Annexing Apoptosis Assay 
The percentage of apoptotic cells was measured using the FITC Annexin V apoptosis detection 
kit (BD Biosciences). Single-cell suspensions were prepared for each group. Cells were washed 
with PBS and suspended in 1× binding buffer before stained with FITC-labeled Annexin V and 
PI for 15 min at room temperature in the dark. Apoptosis was analyzed immediately using the 
FACS LRS fortessa. 
 
RNA-FISH of Cells and FFPE Tissue 
Stellaris® NEAT1 RNA FISH probes either recognizing both NEAT1_1 and NEAT1_2 isoforms 
(SMF-2036-1 conjugated with Quasar® 570), or only the NEAT1_2 isoform (SMF-2037-1 
conjugated with Quasar® 670), were purchased from LGC Biosearch Technologies. 
Preparation of cells and FFPE sections, hybridization, and mounting was performed according 
to the Stellaris® RNA FISH Probes manuals. In brief, cells were seeded onto circular coverslips 
in 12-well dishes and allowed to attach for 2-3 days, before fixed with 4% formaldehyde, and 
permeabilized with 70% EtOH. Hybridization was done at 37ºC in a humidifying chamber for 
at least 4 hours. FFPE tissue sections were cut fresh and placed at 60 degree Celsius for 45 min 
before deparaffinised with xylene. Here, hybridization was performed overnight. Vectashield® 
Mounting Medium containing DAPI was used for mounting of both cells and FFPE sections. 
Images were generated using a Zeiss LSM780 confocal microscope. For cells, 3-dimensial Z-
stack images were taken at 40x magnification (seven pictures, with 0.600 μm distance between 
each picture). Images of FFPE sections were taken at 20x magnification with no Z-stacking. 
All images were processed using ZEN 2012 (black edition) v8.0. NEAT1_2 fluorescence was 
quantified from maximum intensity projections of confocal z-stacks using Fiji [57] running 
ImageJ [58] version 1.52n. An automatic threshold was set in the DAPI channel in order to 
segment individual nuclei using the wand tool. In some cases, nuclear outlines were manually 
traced. The average intensity in the NEAT1_2 channel was then measured for each nucleus.  
 
Clinical Samples 
Archived FFPE needle biopsies were obtained from the Department of Pathology, University 
Hospital of North Norway (UNN) with corresponding hematoxylin and eosin (HE) slides from 
all patients. Samples from 74 patients diagnosed with breast cancer (2012-2018), 27 normal 
samples, 8 samples from lactating females, and 1 sample from a pregnant female were included 
in the study. The samples were handled in accordance with the regulations of the Regional 
Ethics Committee. Histological tumor grade was assessed by the Nottingham Grading System 
[59]. Correlation of NEAT1_2 expression and clinicopathological characteristics were analyzed 
by the Chi square test (χ2-value) using SPSS version 25 (SPSS Inc., Chicago, IL, USA). P-
values < 0.05 (two-tailed) were considered statistically significant.  
 
Gene Expression Analyses in Breast Cancer Cohorts  
NEAT1 gene expression was assessed in three independent breast cancer cohorts; Oslo-2, 
METABRIC [46], and TCGA [47]. The Oslo-2 cohort is an ongoing consecutive study in the 
Oslo region. Matched patient samples are being collected from primary tumor, sentinel lymph 
nodes, peripheral blood, bone marrow, and metastatic lesions. More than 1000 patients have 
been enrolled. To date, gene expression analysis has been completed from about 400 samples. 
Gene expression was measured using SurePrint G3 Human GE 8x60K one-color microarrays 
from Agilent (Agilent Technologies). The data was log2 transformed after normalization. The 
probe A_33_P3263538, covered part of the unique 3’ end of NEAT1_2. The METABRIC 
cohort is composed of 1980 breast cancer patients collected at five different hospitals in the UK 
and Canada. Gene expression was assessed using the Illumina HT-12 v3 microarray and 
downloaded from the European Genome-phenome Archive (EGA) data portal. The data was 
log2 transformed, and unexpressed genes were excluded prior to analysis. The probe, 
ILMN_1675354, covered part of the unique 3’ end of NEAT1_2. Gene expression levels for the 
Caucasian fraction of the TCGA cohort (n= 526) were assayed by Agilent 244K Custom Gene 
Expression G4502A-07-3. The data was log2 transformed after normalization. The probe, 
A_32_P206561, covered parts of the unique 3’ end of NEAT1_2, while the probes A_32_P1036, 
A_32_P1037, A_24_P566917, and A_24_P566916 covered parts of the common region of 
NEAT1_1 and NEAT1_2. The significant differences in gene expression between the five 
molecular subtypes of breast cancer were examined in all three cohorts using the none-
parametric Kruskal-Wallis rank test. A significant Kruskal-Wallis test indicates that at least one 
subtype stochastically dominates one other subgroup. 
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Table 1: NEAT1_2 expression in breast cancer screening cohort and normal breast tissue. 
NEAT1_2 Tumor Normal 
0, n(%) 25 (33.8) 25 (92.6) 
1, n(%) 20 (27.0) 2 (7.4) 
2, n(%) 23 (31.1) 0 (0.0) 
3, n(%) 6 (8.1) 0 (0.0) 
Total, n(%) 74 (100.0) 27(100.0) 
 
  
Table 2. Clinicopathological variables and NEAT1_2 expression in breast cancer screening cohort (n = 74).  
Variable, n(%) 
 
NEAT1_2 expression p  
Total (n=74) 0 (n=25) 1 (n=20) 2 (n=23) 3 (n=6) 
Age at diagnosis <55 10 (34.5) 8 (27.6) 8 (27.6) 3 (10.3) 0.920 29 (39.2)  
>55 15 (33.3) 12 (26.7) 15 (33.3) 3 (6.7) 
 
45 (60.8) 
Histologic grade 1 10 (55.6) 5 (27.8) 3 (16.7) 0 (0.0) 0.027* 18 (24.3)  
2 8 (34.8) 9 (39.1) 5 (21.7) 1 (4.3) 
 
23 (31.1)  
3 7 (22.2) 6 (18.2) 15 (45.5) 5 (15.2) 
 
33 (44.6) 
Tumor type NST 20 (29.9) 20 (29.9) 22 (32.8) 5 (7.5) 0.156 67 (90.5)  
ILC 3 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 
 
3 (4.1)  
Other invasive carsinomaa 2 (50.0) 0 (0.0) 1 (25.0) 1 (25.0) 
 
4 (5.4) 
Tumor diameterb <20 mm 14 (37.8) 12 (32.4) 7 (18.9) 4 (10.8) 0.213 37 (53.6)  
>20 mm 11 (34.4) 6 (18.8) 13 (40.6) 2 (6.3) 
 
32 (46.4) 
Lymph node metastasisb Negative 17 (35.5) 14 (29.2) 13 (27.1) 4 (8.3) 0.990 48 (67.6)  
Positive 8 (34.8) 6 (26.1) 7 (30.4) 2 (8.7) 
 
23 (32.4) 
ER Negative (<1%) 4 (16.7) 7 (29.2) 11 (45.8) 2 (8.3) 0.131 24 (32.4)  
Positive (>1%) 21 (42.0) 13 (26.0) 12 (24.0) 4 (8.0) 
 
50 (67.6) 
PGR Negative (<10%) 6 (18.2) 10 (30.3) 13 (39.4) 4 (12.1) 0.071 33 (44.6)  
Positive (>10%) 19 (46.3) 10 (24.4) 10 (24.4) 2 (4.9) 
 
41 (55.4) 
HER2 Negative (0,+1) 22 (42.3) 13 (25.0) 15 (28.8) 2 (3.8) 0.042* 52 (70.3)  




aTubulolobular carcinoma (n=1), Metaplastic squamous cell carcinoma (n=1), Mucinous carcinoma (n=1), Apocrine carcinoma (n=1) 
 bPatient(s) data missing  
FIGURE LEGENDS 
FIGURE 1: NEAT1_2 expression and paraspeckle formation correlate with tumor grade and 
HER2 positive breast cancer. (a) RNA-FISH analyses of NEAT1_2 in breast formalin-fixed 
paraffin-embedded needle biopsies. NEAT1_2 expression is scored from “0” to “3” based on 
punctuated nuclear NEAT1_2 signals according to the indicated criteria. (b) NEAT1_2 
expression correlates to tumor grade. Data are given as mean (thick black line) ± standard 
deviation (thin black lines). Circles represent single patient scores. P value was calculated by 
the Chi square test (χ2-value). (c) NEAT1_2 expression correlates to HER2. Data are shown as 
mean (thick black line) ± standard deviation (thin black lines). Circles represent single patient 
scores. P value was calculated by the Chi square test (χ2-value).  
 
FIGURE 2: NEAT1_2 expression was verified in an independent breast cancer cohort and in 
breast cancer cell lines. NEAT1_2-specific expression was analyzed in microarray expression 
data from 390 breast cancer patients (Oslo-2). (a) NEAT1_2 expression correlates to HER2 and 
(b) tumor grade. (c) Cells were subjected to RNA-fluorescent in situ hybridization (RNA-FISH) 
using probes recognizing the NEAT1_2 isoform. DAPI was used to visualize the nuclei. The 
overall intensity of the dots per nucleus in at least 250 cells were quantitated. Data are given as 
mean (thick black line) ± standard deviation (thin black lines). Circles represent single cell 
intensities. (d) RNA was isolated and the expression of NEAT1_2 was determined by RT-qPCR. 
The geometric mean of B2M, GAPDH, and RPLP0 was used for normalization. The mean value 
± SD of three biological independent experiments is presented as fold change relative to MCF7 
NEAT1_2 expression. 
 
FIGURE 3: NEAT1_2 expression correlates with the HER2-enriched and Luminal B subtype 
of breast cancer. Gene expression of NEAT1_2 in breast cancer in (a) Oslo-2, (b) METABRIC, 
and in (c) TCGA classified according to the PAM50 signature.  
 
FIGURE 4: Apoptosis is induced in NEAT1-depleted cells treated with lapatinib. (a) SK-BR-
3 cells were transfected with two LNA-GapmeR antisense oligos targeting NEAT1, or a 
negative control oligo. After 48h, cells were treated with 0.05 µM lapatinib or DMSO as control 
for 24h. The percentage of apoptotic cells was measured by annexin V staining and flow 
cytometry. The mean value ± SD of three independent biological experiments is presented. P 
value was calculated using student’s T-test.  
 
FIGURE 5: NEAT1 expression correlates with luminal A subtype of breast cancer in the TCGA 
cohort. Expression of total NEAT1 in PAM50 intrinsic breast cancer subtypes was determined 
using data generated from four independent probes in the TCGA cohort.   
 
FIGURE 6: NEAT1_2 is expressed in lactating breast tissue. (a) RNA-fluorescent in situ 
hybridization (RNA-FISH) analyses of NEAT1_2 in breast tissue from lactating female (n=8) 
and normal tissue (n=27). NEAT1_2 expression is scored from “0” to “3” based on punctuated 
nuclear NEAT1_2 signals according to the indicated criteria in Figure 1A. Data are shown as 
mean (thick black line) ± standard deviation (thin black lines). Circles represent single patient 
scores. P value was calculated using student’s T-test. (b) RNA-FISH images from three 
lactating females. DAPI was used to visualize the nuclei. 
  
Supplementary Table 1. RT-qPCR primers.  
 
Gene Sequence 
NEAT1_2 F: CGGAGGGTCTTGTAACACCAG 
R: AGTCCGGGCAACACAGAAAG 
GAPDH F: GAGCGAGATCCCTCCAAAAT 
R: AAATGAGCCCCAGCCTTCT 
RPLP0 F: GCTGCTGCCCGTGCTGGTG 
R: TGGTGCCCCTGGAGATTTTAGTGG 
B2M F: TCATCCAGCAGAGAATGGAA 
R: TCTGAATGCTCCACTTTTTCAA 
  
SUPPLEMENTARY FIGURE LEGENDS 
SUPPLEMENTARY FIGURE 1: NEAT1_2 is negatively correlated with ER. NEAT1_2-
specific expression was analyzed in microarray expression data from 390 breast cancer patients 
(Oslo-2). 
 
SUPPLEMENTARY FIGURE 2: NEAT1_2 expression and paraspeckle formation in a panel 
of nine breast cancer cell lines. Cells were subjected to RNA-fluorescent in situ hybridization 
(RNA-FISH) using probes recognizing the NEAT1_2 isoform (green signal). DAPI was used to 
visualize the nuclei. 
 
SUPPLEMENTARY FIGURE 3: Knock down efficiency in SK-BR3 cells. Cells were 
transfected with two LNA-gapmeR antisense oligos targeting NEAT1, or a negative control 
oligo. After 48H RNA was isolated and the expression of NEAT1_2 was determined by RT-
qPCR. GAPDH was used for normalization. The mean value ± SD of three biological replicates 
in one experiment is presented as fold change relative to negative control cells. P value was 




0 1Score 0, NegativeNo detection of NEAT1_2,
or detection in less than
10% of tumor cells.
Score 1, Negative
Detection of NEAT1_2 in 
less than 50% of tumor 
cells.
Score 2, Positive
Detection of NEAT1_2 in 
more than 50% of tumor cells.
Punctuated single structures. 
Score 3, Positive
Detection of NEAT1_2 in 
more than 50% of tumor cells.
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ABSTRACT 
The long non-coding RNA NEAT1 is the structural RNA component of nuclear paraspeckles 
and has been implicated in a wide variety of cellular stress response pathways. Emerging 
evidence suggests that NEAT1 plays a role in cytoprotection and cell survival. Abnormal 
NEAT1 expression is associated with cancer and neurodegenerative diseases. Here, we report 
that cells depleted of NEAT1 expression has altered basic autophagy as measured by increased 
number of LC3B-containing punctas in the nucleus and accumulation of the lipidated LC3B-II 
form. Moreover, NEAT1-depeltion enhances the effect of sulforaphane on autophagy. We 
provide evidence that NEAT1 deficiency leads to induction of autophagy through increasing the 
activity of AMP-regulated protein kinase (AMPK) towards ULK1. Our results support the 
notion that NEAT1 plays a role in protecting organelles and macromolecules from damages 
upon cellular stress. 
    
INTRODUCTION 
Nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA that is highly 
conserved in mammalian cells1–3. The NEAT1 locus is transcribed into two overlapping 
isoforms, NEAT1_1 of 3.7 kb and NEAT1_2 of 22.3 kb4. NEAT1 is the structural RNA 
component and critical for the assembly of a class of highly dynamic nuclear ribonucleoprotein 
complexes called paraspeckles5,6. More than 40 proteins have been reported to localize to 
paraspeckles in a manner depending on the cellular context and extracellular cues6–8. The 
paraspeckles change morphology and increase in numbers when NEAT1_2 expression is 
elevated9. NEAT1 levels are upregulated in response to cellular stress including hypoxia, heat 
shock, proteasome inhibitors, DNA damaging reagents, and mitochondrial stress, and NEAT1-
depleted cells have in many cases been shown to be more sensitive to such stressors10–17. Neat1 
knock out mice are viable and healthy, but emerging evidence suggests that NEAT1 expression 
is critical at specific developmental stages18–20. Female mice display compromised mammary 
gland development during puberty and pregnancy, and fail to lactate due to impaired 
proliferation of luminal alveolar cells18. They are also less fertile due to defect corpus luteum 
formation19. Importantly, it was recently shown that maternal and zygotic Neat1-depletion 
frequently led to early developmental arrest at the 16- or 32-cell stage in mouse embryonic 
cells20. Generally, it is now accepted that in certain cellular circumstances and developmental 
stages, NEAT1 and paraspeckles act as hubs that regulate gene expression by sequestering 
certain mRNAs and gene regulatory proteins13,20–27. NEAT1 is abnormally expressed in human 
diseases including cancer and neurodegenerative disorders14,17,28–32. In most cancers, high 
NEAT1 levels are associated with poor clinical outcome. Importantly, it has been shown that 
NEAT1 expression increases in cancer cells treated with chemotherapeutic agents, and NEAT1 
silencing sensitizes cancer cells to drug treatment14,31,33–40. Several studies have demonstrated 
that NEAT1 is overexpressed in devastating neurodegenerative disorders including amyotrophic 
lateral sclerosis (ALS), Huntington's disease, and Alzheimer28–30,32,41. Moreover, 
mislocalization and dysfunction of two paraspeklce-proteins, TAR DNA-binding protein 43 
(TDP-43) and fused in sarcoma (FUS), are frequently observed in ALS42.   
Autophagy is a catabolic process where damaged proteins and organelles are degraded by the 
lysosome and recycled43.  In macroautophagy, hereafter just referred to as autophagy, the 
cellular content to be degraded is engulfed into a double-membrane vesicle called the 
autophagosome, which fuses with the lysosome forming an autolysosome44. A variety of 
cellular stressors that perturb proteostasis, organelle functions and metabolism, induce 
autophagy45. Both basal and induced autophagy are essential for maintenance of cellular 
homeostasis. Autophagy initiation is orchestrated by the Unc-51-like kinase 1 (ULK1) complex 
that together with the VPS34-Beclin1 complex, is critical for the formation of the phagophore 
that subsequently elongates into the autophagosome46,47. ULK1 activity and autophagy 
initiation are negatively regulated by mammalian target of rapamycin, mTOR, that plays an 
instrumental role in coordinating the balance between cell growth and autophagy in response 
to growth factors, nutrients and stress48–50. In contrast, ULK1 activity is stimulated by AMP-
activated protein kinase (AMPK) that is a critical sensor of ATP levels in cells and is activated 
when the levels of AMP relative to ATP increase51. Autophagy is frequently altered in human 
diseases52. In many neurodegenerative disorders, compromised autophagy is associated with 
formation of pathological protein aggregates53. In line with this, genes encoding key 
components of the autophagic pathway, are frequently mutated in ALS, Huntington’s disease, 
and Alzheimer. Even though autophagy protects an organisms from developing cancer, elevated 
autophagy is associated with survival of tumor cells and therapy resistance54. This makes 
autophagy proteins attractive targets in cancer treatment. 
   We have previously shown that the isocyanate sulforaphane (SFN), which is known to elicit 
autophagy, induces NEAT1 expression by activating the heat shock response pathway. Here, 
we report that NEAT1-depletion affects basal autophagy that results in accumulation of the 
lipidated form of microtubule-associated protein 1 light chain 3 beta (LC3B), a marker of 
increased formation of autophagosomes and autolysosomes.  This is accompanied by increased 
formation of punctuated structures containing LC3B. NEAT1 silencing also leads to the 
accumulation of the selective autophagy receptor p62, which indicates that lysosomal activity 
is impaired. Finally, we present evidence that knock down of NEAT1 activates AMPK kinase, 
which then phosphorylates ULK1 at Serine-555 that is critical for induction of autophagy. 
Taken together, our data indicate that NEAT1-depletion induces autophagy and also suggest 
that NEAT1 might be required for normal lysosomal activity. 
 
RESULTS 
NEAT1 depletion leads to the accumulation of autophagosomes 
NEAT1 is a stress-induced transcript that is abnormally expressed in human diseases like cancer 
and neurodegenerative disorders, which are also associated with defective autophagy.  We 
recently showed that NEAT1 is induced at the transcriptional level by the isocyanate 
sulforaphane (SFN), a compound that is known to induce autophagy in cells. This prompted us 
to analyse if NEAT1 is involved cellular autophagy. A hallmark in autophagy is the formation 
of double membrane vesicles called the autophagosomes that engulf the cargo to be delivered 
and degraded by the lysosomes55. The ATG8 family protein member Microtubule-associated 
protein 1 light chain 3 beta (LC3B), is important for autophagosome formation and its 
conjugation to phosphatidylethanolamine forming the lipidated LC3B-II isoform, is a marker 
of autophagy in cells. To determine if NEAT1 has a role in SFN-mediated autophagy, we 
measured by immunoblot analyses the formation of the lipidated LC3B-II form in control cells 
and in cells where NEAT1 was silenced by specific antisense oligonucleotides, which were 
subsequently either left untreated or treated with SFN for 24 hours. Efficient knock down of 
NEAT1 was confirmed by RT-qPCR analyses (supplementary figure 1). We verified what has 
been shown by others, that SFN indeed induces the formation of the LC3B-II (FIG. 1A). 
Interestingly, knockdown of NEAT1 in control cells led to accumulation of LC3B-II, indicating 
that NEAT1-depletion affects basal autophagy. Moreover, NEAT1-depletion enhanced SFN-
mediated lipidation of LC3B. In autophagy, LC3B-II localizes to autophagosomes and 
autolysosomes55. To further study the effect of NEAT1 silencing on LC3B, MCF7 cells were 
transfected with control or NEAT1 antisense oligonucleotides and endogenous LC3B was 
analyzed by immunofluorescence staining and confocal microscopy. NEAT1-depletion induced 
the formation of LC3B containing punctas that displayed a perinuclear localization in the 
majority of the cells (FIG. 1B). Quantitative analyses verified that of the number and volume 
of LC3B-containing punctas increased upon NEAT1 silencing. Finally, we verified that NEAT1-
depletion led to the accumulation of LC3B-II by transfecting cells with a second set of NEAT1-
specific antisense oligonucleotides (FIG. 1C). Autophagy is a dynamic process, and 
accumulation of LC3B-II/autophagosomes at a specific time point could be due to either 
increased in autophagosome formation, or inhibition of their maturation into autolysosomes or 
lysosomal activity (autophagic flux). Consequently, our data so far suggest that NEAT1-
depletion either induces autophagy or interferes with the autophagic flux in MCF7 cells. To 
start delineating the role of NEAT1 in autophagy more precisely, we treated control and NEAT1-
depleted MCF7 cells with the lysosomal inhibitor bafilomycin A1 (BafA1) for 4 hours, and 
assessed its effect on LC3B lipidation compared to untreated cells. As expected, BafA1 caused 
accumulation of LC3B-II in control cells (FIG. 2A). Importantly, LC3B-II continued to 
accumulate in NEAT1-depleted cells after lysosomal inhibition (FIG. 2A, lane 3 and lane 6). 
This was clearly verified by immunofluorescence analyses showing increased number of 
LC3B-contaning punctas in NEAT1-depleted cells treated with BafA1 compared to those left 
untreated (FIG. 2B). Also, the number of punctuated LC3B signals was significantly higher in 
BafA1-treated NEAT1 knock down cells compared to control cells. Even though we can’t rule 
out that lysosomal activity is partially inhibited in NEAT1 knock down cells, our results indicate 
that the on-rate of autophagosome formation is elevated upon NEAT1 depletion.  
p62 is a key selective autophagy receptor that binds to ubiquitinated cargo and mediates 
its association to the inner membrane of the developing phagophore via binding to LC3B and 
other ATG8 members56. Eventually, p62 is degraded with the cargo in the autolysosome. Thus, 
measuring p62 levels in cells can provide important clues about autophagic degradation. We 
therefore performed another western blot analyses of the extracts described in FIG. 2A using 
an antibody that specifically binds to p62. As expected, lysosomal inhibition by 4 hours BafA1 
treatment led to a slight, but consistent, accumulation of the p62 protein (FIG. 2C). Intriguingly, 
p62 protein levels were slightly elevated in untreated NEAT1-depleted cells, and this was 
further enhanced by BafA1. To rule out any cell-specific effect of NEAT1-depletion on LC3B 
and p62 in MCF7 cells, we repeated the immunoblot experiments in control and NEAT1-
silenced BT474 cells. We confirmed that knock down of NEAT1 led to accumulation of both 
LC3B and p62 that was further enhanced by BafA1 treatment also in BT474 (FIG. 2D).  
mTOR activity is not affected by NEAT1 depletion.  
The mTOR kinase is a master regulator of autophagy48–50. In normal physiological conditions, 
mTOR complex 1 (mTORC1), which in addition to mTOR also consists of Raptor and mLST8, 
actively suppresses autophagy by phosphorylating and inhibiting the activity of ULK1. To 
analyse if NEAT1-depletion interferes with mTOR activity, we determined the phosphorylation 
status of Threonine 389 (Thr389) of p70 ribosomal S6 kinase (p70S6K), one of the best 
characterized substrates of mTOR, by immunoblot analyses. We first confirmed that amino acid 
starvation (HBSS) that potently inactivates mTOR, abolished the phosphorylation of Thr389 of 
p70S6K in MCF7 cells (FIG. 3A). In contrast, knock down of NEAT1 in neither MCF7 nor 
BT474 cells, changed the activity of mTOR as assessed by Thr389 p70S6K phosphorylation 
(FIG. 3B).  
 
AMPK is activated in NEAT1-depleted cells  
AMPK is a central kinase in the regulation of cellular metabolism. Upon nutrient starvation and 
different cellular stressors that interfere with ATP production, AMPK is activated which in turn 
elicits autophagy by both inactivating mTORC1 and by directly activating ULK1 through 
phosphorylation of Serine 317 (Ser317) and Serine 555 (Ser555)51,57. To investigate the 
activation of AMPK in NEAT1-silenced cells, we first determined the phosphorylation status 
of Threonine 172 (Thr72) that is critical for AMPK catalytic activity. NEAT1-depletion indeed 
increased the phosphorylation of Thr172 in MCF7 cells (FIG. 4A). We next analysed if the 
increased phosphorylation of AMPK is accompanied by increased phosphorylation of Ser317 
and Ser555 of ULK1. Importantly, NEAT1 knock down enhanced both ULK1 Ser317 and 
ULK1 555 phosphorylation (FIG4B). Taken together, our data suggest that AMPK activity is 
increased in cells as a consequence of reduced NEAT1 expression and that this leads to the 
activation of ULK1 and autophagy.      
 
DISCUSSION 
The long non-coding RNA NEAT1 has emerged as an important regulator of gene expression 
in cellular stress and at certain developmental stages13,17,20–27. NEAT1 expression is activated 
by a wide variety of cellular stressors including hypoxia, heat shock, genotoxic and 
mitochondrial stress10–17. Such stressors can cause serious damage on proteins, DNA, and 
organelles45. To counteract this, the autophagic machinery will be activated in cells to degrade 
dysfunctional macromolecules and organelles, and recycle their components. This prompted us 
to investigate whether NEAT1 is involved in the regulation of autophagy.  Here, we have shown 
that NEAT1-depletion leads to increased formation of LC3B-containing punctas and 
accumulation of the lipidated LC3B-II form in in two different breast cancer cell lines. LC3B-
II continues to accumulate in NEAT1 knockdown cells after inhibiting lysosomal acidification 
and degradation with bafilomycin A1. This indicates that on-rate of autophagy is increased. In 
line with this, we report that the AMPK is activated in NEAT1-depleted cells as measured by 
increased phosphorylation of Serine 172. This is accompanied by increased phosphorylation of 
Serine 555 and Serine 317 of ULK1, which is required for its activation and induction of 
autophagy.  
NEAT1 and paraspeckles have recently been shown to be essential for mitochondrial 
homeostasis27. Wang et al. showed that NEAT1-depletion led to formation of elongated 
mitochondria through a mechanism where the expression and activity of dynamin-related 
protein 1 (DRP1), a protein required for mitochondrial fission, were inhibited. Increased 
autophagy is in many cases known to be followed by mitochondrial elongation58,59. Therefore, 
the formation of elongated mitochondria upon NEAT1 knockout could be a direct consequence 
of increased basal autophagy in the cells. Elongated mitochondria are less prone to be degraded 
by autophagy (mitophagy) and are more efficient in producing ATP, implicating that this is an 
immediate cellular defence mechanism to preserve the mitochondrial functions and avoid cell 
death58,59. However, in the study mentioned above, Wang et al demonstrated that NEAT1-
depletion resulted in reduced respiration and ATP production in the cells, indicating that even 
though the mitochondria had elongated, they were highly dysfunctional. As the AMP-activated 
protein kinase (AMPK) is directly activated when the ATP to AMP ratio drops, it is reasonable 
to assume that dysfunctional mitochondria in NEAT1-depleted cells will lead to AMPK 
activation and induction of autophagy. Generally, AMPK has a central role in regulating 
mitochondrial dynamics and biogenesis, and is activated by agents interfering with 
mitochondrial functions60. In the future, it will indeed be important to analyse if reduced NEAT1 
expression is accompanied by induced mitophagy and further experiments should be 
undertaken to dissect the intricate crosstalk between NEAT1, mitochondrial functions, AMPK 
and autophagy. 
Recently, it was reported that NEAT1-depleted MCF7 cells undergo replication stress and 
display increased levels of -H2A.X, a histone marker of DNA damage14.  Moreover, compared 
to wild type mice, Neat1 knockout mice displayed prolonged accumulation of DNA damages 
upon exposure to the carcinogenic compound DMBA. This was accompanied by enhanced 
stabilization of p53. Accumulation of p53 is known to induce autophagy at least partially by 
activating AMPK61,62. This indicates that NEAT1-depletion could result in accumulation of wild 
type (MCF7) or mutant (BT474) p53 that subsequently induces autophagy. 
We show that LC3B-II in NEAT1 knockdown cells continues to accumulate after 
inhibiting lysosomal activity with bafilomycin B. This made us hypothesize that the on-rate of 
autophagy is increased in NEAT1-depleted cells, which is further supported by AMPK activity 
being enhanced in NEAT1 silenced cells.  Upon induction of autophagy, selective autophagy 
receptors including p62, will bind to ubiquitinated cargo and bring it to the developing 
phagophore by binding to LC3B and other ATG8 members via a LC3-interacting region 
(LIR)56. As p62 is degraded with the cargo in the autolysosome, enhanced autophagy is often 
accompanied with a reduction in p62 protein levels. Here, we show that NEAT1-depletion does 
not lead to reduction, but rather slight accumulation, of p62 protein levels. This might indicate 
that NEAT1 expression is required for normal lysosomal activity. Alternatively, NEAT1 knock 
down might upregulate the expression of the gene encoding p62, SQSTM1. The transcription 
of the SQSTM1 gene has been shown to activated by the transcription factor Nrf263. Nrf2 has a 
key role in eliciting a cytoprotective response to oxidative stress caused by excess formation of 
reactive oxygen species64. As NEAT1-depletion is known to seriously interfere with 
mitochondrial functions, it is reasonable to assume that ROS levels are increased in NEAT1 
knockdown cells. Whether Nrf2 activity and SQSTM1 transcription are elevated in NEAT1-
deficient cells, remain to be determined.  
The long NEAT1_2 isoform is essential for the assembly of paraspeckles. More than 40 
proteins have been demonstrated to localize to paraspeckles5–8. It is therefore logical to envision 
that NEAT1-depletion will lead to mislocalization of paraspeckle proteins. Importantly, 
mislocalization of two paraspeckle-associated proteins, TAR DNA-binding protein 43 (TDP-
43) and fused in sarcoma (FUS), is associated with serious neurodegenerative diseases30,41,42. 
Both proteins are prone to form aggregates in the cytoplasm, which will elicit autophagy in 
order to get them removed65. Thus, it is likely that protein mislocalization upon NEAT1 
deficiency can trigger the autophagic machinery.  
NEAT1 expression is induced by a wide variety of stressors. Emerging evidence 
suggests that NEAT1 and paraspeckle are required to preserve and protect macromolecules and 
organelles, including DNA, proteins and mitochondria, upon stress. We hypothesize that when 
NEAT1 expression is repressed under such conditions, accumulation of damaged 
macromolecules and organelles will trigger autophagy. The link between NEAT1 and 
autophagy should be further studied in human diseases like cancer and neurodegenerative 








Cell culture and treatment 
MCF7 (ATCC® HTB-22™) and BT-474 (ATCC® HTB-20™) were obtained from the 
American Type Culture Collection (ATCC) and maintained in the humidified atmosphere at 
37°C with 5% CO2. MCF7 cells were cultured in minimal essential medium (MEM, Sigma-
Aldrich), and BT474 cells were cultured in Roswell Park Memorial Institute 1640 (RPMI1640, 
Sigma-Aldrich). Both media were supplemented with 10% fetal bovine serum (Biochrom, 
Merck) and 1% penicillin-streptomycin (Sigma-Aldrich). Insulin (0.01mg/ml, Sigma-Aldrich) 
was added to MCF7 culture media. Bafilomycin A1 (BafA1) was purchased from Santa Cruz 
Biotechnology and was added to the cells at a final concentration of 200nM. Hank's Balanced 
Salt Solution (HBSS) was purchased from Sigma, and were used for the starvation of cells. To 
remove all the supplementary nutrition, cells were washed two times with HBSS and then 
incubated in HBSS for specific time points. Experiments on MCF7 were performed when cells 
were between passage 10-30. Cells were tested regularly for mycoplasma. 
 
RNA interference 
Locked nucleic acid (LNA)-GapmeR NEAT1 antisense oligos and control GapmeRs were 
purchased from Qiagene (Table 1). Cells were transfected using Lipofectamine 2000 according 
to the reverse transfection protocol provided by the manufacturer (ThermoFisher Scientific) 
and generally left for 48 hours. Successful knockdown was verified by RT-qPCR.   
 
Reverse transcription and quantitative PCR 
Total RNA was extracted using Direct-zol RNA Miniprep (Zymo Research) according to the 
manufacturer's instruction, and RNA concentration was measured by NanoDrop 2000 (Thermo 
Fisher Scientific). The reverse Transcription (RT) was carried out with the SuperScript™ IV 
Reverse Transcriptase (Thermo Fisher Scientific), following the manufacturer 
recommendations. The quantitative polymerase chain reaction was performed with SYBR 
green reaction mix FastStart Essential DNA Green Master (Roche Life Science) 
using LightCycler 96 (Roche Life Science). 2.5ul of 10 times diluted cDNA was mixed by 
0.25uM of forward and reverse primer in combination with 5ul of SYBR green with the 
following thermal cycle conditions: 95°C 10 minutes and 40 cycles of 95°C 10 seconds, 60°C 
10 seconds and 72°C for 10 seconds. All the primer sequences are provided in Table 1. All the 
experiments were done at least in triplicates. GAPDH was used as reference gene for 
normalization. Data are shown in fold change using ΔΔCq method. 
 
Immunoblotting  
Cells were lysed in 2% SDS, 10% glycerol, and 50mM Tris-HCl, pH 6.8. Protein concentration 
was measured using Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific) according to 
manufacturer’s recommendation. Equal amount of proteins was loaded (20 ug or 30 ug 
depending on the antibody), and proteins were resolved on SDS-PAGE gels and transferred to 
nitrocellulose membranes. Nitrocellulose membranes were blocked with Odyssey® Blocking 
Buffer (PBS) or Odyssey® Blocking Buffer (TBS) (ULK1 antibodies). Both blocking buffers 
were purchased from LI-COR Biosciences. The following primary antibodies were used at 
1:1000 dilution and purchased from Cell Signaling Technology: Rabbit mAb anti-phospho-
AMPK⍺ (Thr172)(40H9) (cat# 2535), Rabbit mAb anti-AMPK⍺ (D63G4) (cat# 5832), Rabbit 
mAb anti-p70 S6 kinase (cat# 9202), Rabbit mAb anti-phospho-p70S6 kinase (Thr 389)( cat# 
9205), Rabbit mAb anti-phospho-ULK1 (Ser555) (D1H4) (cat# 5869). The following 
antibodies were diluted 1:400: Rabbit mAb anti-phospho-ULK1 (Ser 317) (cat# 6887), and 
Rabbit mAb anti-ULK1 (D8H5) (cat# 8054).  Rabbit mAb anti-LC3B was purchased from 
Sigma (1:1000, cat# L7543). Mouse monoclonal anti-p62-LCK was obtained from BD-
bioscience (1:1000, cat# 610833), and Mouse monoclonal anti-Actin was from Millipore 
(1:1000, cat# MAB1501). IRDye®-conjugated secondary antibodies (LI-COR Biosciences) 
was used in a dilution of 1: 10 000 for both goat anti-Rabbit (800CW, cat# 926-32211) and goat 




Cells were seeded on coverslips and fixed and permeabilized in cold (-20) methanol for 10 
minutes. Cells were washed with cold PBS three times and blocked with 2% bovine serum 
(BSA, prepared in PBS-Tween (0.1%)) for 10 minutes at room temperature. Next, cells were 
incubated with anti-LC3-B antibody for 90 minutes (1:400, Sigma, cat# L7543), and then 
incubated with goat anti-rabbit Alexa 488-conjugated secondary antibody (1:1000, Thermo 
Fisher Scientific, cat# A11070) for 45 minutes. Both primary and secondary antibodies were 
diluted in PBST containing 2% BSA. Following extensive washing, coverslips were mounted 
using Vectashield® Antifade Mounting Medium containing DAPI (Vector Laboratories, H-
1200). All images were acquired by Zeiss LSM780 confocal microscope (Carl Zeiss 
Microscopy GmbH, Jena, Germany) using 63x magnification. To take the picture, middle Z 
slice was positioned at DAPI’s best focus, and in total, five slices were imaged with a total high 
of 2.5μm. All the samples were treated similarly, and the same settings were used for all of the 
study groups. At least ten random positions were chosen from each coverslip, and pictures were 
analyzed by the Volocity software (PerkinElmer, version 6.3). Each experiment was performed 





Statistical analyses were done using unpaired Student’s t-Test using the GraphPad software 
(Prism version 7, Mac OS X). P-values <0.05 were defined as statistically significant, and for 
all experiment’s significance is expressed as ***, p ≤ 0.001, **, p ≤ 0.01, and *, p ≤ 0.05. All 
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FIGURE 1. NEAT1-depletion leads to accumulation of lipidated LC3B and formation of 
autophagosomes. A, MCF7 cells were transfected with NEAT1 antisense oligos targeting both 
isoforms of NEAT1, or a negative control oligo. Twenty-four h post-transfection, cells were 
either left untreated or treated with SFN (10µM) for 24 h. LC3B-I and II expression was 
determined by immunoblot analyses. The intensities of the specific signals/bands were 
measured by the Odyssey® Infrared Imaging System and relative values to non-transfected 
cells are shown. Equal loading was verified by re-probing the membranes with an anti-actin 
antibody. B, MCF7 cells were transfected with NEAT1 antisense oligos or a negative control 
oligo. After 48 h, cells were fixed and stained with an anti-LC3B antibody. DAPI was used to 
visualize the nuclei. The number of LC3B-punctas per cell and volume of each puncta/volume 
of the cell were measured in at least 160 cells by the Volocity software. Scale bar, 10 µM. P 
values were calculated using student’s T-test with p < 0.05 considered statistically significant. 
(***, p ≤ 0.001). C, MCF7 cells were transfected with two different sets of NEAT1 antisense 
oligoes (NEAT1 kd #1 and NEAT1 kd #2)  and the expression of LC3B-I and II was determined 
by immunoblot analyses.  Membranes were re-probed with an anti-actin antibody.  
 
FIGURE 2. NEAT1-depletion induces autophagy. A, MCF7 cells were transfected with 
NEAT1 antisense oligos or control oligos. After 48 h, cells were left untreated or treated with 
200 nM bafilomycin A1 (BafA1) for 4 h.  LC3B-I and II expression were measured by 
immunoblot analyses. Membranes were re-probed with an anti-actin antibody to verify equal 
loading. B, MCF7 cells were transfected and treated as in A and stained with an anti-LC3B 
antibody. The number of LC3B-punctas and volume of each dot/volume of the cell were 
measured by the Volocity software in at least 160 cells. Scale bar, 10 µM. P values were 
calculated using student’s T-test with p < 0.05 considered statistically significant (**, p ≤ 0.01, 
*p, ≤ 0.05). C, p62 expression in the same samples as described in A, was determined by 
immunoblot analyses.  D, The experiments described in A, and C, were repeated in BT474 cells. 
 
FIGURE 3. mTOR activity is not affected by NEAT1 depletion. A, MCF7 cells were grown 
in full media or starved in HBSS for 4 hours. The phosphorylation status of Threonine 389 of 
p70S6K and total p70S6K expression were determined by immunoblotting. Membranes were 
re-probed with an anti-actin antibody to verify equal loading. B, BT474 and MCF7 cells were 
transfected with NEAT1 antisense oligos or control oligos. Phosphorylation of Thr389 and total 
p70S6K levels were determined by immunoblot analyses. 
 
FIGURE 4. AMPK is activated in NEAT1-depleted A, NEAT1 was knocked down in MCF7 
and the phosphorylation status of Threonine 172 within AMPK and total AMPK expression, 
were analysed by immunoblotting. B, The phosphorylation status of Serine 317 and Serine 555 
in ULK1, as well as total ULK1 expression, were determined by immunoblot analyses using 
anti-phospho-Ser317 ULK1, anti-phospho-Ser555 ULK1, and anti-ULK1 antibodies, 
respectively. Equal loading was verified by re-probing the membranes with an anti-actin 
antibody.  
 
Supplementary 1. NEAT1 knockdown efficiency in MCF7 cells. MCF7 cells were 
transfected with LNA-gapmeR NEAT1 antisense oligos for 24 hours. NEAT1 and NEAT1_2 
expression was determined by RT-qPCR. The mean value ± SD of three biological replicates 
are shown and presented as fold change relative to Ctrl cells. 
 
 
Table 1.  Primer and ASO sequences 










Name Antisense LNA GapmeR Standard 
NEAT1- #1 
TAAGCACTTTGGAAAG 
 (described in ref 13) 
NEAT1_2- #1 
CTCACACGTCCATCT 
(described in ref 13) 
NEAT1- #2 TGTGGCATCAACGTTA 
NEAT1_2- #2 GAAAGTCATCGCAAGT 
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